*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 78 ASP~? 6.31 CL CL A 305 A 86 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 250 ALA A 26 ALA~? 3.84 OH4 1PE A 311 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 25.71 9.07 -1.28 24.93 9.58 0.62 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 24.25 11.32 4.20 23.54 9.34 4.43 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 19.35 16.64 2.62 20.12 17.75 1.91 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 78 ASP~? 6.31 CL CL A 305 A 86 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 250 ALA A 40 ALA^? 3.90 CL CL A 305 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 25.71 9.07 -1.28 24.93 9.58 0.62 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 24.25 11.32 4.20 23.54 9.34 4.43 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 17.79 5.14 6.68 17.95 6.32 5.72 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 86 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 250 ALA B 26 ALA~? 10.59 CL CL B 309 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 6.34 -17.54 11.68 6.25 -18.99 12.16 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 3 hits 2wwt_o00 naa= 3 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 A 98 SER A 59 SER^? 3.89 CL CL A 305s A 123 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 172 ASP A 78 ASP~? 6.31 CL CL A 305 coo 45.74 29.80 42.79 47.58 31.06 41.64 24.86 2.91 6.28 24.83 4.11 4.27 coo 44.17 25.61 37.60 45.21 25.56 35.81 24.25 11.32 4.20 23.54 9.34 4.43 coo 39.85 24.35 34.94 41.12 25.58 33.83 25.71 9.07 -1.28 24.93 9.58 0.62 3qwd_o00 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o00 naa= 3 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 1 4 # 1 A 61 ASP A 88 ASP^? 16.22 CL CL A 305 M 206 SER A -1 SER.? 8.59 ZN ZN A 303 M 210 ARG A 36 ARG.? -4.82 ZN ZN A 303s M 214 ASN A 35 ASN.? -3.83 C1 CAC A 313s coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 3.33 0.99 -6.09 2.94 -0.67 -7.87 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 9.84 7.66 -4.50 9.21 7.51 -7.47 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 5.46 9.42 0.51 4.48 8.02 1.68 1c17_c11 source 1c17 ATP SYNTHASE SUBUNIT C : 1 hits 1c17_c11 naa= 4 ULMN 4 1d3g_c01 DIHYDROOROTATE DEHYDROGENASE user 1 4 # 1 A 149 PHE A 56 PHE^? 7.07 CL CL A 307 A 215 SER A 59 SER^? 3.89 CL CL A 305s A 218 THR A 57 THR^? 10.92 CL CL A 307 A 255 LYS B 96 LYS.? 11.54 CL CL A 306 coo 44.60 28.41 9.39 42.46 29.45 10.83 28.85 5.55 12.29 27.69 7.22 14.19 coo 38.32 30.82 8.35 40.14 29.77 7.21 24.86 2.91 6.28 24.83 4.11 4.27 coo 39.65 24.77 7.41 41.19 24.89 8.93 30.98 0.89 9.38 30.52 -0.91 10.45 coo 36.63 36.86 14.86 40.52 38.40 10.14 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 4 1d3g_c01 DIHYDROOROTATE DEHYDROGENASE user 2 4 # 2 A 149 PHE B 56 PHE^? 6.57 CL CL B 310 A 215 SER B 59 SER^? 3.99 CL CL B 308s A 218 THR B 57 THR^? 10.93 CL CL B 310 A 255 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo 44.60 28.41 9.39 42.46 29.45 10.83 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 38.32 30.82 8.35 40.14 29.77 7.21 17.09 -11.30 2.44 17.22 -12.60 4.35 coo 39.65 24.77 7.41 41.19 24.89 8.93 19.99 -13.42 -3.76 20.40 -11.62 -4.84 coo 36.63 36.86 14.86 40.52 38.40 10.14 8.76 -5.89 1.16 6.19 -2.58 4.65 1d3g_c01 source 1d3g DIHYDROOROTATE DEHYDROGENASE : 2 hits 1d3g_c01 naa= 4 ULMN 4 1d8h_c02 MRNA TRIPHOSPHATASE CET1 user 1 4 # 1 C 393 ARG A 36 ARG.? -4.82 ZN ZN A 303s C 433 GLU A 66 GLU.? -2.36 ZN ZN A 303s C 456 LYS A 29 LYS~? -2.69 OH6A1PE A 311s C 458 ARG A 27 ARG~? 9.04 CL CL A 305 coo 5.89 19.72 74.11 3.89 22.05 73.98 9.84 7.66 -4.50 9.21 7.51 -7.47 coo 2.64 24.82 79.60 2.66 26.04 77.84 11.68 6.52 -11.11 9.60 6.56 -10.92 coo 2.79 21.47 64.30 3.04 22.87 68.57 14.86 14.41 3.43 16.20 19.44 6.35 coo -0.70 27.77 67.44 -0.05 25.34 69.46 21.75 13.08 -2.42 22.26 10.12 -3.14 1d8h_c02 source 1d8h MRNA TRIPHOSPHATASE CET1 : 1 hits 1d8h_c02 naa= 4 ULMN 4 1odt_c00 CEPHALOSPORIN C DEACETYLASE user 1 4 # 1 C 181 ALA A 26 ALA~? 3.84 OH4 1PE A 311 C 182 GLN A 30 GLN~? 9.53 C14 1PE A 311 C 269 ASP A 78 ASP~? 6.31 CL CL A 305 C 298 HIS A 24 HIS~? 3.26 ZN ZN A 301s coo 19.41 78.76 44.53 18.61 79.22 45.75 19.35 16.64 2.62 20.12 17.75 1.91 coo 24.64 81.35 46.97 24.99 82.28 48.83 13.94 15.22 -2.67 15.06 15.53 -4.45 coo 10.40 79.73 42.00 12.16 80.19 43.16 25.71 9.07 -1.28 24.93 9.58 0.62 coo 13.42 79.87 46.31 15.44 80.29 45.93 24.25 11.32 4.20 23.54 9.34 4.43 ULMN 4 1odt_c00 CEPHALOSPORIN C DEACETYLASE user 2 4 # 2 C 181 ALA B 26 ALA~? 10.59 CL CL B 309 C 182 GLN B 30 GLN~? 15.63 CL CL B 309 C 269 ASP B 78 ASP~? 6.36 ZN ZN B 302 C 298 HIS B 24 HIS~? 3.28 ZN ZN B 302s coo 19.41 78.76 44.53 18.61 79.22 45.75 6.34 -17.54 11.68 6.25 -18.99 12.16 coo 24.64 81.35 46.97 24.99 82.28 48.83 7.17 -14.18 18.22 5.46 -14.21 19.36 coo 10.40 79.73 42.00 12.16 80.19 43.16 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 13.42 79.87 46.31 15.44 80.29 45.93 11.77 -17.25 6.59 12.69 -15.38 6.18 1odt_c00 source 1odt CEPHALOSPORIN C DEACETYLASE : 2 hits 1odt_c00 naa= 4 ULMN 4 1odt_c01 CEPHALOSPORIN C DEACETYLASE user 1 4 # 1 H 181 ALA A 26 ALA~? 3.84 OH4 1PE A 311 H 182 GLN A 30 GLN~? 9.53 C14 1PE A 311 H 269 ASP A 78 ASP~? 6.31 CL CL A 305 H 298 HIS A 24 HIS~? 3.26 ZN ZN A 301s coo 17.71 105.28 65.69 16.95 104.75 64.54 19.35 16.64 2.62 20.12 17.75 1.91 coo 23.16 103.35 63.17 23.71 102.54 61.29 13.94 15.22 -2.67 15.06 15.53 -4.45 coo 8.91 102.95 68.35 10.66 102.77 67.10 25.71 9.07 -1.28 24.93 9.58 0.62 coo 11.89 103.25 63.94 13.96 103.24 64.24 24.25 11.32 4.20 23.54 9.34 4.43 ULMN 4 1odt_c01 CEPHALOSPORIN C DEACETYLASE user 2 4 # 2 H 181 ALA B 26 ALA~? 10.59 CL CL B 309 H 182 GLN B 30 GLN~? 15.63 CL CL B 309 H 269 ASP B 78 ASP~? 6.36 ZN ZN B 302 H 298 HIS B 24 HIS~? 3.28 ZN ZN B 302s coo 17.71 105.28 65.69 16.95 104.75 64.54 6.34 -17.54 11.68 6.25 -18.99 12.16 coo 23.16 103.35 63.17 23.71 102.54 61.29 7.17 -14.18 18.22 5.46 -14.21 19.36 coo 8.91 102.95 68.35 10.66 102.77 67.10 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 11.89 103.25 63.94 13.96 103.24 64.24 11.77 -17.25 6.59 12.69 -15.38 6.18 1odt_c01 source 1odt CEPHALOSPORIN C DEACETYLASE : 2 hits 1odt_c01 naa= 4 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 2 TYR^? -4.58 O2 CAC A 313s B 190 LYS A 92 LYS^? 11.11 CL CL B 310 B 222 ASP B 47 ASP.? 11.08 ZN ZN A 303 coo 7.17 16.59 41.26 8.01 19.20 40.73 10.20 -0.74 -0.90 7.99 0.53 0.19 coo 13.38 20.00 35.06 11.43 22.49 39.53 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 9.76 26.58 38.10 11.63 25.78 38.76 15.08 -4.94 -11.66 14.38 -3.13 -10.90 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR A 3 TYR^? 10.95 ZN ZN A 303 B 190 LYS A 95 LYS.? 9.36 CL CL B 309 B 222 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 7.17 16.59 41.26 8.01 19.20 40.73 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 13.38 20.00 35.06 11.43 22.49 39.53 10.49 -7.40 -1.88 7.13 -10.96 -4.27 coo 9.76 26.58 38.10 11.63 25.78 38.76 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 140 TYR B 2 TYR^? 13.50 CL CL A 306 B 190 LYS B 92 LYS^? 11.01 CL CL A 307 B 222 ASP A 47 ASP.? 12.21 O1 PEG B 312 coo 7.17 16.59 41.26 8.01 19.20 40.73 15.58 -0.36 14.99 13.00 0.51 15.42 coo 13.38 20.00 35.06 11.43 22.49 39.53 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 9.76 26.58 38.10 11.63 25.78 38.76 26.48 -3.27 20.58 24.45 -3.78 20.72 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 140 TYR B 3 TYR^? 11.16 C1 PEG B 312 B 190 LYS B 95 LYS.? 9.10 CL CL A 306 B 222 ASP A 48 ASP.? -15.94 CL CL A 307s coo 7.17 16.59 41.26 8.01 19.20 40.73 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 13.38 20.00 35.06 11.43 22.49 39.53 20.80 3.86 14.18 20.78 8.31 16.72 coo 9.76 26.58 38.10 11.63 25.78 38.76 26.96 2.23 21.50 26.58 3.74 22.88 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 4 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 92 LYS^? 11.11 CL CL B 310 A 222 ASP B 47 ASP.? 11.08 ZN ZN A 303 B 140 TYR A 2 TYR^? -4.58 O2 CAC A 313s coo -4.61 20.12 30.34 -2.74 22.65 25.95 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo -1.04 26.60 27.37 -2.94 25.93 26.69 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 1.51 16.60 24.17 0.82 19.23 24.79 10.20 -0.74 -0.90 7.99 0.53 0.19 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS A 95 LYS.? 9.36 CL CL B 309 A 222 ASP B 48 ASP.? 14.63 ZN ZN A 303 B 140 TYR A 3 TYR^? 10.95 ZN ZN A 303 coo -4.61 20.12 30.34 -2.74 22.65 25.95 10.49 -7.40 -1.88 7.13 -10.96 -4.27 coo -1.04 26.60 27.37 -2.94 25.93 26.69 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 1.51 16.60 24.17 0.82 19.23 24.79 15.55 -0.59 -5.31 14.15 -1.10 -7.68 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 190 LYS B 92 LYS^? 11.01 CL CL A 307 A 222 ASP A 47 ASP.? 12.21 O1 PEG B 312 B 140 TYR B 2 TYR^? 13.50 CL CL A 306 coo -4.61 20.12 30.34 -2.74 22.65 25.95 25.00 -4.81 12.30 28.64 -2.55 7.65 coo -1.04 26.60 27.37 -2.94 25.93 26.69 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 1.51 16.60 24.17 0.82 19.23 24.79 15.58 -0.36 14.99 13.00 0.51 15.42 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 190 LYS B 95 LYS.? 9.10 CL CL A 306 A 222 ASP A 48 ASP.? -15.94 CL CL A 307s B 140 TYR B 3 TYR^? 11.16 C1 PEG B 312 coo -4.61 20.12 30.34 -2.74 22.65 25.95 20.80 3.86 14.18 20.78 8.31 16.72 coo -1.04 26.60 27.37 -2.94 25.93 26.69 26.96 2.23 21.50 26.58 3.74 22.88 coo 1.51 16.60 24.17 0.82 19.23 24.79 20.49 -5.14 16.12 21.33 -4.29 18.62 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 4 hits 1a05_c01 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 17 ARG~? -3.60 CL CL A 307s 265 HIS A 24 HIS~? 3.26 ZN ZN A 301s 274 TYR B 2 TYR^? 13.50 CL CL A 306 coo -15.18 55.46 8.55 -14.82 52.98 10.38 29.80 8.18 9.40 27.73 6.82 7.62 coo -14.48 45.59 11.18 -14.02 47.49 10.42 24.25 11.32 4.20 23.54 9.34 4.43 coo 0.94 52.26 9.16 1.95 54.78 9.91 15.58 -0.36 14.99 13.00 0.51 15.42 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG B 17 ARG~? -3.61 CL CL B 310s 265 HIS B 24 HIS~? 3.28 ZN ZN B 302s 274 TYR A 2 TYR^? -4.58 O2 CAC A 313s coo -15.18 55.46 8.55 -14.82 52.98 10.38 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo -14.48 45.59 11.18 -14.02 47.49 10.42 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 0.94 52.26 9.16 1.95 54.78 9.91 10.20 -0.74 -0.90 7.99 0.53 0.19 1a41_c01 source 1a41 TOPOISOMERASE I : 2 hits 1a41_c01 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 86 TYR^? 7.10 CL CL A 305 A 125 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 156 LYS A 16 LYS~? 15.92 CL CL A 307 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 29.34 5.60 1.24 26.89 6.10 2.52 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 24.25 11.32 4.20 23.54 9.34 4.43 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 2 3 # 2 A 115 TYR B 86 TYR^? 6.73 CL CL B 310 A 125 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 156 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 14.27 -25.10 0.23 14.58 -27.01 3.12 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR A 86 TYR^? 7.10 CL CL A 305 B 125 HIS A 24 HIS~? 3.26 ZN ZN A 301s B 156 LYS A 16 LYS~? 15.92 CL CL A 307 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 29.34 5.60 1.24 26.89 6.10 2.52 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 24.25 11.32 4.20 23.54 9.34 4.43 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 2 3 # 2 B 115 TYR B 86 TYR^? 6.73 CL CL B 310 B 125 HIS B 24 HIS~? 3.28 ZN ZN B 302s B 156 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 14.27 -25.10 0.23 14.58 -27.01 3.12 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c01 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR A 86 TYR^? 7.10 CL CL A 305 C 125 HIS A 24 HIS~? 3.26 ZN ZN A 301s C 156 LYS A 16 LYS~? 15.92 CL CL A 307 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 29.34 5.60 1.24 26.89 6.10 2.52 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 24.25 11.32 4.20 23.54 9.34 4.43 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 2 3 # 2 C 115 TYR B 86 TYR^? 6.73 CL CL B 310 C 125 HIS B 24 HIS~? 3.28 ZN ZN B 302s C 156 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 14.27 -25.10 0.23 14.58 -27.01 3.12 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c02 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 86 TYR^? 7.10 CL CL A 305 D 125 HIS A 24 HIS~? 3.26 ZN ZN A 301s D 156 LYS A 16 LYS~? 15.92 CL CL A 307 coo 54.10 1.42 85.16 54.14 4.17 85.62 29.34 5.60 1.24 26.89 6.10 2.52 coo 61.27 5.43 85.32 62.73 6.38 86.49 24.25 11.32 4.20 23.54 9.34 4.43 coo 60.28 4.62 76.00 58.35 6.41 80.65 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 2 3 # 2 D 115 TYR B 86 TYR^? 6.73 CL CL B 310 D 125 HIS B 24 HIS~? 3.28 ZN ZN B 302s D 156 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 54.10 1.42 85.16 54.14 4.17 85.62 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 61.27 5.43 85.32 62.73 6.38 86.49 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 60.28 4.62 76.00 58.35 6.41 80.65 14.27 -25.10 0.23 14.58 -27.01 3.12 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c03 naa= 3 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 1 3 # 1 44 LYS B 96 LYS.? 11.54 CL CL A 306 141 HIS A 0 HIS.? -3.23 ZN ZN A 303s 333 ARG A 36 ARG.? -4.82 ZN ZN A 303s coo 69.56 26.03 31.04 72.53 30.39 31.84 17.33 4.64 12.77 13.37 4.64 15.16 coo 85.95 39.62 33.57 84.70 40.34 35.09 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 87.31 36.08 32.89 89.57 36.58 34.95 9.84 7.66 -4.50 9.21 7.51 -7.47 1aa6_c01 source 1aa6 FORMATE DEHYDROGENASE H : 1 hits 1aa6_c01 naa= 3 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 1 3 # 1 142 TRP A 74 TRP~? 8.77 CL CL A 305 223 ASP A 73 ASP~? 14.36 ZN ZN A 303 258 LYS A 92 LYS^? 11.11 CL CL B 310 coo 127.19 33.46 26.14 126.78 36.79 28.15 18.76 9.45 -4.73 19.86 8.05 -1.25 coo 126.95 41.66 23.38 128.48 40.72 24.51 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 138.83 37.95 25.17 133.50 36.37 26.52 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 2 3 # 2 142 TRP B 74 TRP~? 9.22 CL CL B 308 223 ASP B 73 ASP~? 8.36 C1 PEG B 312 258 LYS B 92 LYS^? 11.01 CL CL A 307 coo 127.19 33.46 26.14 126.78 36.79 28.15 14.76 -14.11 16.53 14.47 -13.16 12.72 coo 126.95 41.66 23.38 128.48 40.72 24.51 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 138.83 37.95 25.17 133.50 36.37 26.52 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 3 3 # 3 142 TRP B 74 TRP~? 9.22 CL CL B 308 223 ASP B 78 ASP~? 6.36 ZN ZN B 302 258 LYS B 29 LYS~? 10.16 CL CL B 309 coo 127.19 33.46 26.14 126.78 36.79 28.15 14.76 -14.11 16.53 14.47 -13.16 12.72 coo 126.95 41.66 23.38 128.48 40.72 24.51 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 138.83 37.95 25.17 133.50 36.37 26.52 5.16 -12.71 12.47 1.26 -15.97 8.59 1aam_c01 source 1aam ASPARTATE AMINOTRANSFERASE : 3 hits 1aam_c01 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 73 ASP~? 14.36 ZN ZN A 303 214 ASP A 47 ASP.? 12.21 O1 PEG B 312 289 ASP A 78 ASP~? 6.31 CL CL A 305 coo -0.62 65.95 29.97 0.31 67.47 31.05 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 26.86 59.76 46.36 25.42 58.23 45.92 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 9.42 68.07 30.27 7.35 68.27 30.10 25.71 9.07 -1.28 24.93 9.58 0.62 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 73 ASP~? 14.36 ZN ZN A 303 214 ASP A 48 ASP.? -15.94 CL CL A 307s 289 ASP A 78 ASP~? 6.31 CL CL A 305 coo -0.62 65.95 29.97 0.31 67.47 31.05 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 26.86 59.76 46.36 25.42 58.23 45.92 26.96 2.23 21.50 26.58 3.74 22.88 coo 9.42 68.07 30.27 7.35 68.27 30.10 25.71 9.07 -1.28 24.93 9.58 0.62 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 78 ASP~? 6.31 CL CL A 305 214 ASP B 73 ASP~? 8.36 C1 PEG B 312 289 ASP A 9 ASP^? 7.20 CL CL A 307 coo -0.62 65.95 29.97 0.31 67.47 31.05 25.71 9.07 -1.28 24.93 9.58 0.62 coo 26.86 59.76 46.36 25.42 58.23 45.92 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 9.42 68.07 30.27 7.35 68.27 30.10 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 73 ASP~? 8.36 C1 PEG B 312 214 ASP B 47 ASP.? 11.08 ZN ZN A 303 289 ASP B 78 ASP~? 6.36 ZN ZN B 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 26.86 59.76 46.36 25.42 58.23 45.92 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 9.42 68.07 30.27 7.35 68.27 30.10 16.87 -17.86 9.95 15.14 -17.20 8.90 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 73 ASP~? 8.36 C1 PEG B 312 214 ASP B 48 ASP.? 14.63 ZN ZN A 303 289 ASP B 78 ASP~? 6.36 ZN ZN B 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 26.86 59.76 46.36 25.42 58.23 45.92 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 9.42 68.07 30.27 7.35 68.27 30.10 16.87 -17.86 9.95 15.14 -17.20 8.90 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 78 ASP~? 6.36 ZN ZN B 302 214 ASP A 73 ASP~? 14.36 ZN ZN A 303 289 ASP B 9 ASP^? 7.08 CL CL B 310 coo -0.62 65.95 29.97 0.31 67.47 31.05 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 26.86 59.76 46.36 25.42 58.23 45.92 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 9.42 68.07 30.27 7.35 68.27 30.10 20.52 -16.92 -1.41 18.60 -16.56 -0.65 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 6 hits 1amy_c01 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 9 ASP^? 7.20 CL CL A 307 227 GLU A 82 GLU~? -16.67 C13 1PE A 311s 289 ASP A 88 ASP^? 16.22 CL CL A 305 coo -0.62 65.95 29.97 0.31 67.47 31.05 32.44 3.50 6.30 30.77 4.75 6.60 coo 3.96 55.76 41.24 4.83 57.69 41.17 33.07 14.53 -4.24 32.37 16.29 -5.09 coo 9.42 68.07 30.27 7.35 68.27 30.10 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 73 ASP~? 14.36 ZN ZN A 303 227 GLU A 34 GLU~? 9.95 C2 CAC A 313 289 ASP A 78 ASP~? 6.31 CL CL A 305 coo -0.62 65.95 29.97 0.31 67.47 31.05 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 3.96 55.76 41.24 4.83 57.69 41.17 10.18 12.55 -3.49 11.83 11.91 -4.60 coo 9.42 68.07 30.27 7.35 68.27 30.10 25.71 9.07 -1.28 24.93 9.58 0.62 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP B 9 ASP^? 7.08 CL CL B 310 227 GLU B 82 GLU~? -1.87 ZN ZN B 304s 289 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo -0.62 65.95 29.97 0.31 67.47 31.05 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 3.96 55.76 41.24 4.83 57.69 41.17 17.85 -26.45 10.11 16.17 -26.92 11.31 coo 9.42 68.07 30.27 7.35 68.27 30.10 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 73 ASP~? 8.36 C1 PEG B 312 227 GLU B 34 GLU~? 16.28 CL CL B 308 289 ASP B 78 ASP~? 6.36 ZN ZN B 302 coo -0.62 65.95 29.97 0.31 67.47 31.05 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 3.96 55.76 41.24 4.83 57.69 41.17 6.76 -9.82 20.52 8.48 -10.92 21.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 16.87 -17.86 9.95 15.14 -17.20 8.90 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 78 ASP~? 6.36 ZN ZN B 302 227 GLU B 22 GLU~? 10.35 CL CL B 309 289 ASP B 9 ASP^? 7.08 CL CL B 310 coo -0.62 65.95 29.97 0.31 67.47 31.05 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 3.96 55.76 41.24 4.83 57.69 41.17 3.91 -22.17 5.69 2.98 -20.35 5.17 coo 9.42 68.07 30.27 7.35 68.27 30.10 20.52 -16.92 -1.41 18.60 -16.56 -0.65 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 78 ASP~? 6.36 ZN ZN B 302 227 GLU B 34 GLU~? 16.28 CL CL B 308 289 ASP B 73 ASP~? 8.36 C1 PEG B 312 coo -0.62 65.95 29.97 0.31 67.47 31.05 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 3.96 55.76 41.24 4.83 57.69 41.17 6.76 -9.82 20.52 8.48 -10.92 21.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 21.44 -15.50 19.28 23.24 -15.58 20.39 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 6 hits 1amy_c06 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG B 27 ARG~? 9.37 CL CL B 308 B 342 ASP B 73 ASP~? 8.36 C1 PEG B 312 B 531 ARG B 36 ARG.? 14.37 CL CL B 308 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 12.55 -18.09 13.90 15.25 -16.65 13.55 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 10.68 -7.55 19.92 12.72 -9.80 19.82 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 1 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 21 ARG~? 8.34 C22 1PE A 311s A 342 ASP A 9 ASP^? 7.20 CL CL A 307 A 531 ARG A 27 ARG~? 9.04 CL CL A 305 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 25.14 13.51 10.69 25.11 15.00 13.42 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 32.44 3.50 6.30 30.77 4.75 6.60 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 21.75 13.08 -2.42 22.26 10.12 -3.14 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 1 hits 1asy_c01 naa= 3 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 A 140 TRP A 74 TRP~? 8.77 CL CL A 305 A 222 ASP A 73 ASP~? 14.36 ZN ZN A 303 A 258 LYS A 92 LYS^? 11.11 CL CL B 310 coo 89.83 15.40 0.01 90.61 18.86 1.71 18.76 9.45 -4.73 19.86 8.05 -1.25 coo 82.92 20.43 2.47 84.82 20.45 1.55 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 A 140 TRP A 74 TRP~? 8.77 CL CL A 305 A 222 ASP A 78 ASP~? 6.31 CL CL A 305 A 258 LYS A 29 LYS~? -2.69 OH6A1PE A 311s coo 89.83 15.40 0.01 90.61 18.86 1.71 18.76 9.45 -4.73 19.86 8.05 -1.25 coo 82.92 20.43 2.47 84.82 20.45 1.55 25.71 9.07 -1.28 24.93 9.58 0.62 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 14.86 14.41 3.43 16.20 19.44 6.35 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 A 140 TRP B 74 TRP~? 9.22 CL CL B 308 A 222 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 258 LYS B 29 LYS~? 10.16 CL CL B 309 coo 89.83 15.40 0.01 90.61 18.86 1.71 14.76 -14.11 16.53 14.47 -13.16 12.72 coo 82.92 20.43 2.47 84.82 20.45 1.55 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 5.16 -12.71 12.47 1.26 -15.97 8.59 1ay4_c02 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 3 hits 1ay4_c02 naa= 3 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 B 140 TRP A 74 TRP~? 8.77 CL CL A 305 B 222 ASP A 78 ASP~? 6.31 CL CL A 305 B 258 LYS A 29 LYS~? -2.69 OH6A1PE A 311s coo 103.45 44.39 16.20 102.66 41.02 14.32 18.76 9.45 -4.73 19.86 8.05 -1.25 coo 110.10 38.66 15.58 108.40 39.41 14.53 25.71 9.07 -1.28 24.93 9.58 0.62 coo 107.51 45.54 4.76 105.41 44.51 10.25 14.86 14.41 3.43 16.20 19.44 6.35 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 B 140 TRP B 74 TRP~? 9.22 CL CL B 308 B 222 ASP B 78 ASP~? 6.36 ZN ZN B 302 B 258 LYS B 29 LYS~? 10.16 CL CL B 309 coo 103.45 44.39 16.20 102.66 41.02 14.32 14.76 -14.11 16.53 14.47 -13.16 12.72 coo 110.10 38.66 15.58 108.40 39.41 14.53 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 107.51 45.54 4.76 105.41 44.51 10.25 5.16 -12.71 12.47 1.26 -15.97 8.59 1ay4_c03 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 2 hits 1ay4_c03 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 47 ASP.? 12.21 O1 PEG B 312 A 182 GLU A 49 GLU.? 12.26 CL CL A 306 A 286 ASN B 67 ASN~? 12.71 C1 PEG B 312 coo 26.03 44.66 108.90 25.67 42.61 108.82 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 18.06 44.02 105.38 18.08 45.37 107.03 21.20 3.66 19.03 19.27 4.46 18.88 coo 25.47 38.28 112.06 27.26 39.30 111.54 22.54 -6.70 23.21 22.14 -8.65 23.93 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP B 47 ASP.? 11.08 ZN ZN A 303 A 182 GLU B 49 GLU.? 12.07 C2 CAC A 313 A 286 ASN A 67 ASN~? 8.15 ZN ZN A 303 coo 26.03 44.66 108.90 25.67 42.61 108.82 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 18.06 44.02 105.38 18.08 45.37 107.03 7.03 -7.10 -6.90 6.04 -5.38 -6.16 coo 25.47 38.28 112.06 27.26 39.30 111.54 14.02 0.88 -12.67 14.89 2.62 -13.50 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 2 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 47 ASP.? 12.21 O1 PEG B 312 B 182 GLU A 49 GLU.? 12.26 CL CL A 306 B 286 ASN B 67 ASN~? 12.71 C1 PEG B 312 coo 13.82 69.26 132.27 11.87 70.14 132.51 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 8.74 63.05 136.42 9.87 62.19 134.79 21.20 3.66 19.03 19.27 4.46 18.88 coo 8.26 72.60 129.22 10.14 73.45 129.80 22.54 -6.70 23.21 22.14 -8.65 23.93 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP B 47 ASP.? 11.08 ZN ZN A 303 B 182 GLU B 49 GLU.? 12.07 C2 CAC A 313 B 286 ASN A 67 ASN~? 8.15 ZN ZN A 303 coo 13.82 69.26 132.27 11.87 70.14 132.51 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 8.74 63.05 136.42 9.87 62.19 134.79 7.03 -7.10 -6.90 6.04 -5.38 -6.16 coo 8.26 72.60 129.22 10.14 73.45 129.80 14.02 0.88 -12.67 14.89 2.62 -13.50 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 2 hits 1b57_c01 naa= 3 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 A 18 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 91 ARG A 17 ARG~? -3.60 CL CL A 307s A 129 SER A 59 SER^? 3.89 CL CL A 305s coo 24.39 47.01 49.70 26.42 47.04 49.21 24.25 11.32 4.20 23.54 9.34 4.43 coo 25.98 44.20 42.23 28.53 42.98 43.43 29.80 8.18 9.40 27.73 6.82 7.62 coo 30.00 49.76 45.68 28.73 48.72 47.47 24.86 2.91 6.28 24.83 4.11 4.27 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 A 18 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 91 ARG B 17 ARG~? -3.61 CL CL B 310s A 129 SER B 59 SER^? 3.99 CL CL B 308s coo 24.39 47.01 49.70 26.42 47.04 49.21 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 25.98 44.20 42.23 28.53 42.98 43.43 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo 30.00 49.76 45.68 28.73 48.72 47.47 17.09 -11.30 2.44 17.22 -12.60 4.35 1b6t_c00 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 2 hits 1b6t_c00 naa= 3 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 B 18 HIS A 24 HIS~? 3.26 ZN ZN A 301s B 91 ARG A 17 ARG~? -3.60 CL CL A 307s B 129 SER A 59 SER^? 3.89 CL CL A 305s coo 18.19 17.03 40.71 18.55 17.18 38.64 24.25 11.32 4.20 23.54 9.34 4.43 coo 25.60 21.10 38.54 23.57 20.93 36.25 29.80 8.18 9.40 27.73 6.82 7.62 coo 21.33 14.29 34.62 19.25 14.88 35.71 24.86 2.91 6.28 24.83 4.11 4.27 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 B 18 HIS B 24 HIS~? 3.28 ZN ZN B 302s B 91 ARG B 17 ARG~? -3.61 CL CL B 310s B 129 SER B 59 SER^? 3.99 CL CL B 308s coo 18.19 17.03 40.71 18.55 17.18 38.64 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 25.60 21.10 38.54 23.57 20.93 36.25 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo 21.33 14.29 34.62 19.25 14.88 35.71 17.09 -11.30 2.44 17.22 -12.60 4.35 1b6t_c01 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 2 hits 1b6t_c01 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 86 TYR^? 7.10 CL CL A 305 A 230 ASP A 88 ASP^? 16.22 CL CL A 305 A 273 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 9.23 21.44 106.88 10.18 19.34 105.31 29.34 5.60 1.24 26.89 6.10 2.52 coo 1.45 22.80 104.16 2.58 21.02 104.01 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 2.97 11.64 107.87 6.59 15.13 107.03 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR B 86 TYR^? 6.73 CL CL B 310 A 230 ASP B 88 ASP^? 4.66 O4 PEG B 312 A 273 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 9.23 21.44 106.88 10.18 19.34 105.31 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 1.45 22.80 104.16 2.58 21.02 104.01 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 2.97 11.64 107.87 6.59 15.13 107.03 23.06 -12.55 15.81 27.03 -9.57 14.36 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 86 TYR^? 7.10 CL CL A 305 B 230 ASP A 88 ASP^? 16.22 CL CL A 305 B 273 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 11.81 13.41 73.03 10.00 13.03 75.12 29.34 5.60 1.24 26.89 6.10 2.52 coo 19.17 11.01 76.14 17.26 10.42 76.77 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 11.10 2.31 76.60 10.24 7.24 75.62 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR B 86 TYR^? 6.73 CL CL B 310 B 230 ASP B 88 ASP^? 4.66 O4 PEG B 312 B 273 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 11.81 13.41 73.03 10.00 13.03 75.12 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 19.17 11.01 76.14 17.26 10.42 76.77 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 11.10 2.31 76.60 10.24 7.24 75.62 23.06 -12.55 15.81 27.03 -9.57 14.36 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 6 PHE^? 10.79 CL CL A 305 A 159 ASP A 88 ASP^? 16.22 CL CL A 305 A 188 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 13.91 34.58 14.67 12.95 36.00 12.47 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 20.97 28.40 16.26 20.19 30.15 15.34 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 22.55 41.65 15.60 18.92 37.20 14.63 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 6 PHE^? 10.79 CL CL A 305 A 159 ASP A 88 ASP^? 16.22 CL CL A 305 A 188 LYS A 92 LYS^? 11.11 CL CL B 310 coo 13.91 34.58 14.67 12.95 36.00 12.47 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 20.97 28.40 16.26 20.19 30.15 15.34 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 22.55 41.65 15.60 18.92 37.20 14.63 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 56 PHE^? 7.07 CL CL A 307 A 159 ASP A 48 ASP.? -15.94 CL CL A 307s A 188 LYS B 92 LYS^? 11.01 CL CL A 307 coo 13.91 34.58 14.67 12.95 36.00 12.47 28.85 5.55 12.29 27.69 7.22 14.19 coo 20.97 28.40 16.26 20.19 30.15 15.34 26.96 2.23 21.50 26.58 3.74 22.88 coo 22.55 41.65 15.60 18.92 37.20 14.63 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE A 56 PHE^? 7.07 CL CL A 307 A 159 ASP A 48 ASP.? -15.94 CL CL A 307s A 188 LYS B 96 LYS.? 11.54 CL CL A 306 coo 13.91 34.58 14.67 12.95 36.00 12.47 28.85 5.55 12.29 27.69 7.22 14.19 coo 20.97 28.40 16.26 20.19 30.15 15.34 26.96 2.23 21.50 26.58 3.74 22.88 coo 22.55 41.65 15.60 18.92 37.20 14.63 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE A 65 PHE.? 9.58 C2 CAC A 313 A 159 ASP A 73 ASP~? 14.36 ZN ZN A 303 A 188 LYS A 92 LYS^? 11.11 CL CL B 310 coo 13.91 34.58 14.67 12.95 36.00 12.47 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 20.97 28.40 16.26 20.19 30.15 15.34 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 22.55 41.65 15.60 18.92 37.20 14.63 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE B 6 PHE^? 11.00 CL CL B 308 A 159 ASP B 88 ASP^? 4.66 O4 PEG B 312 A 188 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 13.91 34.58 14.67 12.95 36.00 12.47 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 20.97 28.40 16.26 20.19 30.15 15.34 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 22.55 41.65 15.60 18.92 37.20 14.63 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 7 3 # 7 A 88 PHE B 6 PHE^? 11.00 CL CL B 308 A 159 ASP B 88 ASP^? 4.66 O4 PEG B 312 A 188 LYS B 92 LYS^? 11.01 CL CL A 307 coo 13.91 34.58 14.67 12.95 36.00 12.47 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 20.97 28.40 16.26 20.19 30.15 15.34 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 22.55 41.65 15.60 18.92 37.20 14.63 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 8 3 # 8 A 88 PHE B 56 PHE^? 6.57 CL CL B 310 A 159 ASP B 48 ASP.? 14.63 ZN ZN A 303 A 188 LYS A 92 LYS^? 11.11 CL CL B 310 coo 13.91 34.58 14.67 12.95 36.00 12.47 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 20.97 28.40 16.26 20.19 30.15 15.34 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 22.55 41.65 15.60 18.92 37.20 14.63 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 9 3 # 9 A 88 PHE B 56 PHE^? 6.57 CL CL B 310 A 159 ASP B 48 ASP.? 14.63 ZN ZN A 303 A 188 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo 13.91 34.58 14.67 12.95 36.00 12.47 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 20.97 28.40 16.26 20.19 30.15 15.34 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 22.55 41.65 15.60 18.92 37.20 14.63 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 10 3 # 10 A 88 PHE B 65 PHE.? 11.19 C1 PEG B 312 A 159 ASP B 73 ASP~? 8.36 C1 PEG B 312 A 188 LYS B 92 LYS^? 11.01 CL CL A 307 coo 13.91 34.58 14.67 12.95 36.00 12.47 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 20.97 28.40 16.26 20.19 30.15 15.34 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 22.55 41.65 15.60 18.92 37.20 14.63 25.00 -4.81 12.30 28.64 -2.55 7.65 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 10 hits 1b9h_c02 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 21 ARG~? 8.34 C22 1PE A 311s 183 LYS B 96 LYS.? 11.54 CL CL A 306 317 ARG A 36 ARG.? -4.82 ZN ZN A 303s coo 76.57 109.19 73.41 73.86 110.26 72.16 25.14 13.51 10.69 25.11 15.00 13.42 coo 82.09 117.51 66.37 80.60 114.32 71.44 17.33 4.64 12.77 13.37 4.64 15.16 coo 65.21 120.62 58.76 63.62 123.14 59.66 9.84 7.66 -4.50 9.21 7.51 -7.47 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG B 21 ARG~? 10.16 CL CL B 310 183 LYS A 96 LYS.? 5.78 O2 CAC A 313 317 ARG B 36 ARG.? 14.37 CL CL B 308 coo 76.57 109.19 73.41 73.86 110.26 72.16 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo 82.09 117.51 66.37 80.60 114.32 71.44 8.76 -5.89 1.16 6.19 -2.58 4.65 coo 65.21 120.62 58.76 63.62 123.14 59.66 10.68 -7.55 19.92 12.72 -9.80 19.82 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 2 hits 1bib_c00 naa= 3 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 1 3 # 1 A 102 TRP A 74 TRP~? 8.77 CL CL A 305 A 174 ASP A 78 ASP~? 6.31 CL CL A 305 A 198 LYS A 29 LYS~? -2.69 OH6A1PE A 311s coo 21.59 67.76 35.19 19.10 64.95 36.34 18.76 9.45 -4.73 19.86 8.05 -1.25 coo 19.39 73.14 39.98 19.70 71.07 40.14 25.71 9.07 -1.28 24.93 9.58 0.62 coo 27.94 65.10 43.55 24.20 64.94 40.01 14.86 14.41 3.43 16.20 19.44 6.35 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 2 3 # 2 A 102 TRP B 74 TRP~? 9.22 CL CL B 308 A 174 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 198 LYS B 29 LYS~? 10.16 CL CL B 309 coo 21.59 67.76 35.19 19.10 64.95 36.34 14.76 -14.11 16.53 14.47 -13.16 12.72 coo 19.39 73.14 39.98 19.70 71.07 40.14 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 27.94 65.10 43.55 24.20 64.94 40.01 5.16 -12.71 12.47 1.26 -15.97 8.59 1bjo_c00 source 1bjo PHOSPHOSERINE AMINOTRANSFERASE : 2 hits 1bjo_c00 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 6 PHE^? 10.79 CL CL A 305 A 205 ASP A 78 ASP~? 6.31 CL CL A 305 A 236 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 4.14 2.10 36.34 6.69 3.08 36.92 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 25.71 9.07 -1.28 24.93 9.58 0.62 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 65 PHE.? 9.58 C2 CAC A 313 A 205 ASP B 48 ASP.? 14.63 ZN ZN A 303 A 236 LYS A 95 LYS.? 9.36 CL CL B 309 coo 4.14 2.10 36.34 6.69 3.08 36.92 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 65 PHE.? 9.58 C2 CAC A 313 A 205 ASP B 48 ASP.? 14.63 ZN ZN A 303 A 236 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo 4.14 2.10 36.34 6.69 3.08 36.92 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE B 6 PHE^? 11.00 CL CL B 308 A 205 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 236 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 4.14 2.10 36.34 6.69 3.08 36.92 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE B 65 PHE.? 11.19 C1 PEG B 312 A 205 ASP A 48 ASP.? -15.94 CL CL A 307s A 236 LYS B 95 LYS.? 9.10 CL CL A 306 coo 4.14 2.10 36.34 6.69 3.08 36.92 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 26.96 2.23 21.50 26.58 3.74 22.88 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 20.80 3.86 14.18 20.78 8.31 16.72 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 5 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 32 GLN~? 8.22 OH7A1PE A 311 A 91 LEU A 28 LEU~? 5.10 CL CL A 306s A 133 GLU A 34 GLU~? 9.95 C2 CAC A 313 coo 43.58 43.67 66.73 42.32 42.78 68.15 10.42 11.79 5.14 11.19 12.00 7.08 coo 38.58 45.09 70.44 38.28 45.21 72.59 17.78 10.94 3.74 19.04 9.32 2.94 coo 44.05 36.87 70.65 43.15 38.64 69.97 10.18 12.55 -3.49 11.83 11.91 -4.60 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 32 GLN~? 8.22 OH7A1PE A 311 A 91 LEU A 37 LEU^? -6.67 O1 CAC A 313s A 133 GLU A 34 GLU~? 9.95 C2 CAC A 313 coo 43.58 43.67 66.73 42.32 42.78 68.15 10.42 11.79 5.14 11.19 12.00 7.08 coo 38.58 45.09 70.44 38.28 45.21 72.59 12.54 7.66 2.93 14.55 7.55 3.70 coo 44.05 36.87 70.65 43.15 38.64 69.97 10.18 12.55 -3.49 11.83 11.91 -4.60 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN B 32 GLN~? 10.33 CL CL B 309 A 91 LEU B 28 LEU~? 5.18 CL CL B 309 A 133 GLU B 34 GLU~? 16.28 CL CL B 308 coo 43.58 43.67 66.73 42.32 42.78 68.15 4.16 -7.29 12.58 3.46 -7.62 10.61 coo 38.58 45.09 70.44 38.28 45.21 72.59 9.08 -12.49 10.11 10.99 -12.16 9.14 coo 44.05 36.87 70.65 43.15 38.64 69.97 6.76 -9.82 20.52 8.48 -10.92 21.08 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 32 GLN~? 10.33 CL CL B 309 A 91 LEU B 37 LEU^? 8.67 CL CL B 308 A 133 GLU B 34 GLU~? 16.28 CL CL B 308 coo 43.58 43.67 66.73 42.32 42.78 68.15 4.16 -7.29 12.58 3.46 -7.62 10.61 coo 38.58 45.09 70.44 38.28 45.21 72.59 9.07 -6.74 12.55 9.82 -7.92 10.89 coo 44.05 36.87 70.65 43.15 38.64 69.97 6.76 -9.82 20.52 8.48 -10.92 21.08 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 4 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 32 GLN~? 8.22 OH7A1PE A 311 B 591 LEU A 28 LEU~? 5.10 CL CL A 306s B 633 GLU A 34 GLU~? 9.95 C2 CAC A 313 coo 88.06 44.34 57.19 89.06 45.53 55.74 10.42 11.79 5.14 11.19 12.00 7.08 coo 86.70 48.66 52.61 87.15 48.69 50.51 17.78 10.94 3.74 19.04 9.32 2.94 coo 95.42 44.52 54.43 93.46 45.31 54.70 10.18 12.55 -3.49 11.83 11.91 -4.60 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN A 32 GLN~? 8.22 OH7A1PE A 311 B 591 LEU A 37 LEU^? -6.67 O1 CAC A 313s B 633 GLU A 34 GLU~? 9.95 C2 CAC A 313 coo 88.06 44.34 57.19 89.06 45.53 55.74 10.42 11.79 5.14 11.19 12.00 7.08 coo 86.70 48.66 52.61 87.15 48.69 50.51 12.54 7.66 2.93 14.55 7.55 3.70 coo 95.42 44.52 54.43 93.46 45.31 54.70 10.18 12.55 -3.49 11.83 11.91 -4.60 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN B 32 GLN~? 10.33 CL CL B 309 B 591 LEU B 28 LEU~? 5.18 CL CL B 309 B 633 GLU B 34 GLU~? 16.28 CL CL B 308 coo 88.06 44.34 57.19 89.06 45.53 55.74 4.16 -7.29 12.58 3.46 -7.62 10.61 coo 86.70 48.66 52.61 87.15 48.69 50.51 9.08 -12.49 10.11 10.99 -12.16 9.14 coo 95.42 44.52 54.43 93.46 45.31 54.70 6.76 -9.82 20.52 8.48 -10.92 21.08 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN B 32 GLN~? 10.33 CL CL B 309 B 591 LEU B 37 LEU^? 8.67 CL CL B 308 B 633 GLU B 34 GLU~? 16.28 CL CL B 308 coo 88.06 44.34 57.19 89.06 45.53 55.74 4.16 -7.29 12.58 3.46 -7.62 10.61 coo 86.70 48.66 52.61 87.15 48.69 50.51 9.07 -6.74 12.55 9.82 -7.92 10.89 coo 95.42 44.52 54.43 93.46 45.31 54.70 6.76 -9.82 20.52 8.48 -10.92 21.08 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 4 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 32 GLN~? 8.22 OH7A1PE A 311 C1091 LEU A 28 LEU~? 5.10 CL CL A 306s C1133 GLU A 34 GLU~? 9.95 C2 CAC A 313 coo 68.29 34.44 43.03 66.67 34.74 44.37 10.42 11.79 5.14 11.19 12.00 7.08 coo 65.83 38.95 47.05 65.46 38.90 49.20 17.78 10.94 3.74 19.04 9.32 2.94 coo 63.14 29.39 46.25 63.84 31.31 45.74 10.18 12.55 -3.49 11.83 11.91 -4.60 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN A 32 GLN~? 8.22 OH7A1PE A 311 C1091 LEU A 37 LEU^? -6.67 O1 CAC A 313s C1133 GLU A 34 GLU~? 9.95 C2 CAC A 313 coo 68.29 34.44 43.03 66.67 34.74 44.37 10.42 11.79 5.14 11.19 12.00 7.08 coo 65.83 38.95 47.05 65.46 38.90 49.20 12.54 7.66 2.93 14.55 7.55 3.70 coo 63.14 29.39 46.25 63.84 31.31 45.74 10.18 12.55 -3.49 11.83 11.91 -4.60 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN B 32 GLN~? 10.33 CL CL B 309 C1091 LEU B 28 LEU~? 5.18 CL CL B 309 C1133 GLU B 34 GLU~? 16.28 CL CL B 308 coo 68.29 34.44 43.03 66.67 34.74 44.37 4.16 -7.29 12.58 3.46 -7.62 10.61 coo 65.83 38.95 47.05 65.46 38.90 49.20 9.08 -12.49 10.11 10.99 -12.16 9.14 coo 63.14 29.39 46.25 63.84 31.31 45.74 6.76 -9.82 20.52 8.48 -10.92 21.08 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN B 32 GLN~? 10.33 CL CL B 309 C1091 LEU B 37 LEU^? 8.67 CL CL B 308 C1133 GLU B 34 GLU~? 16.28 CL CL B 308 coo 68.29 34.44 43.03 66.67 34.74 44.37 4.16 -7.29 12.58 3.46 -7.62 10.61 coo 65.83 38.95 47.05 65.46 38.90 49.20 9.07 -6.74 12.55 9.82 -7.92 10.89 coo 63.14 29.39 46.25 63.84 31.31 45.74 6.76 -9.82 20.52 8.48 -10.92 21.08 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 4 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 32 GLN~? 8.22 OH7A1PE A 311 A 91 LEU A 28 LEU~? 5.10 CL CL A 306s A 133 GLU A 34 GLU~? 9.95 C2 CAC A 313 coo 38.23 53.34 67.59 38.84 53.87 69.56 10.42 11.79 5.14 11.19 12.00 7.08 coo 35.40 53.22 73.30 35.37 54.87 74.74 17.78 10.94 3.74 19.04 9.32 2.94 coo 45.08 56.04 70.60 43.15 55.19 70.77 10.18 12.55 -3.49 11.83 11.91 -4.60 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 32 GLN~? 8.22 OH7A1PE A 311 A 91 LEU A 37 LEU^? -6.67 O1 CAC A 313s A 133 GLU A 34 GLU~? 9.95 C2 CAC A 313 coo 38.23 53.34 67.59 38.84 53.87 69.56 10.42 11.79 5.14 11.19 12.00 7.08 coo 35.40 53.22 73.30 35.37 54.87 74.74 12.54 7.66 2.93 14.55 7.55 3.70 coo 45.08 56.04 70.60 43.15 55.19 70.77 10.18 12.55 -3.49 11.83 11.91 -4.60 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 64 GLN^? -3.49 C2 CAC A 313s A 91 LEU A 37 LEU^? -6.67 O1 CAC A 313s A 133 GLU A 34 GLU~? 9.95 C2 CAC A 313 coo 38.23 53.34 67.59 38.84 53.87 69.56 9.17 2.67 -2.61 7.16 3.33 -2.48 coo 35.40 53.22 73.30 35.37 54.87 74.74 12.54 7.66 2.93 14.55 7.55 3.70 coo 45.08 56.04 70.60 43.15 55.19 70.77 10.18 12.55 -3.49 11.83 11.91 -4.60 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 32 GLN~? 10.33 CL CL B 309 A 91 LEU B 28 LEU~? 5.18 CL CL B 309 A 133 GLU B 34 GLU~? 16.28 CL CL B 308 coo 38.23 53.34 67.59 38.84 53.87 69.56 4.16 -7.29 12.58 3.46 -7.62 10.61 coo 35.40 53.22 73.30 35.37 54.87 74.74 9.08 -12.49 10.11 10.99 -12.16 9.14 coo 45.08 56.04 70.60 43.15 55.19 70.77 6.76 -9.82 20.52 8.48 -10.92 21.08 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 32 GLN~? 10.33 CL CL B 309 A 91 LEU B 37 LEU^? 8.67 CL CL B 308 A 133 GLU B 34 GLU~? 16.28 CL CL B 308 coo 38.23 53.34 67.59 38.84 53.87 69.56 4.16 -7.29 12.58 3.46 -7.62 10.61 coo 35.40 53.22 73.30 35.37 54.87 74.74 9.07 -6.74 12.55 9.82 -7.92 10.89 coo 45.08 56.04 70.60 43.15 55.19 70.77 6.76 -9.82 20.52 8.48 -10.92 21.08 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 5 hits 1bsj_c00 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU A 22 GLU~? -5.00 C13 1PE A 311s A 65 ARG A 27 ARG~? 9.04 CL CL A 305 A 85 HIS A 24 HIS~? 3.26 ZN ZN A 301s coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 23.55 20.26 6.43 24.10 22.30 6.48 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 21.75 13.08 -2.42 22.26 10.12 -3.14 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 24.25 11.32 4.20 23.54 9.34 4.43 ULMN 3 1c54_c00 RIBONUCLEASE SA user 2 3 # 2 A 54 GLU A 82 GLU~? -16.67 C13 1PE A 311s A 65 ARG A 27 ARG~? 9.04 CL CL A 305 A 85 HIS A 24 HIS~? 3.26 ZN ZN A 301s coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 33.07 14.53 -4.24 32.37 16.29 -5.09 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 21.75 13.08 -2.42 22.26 10.12 -3.14 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 24.25 11.32 4.20 23.54 9.34 4.43 ULMN 3 1c54_c00 RIBONUCLEASE SA user 3 3 # 3 A 54 GLU B 82 GLU~? -1.87 ZN ZN B 304s A 65 ARG B 27 ARG~? 9.37 CL CL B 308 A 85 HIS B 24 HIS~? 3.28 ZN ZN B 302s coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 17.85 -26.45 10.11 16.17 -26.92 11.31 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 12.55 -18.09 13.90 15.25 -16.65 13.55 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 11.77 -17.25 6.59 12.69 -15.38 6.18 1c54_c00 source 1c54 RIBONUCLEASE SA : 3 hits 1c54_c00 naa= 3 ULMN 3 1c82_c01 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 408 TYR A 80 TYR~? 5.67 CL CL A 307 A 462 ARG A 21 ARG~? 8.34 C22 1PE A 311s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 24.25 11.32 4.20 23.54 9.34 4.43 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 28.47 9.96 3.42 27.66 10.97 5.91 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 25.14 13.51 10.69 25.11 15.00 13.42 ULMN 3 1c82_c01 HYALURONATE LYASE user 2 3 # 2 A 399 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 408 TYR A 80 TYR~? 5.67 CL CL A 307 A 462 ARG A 27 ARG~? 9.04 CL CL A 305 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 24.25 11.32 4.20 23.54 9.34 4.43 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 28.47 9.96 3.42 27.66 10.97 5.91 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 21.75 13.08 -2.42 22.26 10.12 -3.14 ULMN 3 1c82_c01 HYALURONATE LYASE user 3 3 # 3 A 399 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 408 TYR B 80 TYR~? 5.35 CL CL B 310 A 462 ARG B 21 ARG~? 10.16 CL CL B 310 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 7.31 -19.18 1.19 5.97 -20.30 -1.38 ULMN 3 1c82_c01 HYALURONATE LYASE user 4 3 # 4 A 399 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 408 TYR B 80 TYR~? 5.35 CL CL B 310 A 462 ARG B 27 ARG~? 9.37 CL CL B 308 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 12.55 -18.09 13.90 15.25 -16.65 13.55 1c82_c01 source 1c82 HYALURONATE LYASE : 4 hits 1c82_c01 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 16 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 67 GLY B 84 GLY.? 11.09 O4 PEG B 312 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 20.99 -24.23 3.61 20.27 -23.84 3.57 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 1 hits 1cb7_c06 naa= 3 ULMN 3 1cb8_c01 CHONDROITINASE AC user 1 3 # 1 A 225 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 234 TYR A 80 TYR~? 5.67 CL CL A 307 A 288 ARG A 21 ARG~? 8.34 C22 1PE A 311s coo 27.04 28.61 41.75 26.86 28.65 43.84 24.25 11.32 4.20 23.54 9.34 4.43 coo 21.80 30.48 43.67 23.70 29.06 45.12 28.47 9.96 3.42 27.66 10.97 5.91 coo 24.79 22.62 45.60 24.87 25.42 46.81 25.14 13.51 10.69 25.11 15.00 13.42 ULMN 3 1cb8_c01 CHONDROITINASE AC user 2 3 # 2 A 225 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 234 TYR A 80 TYR~? 5.67 CL CL A 307 A 288 ARG A 27 ARG~? 9.04 CL CL A 305 coo 27.04 28.61 41.75 26.86 28.65 43.84 24.25 11.32 4.20 23.54 9.34 4.43 coo 21.80 30.48 43.67 23.70 29.06 45.12 28.47 9.96 3.42 27.66 10.97 5.91 coo 24.79 22.62 45.60 24.87 25.42 46.81 21.75 13.08 -2.42 22.26 10.12 -3.14 ULMN 3 1cb8_c01 CHONDROITINASE AC user 3 3 # 3 A 225 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 234 TYR B 80 TYR~? 5.35 CL CL B 310 A 288 ARG B 21 ARG~? 10.16 CL CL B 310 coo 27.04 28.61 41.75 26.86 28.65 43.84 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 21.80 30.48 43.67 23.70 29.06 45.12 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 24.79 22.62 45.60 24.87 25.42 46.81 7.31 -19.18 1.19 5.97 -20.30 -1.38 ULMN 3 1cb8_c01 CHONDROITINASE AC user 4 3 # 4 A 225 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 234 TYR B 80 TYR~? 5.35 CL CL B 310 A 288 ARG B 27 ARG~? 9.37 CL CL B 308 coo 27.04 28.61 41.75 26.86 28.65 43.84 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 21.80 30.48 43.67 23.70 29.06 45.12 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 24.79 22.62 45.60 24.87 25.42 46.81 12.55 -18.09 13.90 15.25 -16.65 13.55 1cb8_c01 source 1cb8 CHONDROITINASE AC : 4 hits 1cb8_c01 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 17 ARG~? -3.60 CL CL A 307s 127 ARG A 21 ARG~? 8.34 C22 1PE A 311s 270 GLU A 49 GLU.? 12.26 CL CL A 306 coo -0.83 25.63 1.57 0.97 28.05 0.90 29.80 8.18 9.40 27.73 6.82 7.62 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 25.14 13.51 10.69 25.11 15.00 13.42 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 21.20 3.66 19.03 19.27 4.46 18.88 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG A 21 ARG~? 8.34 C22 1PE A 311s 127 ARG A 17 ARG~? -3.60 CL CL A 307s 270 GLU A 49 GLU.? 12.26 CL CL A 306 coo -0.83 25.63 1.57 0.97 28.05 0.90 25.14 13.51 10.69 25.11 15.00 13.42 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 29.80 8.18 9.40 27.73 6.82 7.62 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 21.20 3.66 19.03 19.27 4.46 18.88 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 2 hits 1cbx_c01 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 9 ASP^? 7.20 CL CL A 307 264 GLU A 22 GLU~? -5.00 C13 1PE A 311s 328 ASP A 78 ASP~? 6.31 CL CL A 305 coo 45.62 80.42 43.69 45.65 82.01 45.07 32.44 3.50 6.30 30.77 4.75 6.60 coo 59.69 92.71 39.85 58.53 92.03 41.47 23.55 20.26 6.43 24.10 22.30 6.48 coo 45.39 90.72 40.63 45.07 89.14 41.90 25.71 9.07 -1.28 24.93 9.58 0.62 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 78 ASP~? 6.31 CL CL A 305 264 GLU A 15 GLU~? 17.38 CL CL A 307 328 ASP A 9 ASP^? 7.20 CL CL A 307 coo 45.62 80.42 43.69 45.65 82.01 45.07 25.71 9.07 -1.28 24.93 9.58 0.62 coo 59.69 92.71 39.85 58.53 92.03 41.47 36.85 15.40 11.10 38.87 16.11 11.22 coo 45.39 90.72 40.63 45.07 89.14 41.90 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP B 9 ASP^? 7.08 CL CL B 310 264 GLU B 22 GLU~? 10.35 CL CL B 309 328 ASP B 78 ASP~? 6.36 ZN ZN B 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 59.69 92.71 39.85 58.53 92.03 41.47 3.91 -22.17 5.69 2.98 -20.35 5.17 coo 45.39 90.72 40.63 45.07 89.14 41.90 16.87 -17.86 9.95 15.14 -17.20 8.90 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP B 88 ASP^? 4.66 O4 PEG B 312 264 GLU B 15 GLU~? 13.88 CL CL B 310 328 ASP B 78 ASP~? 6.36 ZN ZN B 302 coo 45.62 80.42 43.69 45.65 82.01 45.07 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 59.69 92.71 39.85 58.53 92.03 41.47 15.04 -27.14 -3.41 16.60 -25.82 -3.70 coo 45.39 90.72 40.63 45.07 89.14 41.90 16.87 -17.86 9.95 15.14 -17.20 8.90 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 4 hits 1cdg_c00 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 55 GLY.? 11.02 CL CL A 307 A 228 SER A 52 SER~? 16.21 CL CL A 307 A 549 ASP A 48 ASP.? -15.94 CL CL A 307s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 32.43 5.49 14.62 32.30 4.76 14.95 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 31.84 7.85 19.89 31.12 7.70 22.23 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 26.96 2.23 21.50 26.58 3.74 22.88 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 1 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 55 GLY.? 11.02 CL CL A 307 B1228 SER A 52 SER~? 16.21 CL CL A 307 B1549 ASP A 48 ASP.? -15.94 CL CL A 307s coo 126.34 72.75 125.66 125.95 73.27 126.11 32.43 5.49 14.62 32.30 4.76 14.95 coo 131.65 74.68 129.41 130.31 72.73 128.82 31.84 7.85 19.89 31.12 7.70 22.23 coo 134.72 69.43 130.42 133.03 70.65 130.08 26.96 2.23 21.50 26.58 3.74 22.88 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY B 41 GLY^? -3.88 CL CL B 309s B1228 SER B 59 SER^? 3.99 CL CL B 308s B1549 ASP B 9 ASP^? 7.08 CL CL B 310 coo 126.34 72.75 125.66 125.95 73.27 126.11 11.75 -9.68 2.90 12.54 -9.55 3.14 coo 131.65 74.68 129.41 130.31 72.73 128.82 17.09 -11.30 2.44 17.22 -12.60 4.35 coo 134.72 69.43 130.42 133.03 70.65 130.08 20.52 -16.92 -1.41 18.60 -16.56 -0.65 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY B 55 GLY.? 10.53 CL CL B 310 B1228 SER B 52 SER~? -15.43 CL CL B 310s B1549 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 126.34 72.75 125.66 125.95 73.27 126.11 14.71 -16.40 -7.41 14.86 -15.73 -7.82 coo 131.65 74.68 129.41 130.31 72.73 128.82 9.78 -16.42 -10.12 8.17 -17.33 -11.63 coo 134.72 69.43 130.42 133.03 70.65 130.08 10.78 -8.54 -11.40 8.75 -9.01 -11.79 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 3 hits 1cjy_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 3 TYR^? 10.95 ZN ZN A 303 A 173 ASP B 47 ASP.? 11.08 ZN ZN A 303 C 48 ARG A 36 ARG.? -4.82 ZN ZN A 303s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 24.35 4.55 25.11 25.94 3.23 25.53 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 9.84 7.66 -4.50 9.21 7.51 -7.47 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR A 80 TYR~? 5.67 CL CL A 307 A 173 ASP A 9 ASP^? 7.20 CL CL A 307 C 48 ARG A 21 ARG~? 8.34 C22 1PE A 311s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 28.47 9.96 3.42 27.66 10.97 5.91 coo 24.35 4.55 25.11 25.94 3.23 25.53 32.44 3.50 6.30 30.77 4.75 6.60 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 25.14 13.51 10.69 25.11 15.00 13.42 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR A 86 TYR^? 7.10 CL CL A 305 A 173 ASP A 88 ASP^? 16.22 CL CL A 305 C 48 ARG A 17 ARG~? -3.60 CL CL A 307s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 29.34 5.60 1.24 26.89 6.10 2.52 coo 24.35 4.55 25.11 25.94 3.23 25.53 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 29.80 8.18 9.40 27.73 6.82 7.62 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 101 TYR B 80 TYR~? 5.35 CL CL B 310 A 173 ASP B 9 ASP^? 7.08 CL CL B 310 C 48 ARG B 21 ARG~? 10.16 CL CL B 310 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 24.35 4.55 25.11 25.94 3.23 25.53 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 7.31 -19.18 1.19 5.97 -20.30 -1.38 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 101 TYR B 80 TYR~? 5.35 CL CL B 310 A 173 ASP B 78 ASP~? 6.36 ZN ZN B 302 C 48 ARG B 21 ARG~? 10.16 CL CL B 310 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 24.35 4.55 25.11 25.94 3.23 25.53 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 7.31 -19.18 1.19 5.97 -20.30 -1.38 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 101 TYR B 86 TYR^? 6.73 CL CL B 310 A 173 ASP B 88 ASP^? 4.66 O4 PEG B 312 C 48 ARG B 17 ARG~? -3.61 CL CL B 310s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 24.35 4.55 25.11 25.94 3.23 25.53 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 14.51 -18.33 -1.30 15.06 -15.90 0.47 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 6 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 17 ARG~? -3.60 CL CL A 307s C 101 TYR A 86 TYR^? 7.10 CL CL A 305 C 173 ASP A 88 ASP^? 16.22 CL CL A 305 coo 32.27 5.62 48.15 31.93 6.48 51.06 29.80 8.18 9.40 27.73 6.82 7.62 coo 29.64 3.64 57.39 31.22 5.14 55.65 29.34 5.60 1.24 26.89 6.10 2.52 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG A 21 ARG~? 8.34 C22 1PE A 311s C 101 TYR A 80 TYR~? 5.67 CL CL A 307 C 173 ASP A 9 ASP^? 7.20 CL CL A 307 coo 32.27 5.62 48.15 31.93 6.48 51.06 25.14 13.51 10.69 25.11 15.00 13.42 coo 29.64 3.64 57.39 31.22 5.14 55.65 28.47 9.96 3.42 27.66 10.97 5.91 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG A 21 ARG~? 8.34 C22 1PE A 311s C 101 TYR A 80 TYR~? 5.67 CL CL A 307 C 173 ASP A 78 ASP~? 6.31 CL CL A 305 coo 32.27 5.62 48.15 31.93 6.48 51.06 25.14 13.51 10.69 25.11 15.00 13.42 coo 29.64 3.64 57.39 31.22 5.14 55.65 28.47 9.96 3.42 27.66 10.97 5.91 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 25.71 9.07 -1.28 24.93 9.58 0.62 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 48 ARG A 36 ARG.? -4.82 ZN ZN A 303s C 101 TYR A 3 TYR^? 10.95 ZN ZN A 303 C 173 ASP B 47 ASP.? 11.08 ZN ZN A 303 coo 32.27 5.62 48.15 31.93 6.48 51.06 9.84 7.66 -4.50 9.21 7.51 -7.47 coo 29.64 3.64 57.39 31.22 5.14 55.65 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 15.08 -4.94 -11.66 14.38 -3.13 -10.90 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 48 ARG B 17 ARG~? -3.61 CL CL B 310s C 101 TYR B 86 TYR^? 6.73 CL CL B 310 C 173 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 32.27 5.62 48.15 31.93 6.48 51.06 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo 29.64 3.64 57.39 31.22 5.14 55.65 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 48 ARG B 21 ARG~? 10.16 CL CL B 310 C 101 TYR B 80 TYR~? 5.35 CL CL B 310 C 173 ASP B 9 ASP^? 7.08 CL CL B 310 coo 32.27 5.62 48.15 31.93 6.48 51.06 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo 29.64 3.64 57.39 31.22 5.14 55.65 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 20.52 -16.92 -1.41 18.60 -16.56 -0.65 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 48 ARG B 21 ARG~? 10.16 CL CL B 310 C 101 TYR B 80 TYR~? 5.35 CL CL B 310 C 173 ASP B 78 ASP~? 6.36 ZN ZN B 302 coo 32.27 5.62 48.15 31.93 6.48 51.06 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo 29.64 3.64 57.39 31.22 5.14 55.65 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 16.87 -17.86 9.95 15.14 -17.20 8.90 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 17 ARG~? -3.60 CL CL A 307s D 101 TYR A 86 TYR^? 7.10 CL CL A 305 D 173 ASP A 88 ASP^? 16.22 CL CL A 305 coo 69.08 8.58 32.60 69.70 10.81 30.58 29.80 8.18 9.40 27.73 6.82 7.62 coo 71.77 11.86 24.26 70.23 12.22 26.56 29.34 5.60 1.24 26.89 6.10 2.52 coo 71.60 6.14 19.25 70.26 6.87 20.69 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG A 21 ARG~? 8.34 C22 1PE A 311s D 101 TYR A 80 TYR~? 5.67 CL CL A 307 D 173 ASP A 9 ASP^? 7.20 CL CL A 307 coo 69.08 8.58 32.60 69.70 10.81 30.58 25.14 13.51 10.69 25.11 15.00 13.42 coo 71.77 11.86 24.26 70.23 12.22 26.56 28.47 9.96 3.42 27.66 10.97 5.91 coo 71.60 6.14 19.25 70.26 6.87 20.69 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG A 36 ARG.? -4.82 ZN ZN A 303s D 101 TYR A 3 TYR^? 10.95 ZN ZN A 303 D 173 ASP B 47 ASP.? 11.08 ZN ZN A 303 coo 69.08 8.58 32.60 69.70 10.81 30.58 9.84 7.66 -4.50 9.21 7.51 -7.47 coo 71.77 11.86 24.26 70.23 12.22 26.56 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 71.60 6.14 19.25 70.26 6.87 20.69 15.08 -4.94 -11.66 14.38 -3.13 -10.90 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 48 ARG B 17 ARG~? -3.61 CL CL B 310s D 101 TYR B 86 TYR^? 6.73 CL CL B 310 D 173 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 69.08 8.58 32.60 69.70 10.81 30.58 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo 71.77 11.86 24.26 70.23 12.22 26.56 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 71.60 6.14 19.25 70.26 6.87 20.69 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 48 ARG B 21 ARG~? 10.16 CL CL B 310 D 101 TYR B 80 TYR~? 5.35 CL CL B 310 D 173 ASP B 9 ASP^? 7.08 CL CL B 310 coo 69.08 8.58 32.60 69.70 10.81 30.58 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo 71.77 11.86 24.26 70.23 12.22 26.56 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 71.60 6.14 19.25 70.26 6.87 20.69 20.52 -16.92 -1.41 18.60 -16.56 -0.65 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 48 ARG B 21 ARG~? 10.16 CL CL B 310 D 101 TYR B 80 TYR~? 5.35 CL CL B 310 D 173 ASP B 78 ASP~? 6.36 ZN ZN B 302 coo 69.08 8.58 32.60 69.70 10.81 30.58 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo 71.77 11.86 24.26 70.23 12.22 26.56 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 71.60 6.14 19.25 70.26 6.87 20.69 16.87 -17.86 9.95 15.14 -17.20 8.90 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 6 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 3 TYR^? 10.95 ZN ZN A 303 B 173 ASP B 47 ASP.? 11.08 ZN ZN A 303 D 48 ARG A 36 ARG.? -4.82 ZN ZN A 303s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 9.84 7.66 -4.50 9.21 7.51 -7.47 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR A 80 TYR~? 5.67 CL CL A 307 B 173 ASP A 9 ASP^? 7.20 CL CL A 307 D 48 ARG A 21 ARG~? 8.34 C22 1PE A 311s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 28.47 9.96 3.42 27.66 10.97 5.91 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 32.44 3.50 6.30 30.77 4.75 6.60 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 25.14 13.51 10.69 25.11 15.00 13.42 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR A 86 TYR^? 7.10 CL CL A 305 B 173 ASP A 88 ASP^? 16.22 CL CL A 305 D 48 ARG A 17 ARG~? -3.60 CL CL A 307s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 29.34 5.60 1.24 26.89 6.10 2.52 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 29.80 8.18 9.40 27.73 6.82 7.62 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR B 80 TYR~? 5.35 CL CL B 310 B 173 ASP B 9 ASP^? 7.08 CL CL B 310 D 48 ARG B 21 ARG~? 10.16 CL CL B 310 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 7.31 -19.18 1.19 5.97 -20.30 -1.38 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 101 TYR B 80 TYR~? 5.35 CL CL B 310 B 173 ASP B 78 ASP~? 6.36 ZN ZN B 302 D 48 ARG B 21 ARG~? 10.16 CL CL B 310 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 7.31 -19.18 1.19 5.97 -20.30 -1.38 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 101 TYR B 86 TYR^? 6.73 CL CL B 310 B 173 ASP B 88 ASP^? 4.66 O4 PEG B 312 D 48 ARG B 17 ARG~? -3.61 CL CL B 310s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 14.51 -18.33 -1.30 15.06 -15.90 0.47 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 6 hits 1cs1_c03 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA A 45 ALA.? 12.68 CL CL A 307 A 74 ASN A 43 ASN^? 7.86 CL CL A 307 A 75 GLY A 58 GLY^? 7.04 CL CL A 307 coo -1.80 62.71 122.76 -1.88 63.70 123.92 30.85 -0.04 14.74 32.25 0.57 14.48 coo 1.20 66.40 122.20 2.03 64.53 121.46 25.90 0.17 10.25 24.19 -0.21 9.00 coo 4.68 65.84 125.52 4.11 65.60 126.05 28.51 2.01 6.75 28.22 2.24 7.53 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 2 3 # 2 A 1 ALA B 45 ALA.? 12.47 CL CL B 310 A 74 ASN B 43 ASN^? 8.09 CL CL B 308 A 75 GLY B 58 GLY^? 7.10 CL CL B 310 coo -1.80 62.71 122.76 -1.88 63.70 123.92 17.71 -11.65 -8.32 18.01 -13.13 -8.63 coo 1.20 66.40 122.20 2.03 64.53 121.46 17.50 -9.23 -1.99 17.56 -8.09 -0.19 coo 4.68 65.84 125.52 4.11 65.60 126.05 19.36 -13.08 -0.04 18.65 -12.88 -0.47 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 45 ALA.? 12.68 CL CL A 307 B 74 ASN A 43 ASN^? 7.86 CL CL A 307 B 75 GLY A 58 GLY^? 7.04 CL CL A 307 coo 39.21 14.97 27.55 40.19 16.01 27.08 30.85 -0.04 14.74 32.25 0.57 14.48 coo 43.06 12.94 25.74 42.26 11.81 27.44 25.90 0.17 10.25 24.19 -0.21 9.00 coo 46.38 13.54 29.18 46.14 14.29 29.26 28.51 2.01 6.75 28.22 2.24 7.53 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 1 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 45 ALA.? 12.68 CL CL A 307 C 74 ASN A 43 ASN^? 7.86 CL CL A 307 C 75 GLY A 58 GLY^? 7.04 CL CL A 307 coo 16.14 15.08 36.63 15.28 14.65 37.81 30.85 -0.04 14.74 32.25 0.57 14.48 coo 11.60 16.13 36.70 12.80 17.74 35.96 25.90 0.17 10.25 24.19 -0.21 9.00 coo 10.99 19.23 40.32 11.50 18.77 40.74 28.51 2.01 6.75 28.22 2.24 7.53 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 1 hits 1ct9_c06 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 48 ASP.? -15.94 CL CL A 307s 315 GLU A 49 GLU.? 12.26 CL CL A 306 390 TYR B 3 TYR^? 11.16 C1 PEG B 312 coo 32.46 99.13 19.34 30.94 100.38 20.07 26.96 2.23 21.50 26.58 3.74 22.88 coo 32.04 94.22 18.23 30.57 94.75 16.88 21.20 3.66 19.03 19.27 4.46 18.88 coo 21.10 94.74 18.36 23.09 96.71 18.59 20.49 -5.14 16.12 21.33 -4.29 18.62 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP B 48 ASP.? 14.63 ZN ZN A 303 315 GLU B 49 GLU.? 12.07 C2 CAC A 313 390 TYR A 2 TYR^? -4.58 O2 CAC A 313s coo 32.46 99.13 19.34 30.94 100.38 20.07 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 32.04 94.22 18.23 30.57 94.75 16.88 7.03 -7.10 -6.90 6.04 -5.38 -6.16 coo 21.10 94.74 18.36 23.09 96.71 18.59 10.20 -0.74 -0.90 7.99 0.53 0.19 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 3 # 3 313 ASP B 48 ASP.? 14.63 ZN ZN A 303 315 GLU B 49 GLU.? 12.07 C2 CAC A 313 390 TYR A 3 TYR^? 10.95 ZN ZN A 303 coo 32.46 99.13 19.34 30.94 100.38 20.07 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 32.04 94.22 18.23 30.57 94.75 16.88 7.03 -7.10 -6.90 6.04 -5.38 -6.16 coo 21.10 94.74 18.36 23.09 96.71 18.59 15.55 -0.59 -5.31 14.15 -1.10 -7.68 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 3 hits 1ctn_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 73 ASP~? 14.36 ZN ZN A 303 A 56 ILE A 5 ILE^? 7.37 CL CL A 305 A 82 TYR A 3 TYR^? 10.95 ZN ZN A 303 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 21.26 1.75 -0.62 21.38 2.86 -1.42 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 15.55 -0.59 -5.31 14.15 -1.10 -7.68 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP B 73 ASP~? 8.36 C1 PEG B 312 A 56 ILE B 5 ILE^? 7.61 CL CL B 308 A 82 TYR B 3 TYR^? 11.16 C1 PEG B 312 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 19.44 -9.64 9.82 19.06 -10.66 10.70 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 20.49 -5.14 16.12 21.33 -4.29 18.62 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 2 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 73 ASP~? 14.36 ZN ZN A 303 B 56 ILE A 5 ILE^? 7.37 CL CL A 305 B 82 TYR A 3 TYR^? 10.95 ZN ZN A 303 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 21.26 1.75 -0.62 21.38 2.86 -1.42 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 15.55 -0.59 -5.31 14.15 -1.10 -7.68 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP B 73 ASP~? 8.36 C1 PEG B 312 B 56 ILE B 5 ILE^? 7.61 CL CL B 308 B 82 TYR B 3 TYR^? 11.16 C1 PEG B 312 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 19.44 -9.64 9.82 19.06 -10.66 10.70 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 20.49 -5.14 16.12 21.33 -4.29 18.62 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 2 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 3 TYR^? 10.95 ZN ZN A 303 A 243 ASP A 9 ASP^? 7.20 CL CL A 307 A 272 LYS A 16 LYS~? 15.92 CL CL A 307 coo 2.03 68.31 21.46 0.66 68.36 23.90 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 16.93 55.67 9.65 17.16 54.23 11.19 32.44 3.50 6.30 30.77 4.75 6.60 coo 14.13 45.79 13.40 14.25 49.41 18.30 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 3 TYR^? 10.95 ZN ZN A 303 A 243 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 272 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 2.03 68.31 21.46 0.66 68.36 23.90 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 16.93 55.67 9.65 17.16 54.23 11.19 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 14.13 45.79 13.40 14.25 49.41 18.30 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR A 3 TYR^? 10.95 ZN ZN A 303 A 243 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 272 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 2.03 68.31 21.46 0.66 68.36 23.90 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 16.93 55.67 9.65 17.16 54.23 11.19 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 14.13 45.79 13.40 14.25 49.41 18.30 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR A 80 TYR~? 5.67 CL CL A 307 A 243 ASP A 47 ASP.? 12.21 O1 PEG B 312 A 272 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 2.03 68.31 21.46 0.66 68.36 23.90 28.47 9.96 3.42 27.66 10.97 5.91 coo 16.93 55.67 9.65 17.16 54.23 11.19 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 14.13 45.79 13.40 14.25 49.41 18.30 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR B 3 TYR^? 11.16 C1 PEG B 312 A 243 ASP A 78 ASP~? 6.31 CL CL A 305 A 272 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 2.03 68.31 21.46 0.66 68.36 23.90 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 16.93 55.67 9.65 17.16 54.23 11.19 25.71 9.07 -1.28 24.93 9.58 0.62 coo 14.13 45.79 13.40 14.25 49.41 18.30 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR B 3 TYR^? 11.16 C1 PEG B 312 A 243 ASP A 88 ASP^? 16.22 CL CL A 305 A 272 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 2.03 68.31 21.46 0.66 68.36 23.90 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 16.93 55.67 9.65 17.16 54.23 11.19 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 14.13 45.79 13.40 14.25 49.41 18.30 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR B 3 TYR^? 11.16 C1 PEG B 312 A 243 ASP B 9 ASP^? 7.08 CL CL B 310 A 272 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 2.03 68.31 21.46 0.66 68.36 23.90 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 16.93 55.67 9.65 17.16 54.23 11.19 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 14.13 45.79 13.40 14.25 49.41 18.30 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR B 80 TYR~? 5.35 CL CL B 310 A 243 ASP B 47 ASP.? 11.08 ZN ZN A 303 A 272 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 2.03 68.31 21.46 0.66 68.36 23.90 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 16.93 55.67 9.65 17.16 54.23 11.19 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 14.13 45.79 13.40 14.25 49.41 18.30 22.18 2.53 -8.14 23.09 -3.13 -10.80 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 8 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 29 LYS~? -2.69 OH6A1PE A 311s A 177 GLU A 22 GLU~? -5.00 C13 1PE A 311s A 201 LEU A 25 LEU~? 4.38 C22 1PE A 311 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 14.86 14.41 3.43 16.20 19.44 6.35 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 23.55 20.26 6.43 24.10 22.30 6.48 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 20.72 14.86 6.54 21.02 13.91 8.48 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS B 29 LYS~? 10.16 CL CL B 309 A 177 GLU B 22 GLU~? 10.35 CL CL B 309 A 201 LEU B 25 LEU~? 5.32 CL CL B 309 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 5.16 -12.71 12.47 1.26 -15.97 8.59 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 3.91 -22.17 5.69 2.98 -20.35 5.17 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 6.36 -16.53 7.28 6.24 -15.77 5.24 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 2 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 29 LYS~? -2.69 OH6A1PE A 311s B 177 GLU A 22 GLU~? -5.00 C13 1PE A 311s B 201 LEU A 25 LEU~? 4.38 C22 1PE A 311 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 14.86 14.41 3.43 16.20 19.44 6.35 coo 27.00 6.35 51.01 26.30 4.53 50.18 23.55 20.26 6.43 24.10 22.30 6.48 coo 23.74 1.68 49.50 22.87 -0.24 49.97 20.72 14.86 6.54 21.02 13.91 8.48 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS B 29 LYS~? 10.16 CL CL B 309 B 177 GLU B 22 GLU~? 10.35 CL CL B 309 B 201 LEU B 25 LEU~? 5.32 CL CL B 309 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 5.16 -12.71 12.47 1.26 -15.97 8.59 coo 27.00 6.35 51.01 26.30 4.53 50.18 3.91 -22.17 5.69 2.98 -20.35 5.17 coo 23.74 1.68 49.50 22.87 -0.24 49.97 6.36 -16.53 7.28 6.24 -15.77 5.24 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS B 29 LYS~? 10.16 CL CL B 309 B 177 GLU B 34 GLU~? 16.28 CL CL B 308 B 201 LEU B 31 LEU~? 10.17 CL CL B 308 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 5.16 -12.71 12.47 1.26 -15.97 8.59 coo 27.00 6.35 51.01 26.30 4.53 50.18 6.76 -9.82 20.52 8.48 -10.92 21.08 coo 23.74 1.68 49.50 22.87 -0.24 49.97 9.79 -9.88 15.03 11.78 -10.48 15.51 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 3 hits 1daa_c01 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR A 39 THR^? 8.50 CL CL A 305 A 156 TYR B 2 TYR^? 13.50 CL CL A 306 A 160 LYS B 96 LYS.? 11.54 CL CL A 306 coo 10.50 56.87 17.73 11.24 57.93 19.43 14.21 3.91 6.70 14.94 2.35 8.05 coo 11.64 63.07 23.95 11.76 62.47 21.20 15.58 -0.36 14.99 13.00 0.51 15.42 coo 5.78 61.30 21.65 8.04 62.89 17.54 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 2 3 # 2 A 132 THR B 39 THR^? 8.33 O2 CAC A 313 A 156 TYR A 2 TYR^? -4.58 O2 CAC A 313s A 160 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo 10.50 56.87 17.73 11.24 57.93 19.43 10.69 -4.51 7.70 11.48 -3.65 5.83 coo 11.64 63.07 23.95 11.76 62.47 21.20 10.20 -0.74 -0.90 7.99 0.53 0.19 coo 5.78 61.30 21.65 8.04 62.89 17.54 8.76 -5.89 1.16 6.19 -2.58 4.65 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 2 hits 1db3_c01 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 22 GLU~? -5.00 C13 1PE A 311s A 226 THR A 57 THR^? 10.92 CL CL A 307 A 229 LYS B 92 LYS^? 11.01 CL CL A 307 coo 9.66 102.78 70.07 9.79 101.18 71.42 23.55 20.26 6.43 24.10 22.30 6.48 coo 7.24 97.46 49.60 8.11 95.69 48.80 30.98 0.89 9.38 30.52 -0.91 10.45 coo 10.53 97.56 43.71 9.33 93.71 47.17 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 82 GLU~? -16.67 C13 1PE A 311s A 226 THR A 57 THR^? 10.92 CL CL A 307 A 229 LYS B 92 LYS^? 11.01 CL CL A 307 coo 9.66 102.78 70.07 9.79 101.18 71.42 33.07 14.53 -4.24 32.37 16.29 -5.09 coo 7.24 97.46 49.60 8.11 95.69 48.80 30.98 0.89 9.38 30.52 -0.91 10.45 coo 10.53 97.56 43.71 9.33 93.71 47.17 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU B 22 GLU~? 10.35 CL CL B 309 A 226 THR B 57 THR^? 10.93 CL CL B 310 A 229 LYS A 92 LYS^? 11.11 CL CL B 310 coo 9.66 102.78 70.07 9.79 101.18 71.42 3.91 -22.17 5.69 2.98 -20.35 5.17 coo 7.24 97.46 49.60 8.11 95.69 48.80 19.99 -13.42 -3.76 20.40 -11.62 -4.84 coo 10.53 97.56 43.71 9.33 93.71 47.17 19.55 -4.78 -4.39 22.13 -9.97 -1.89 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 3 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU B 22 GLU~? 10.35 CL CL B 309 B 226 THR B 57 THR^? 10.93 CL CL B 310 B 229 LYS A 92 LYS^? 11.11 CL CL B 310 coo 15.90 87.61 49.61 13.92 86.96 49.36 3.91 -22.17 5.69 2.98 -20.35 5.17 coo 20.74 95.78 68.68 19.29 96.84 69.83 19.99 -13.42 -3.76 20.40 -11.62 -4.84 coo 22.32 101.61 71.64 17.89 98.63 71.55 19.55 -4.78 -4.39 22.13 -9.97 -1.89 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU B 22 GLU~? 10.35 CL CL B 309 C 226 THR B 57 THR^? 10.93 CL CL B 310 C 229 LYS A 92 LYS^? 11.11 CL CL B 310 coo 5.43 40.40 61.63 4.27 41.99 60.90 3.91 -22.17 5.69 2.98 -20.35 5.17 coo 22.16 45.88 73.63 23.23 47.70 73.25 19.99 -13.42 -3.76 20.40 -11.62 -4.84 coo 28.90 45.91 73.55 25.22 49.72 72.97 19.55 -4.78 -4.39 22.13 -9.97 -1.89 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU B 22 GLU~? 10.35 CL CL B 309 D 226 THR B 57 THR^? 10.93 CL CL B 310 D 229 LYS A 92 LYS^? 11.11 CL CL B 310 coo 26.07 55.89 66.14 25.33 56.50 68.01 3.91 -22.17 5.69 2.98 -20.35 5.17 coo 11.79 47.62 52.67 10.10 46.51 53.39 19.99 -13.42 -3.76 20.40 -11.62 -4.84 coo 10.05 41.79 49.80 7.94 44.71 53.76 19.55 -4.78 -4.39 22.13 -9.97 -1.89 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c07 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s 150 LYS A 96 LYS.? 5.78 O2 CAC A 313 186 ASN A 67 ASN~? 8.15 ZN ZN A 303 coo 32.88 50.55 24.33 31.89 51.78 26.65 10.20 -0.74 -0.90 7.99 0.53 0.19 coo 27.04 52.42 22.30 26.88 49.99 27.00 8.76 -5.89 1.16 6.19 -2.58 4.65 coo 36.98 50.30 37.29 35.85 50.29 35.50 14.02 0.88 -12.67 14.89 2.62 -13.50 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 150 LYS A 72 LYS~? 17.83 ZN ZN A 303 186 ASN A 35 ASN.? -3.83 C1 CAC A 313s coo 32.88 50.55 24.33 31.89 51.78 26.65 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 27.04 52.42 22.30 26.88 49.99 27.00 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 36.98 50.30 37.29 35.85 50.29 35.50 5.46 9.42 0.51 4.48 8.02 1.68 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR B 2 TYR^? 13.50 CL CL A 306 150 LYS B 96 LYS.? 11.54 CL CL A 306 186 ASN B 67 ASN~? 12.71 C1 PEG B 312 coo 32.88 50.55 24.33 31.89 51.78 26.65 15.58 -0.36 14.99 13.00 0.51 15.42 coo 27.04 52.42 22.30 26.88 49.99 27.00 17.33 4.64 12.77 13.37 4.64 15.16 coo 36.98 50.30 37.29 35.85 50.29 35.50 22.54 -6.70 23.21 22.14 -8.65 23.93 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 150 LYS B 72 LYS~? -3.48 O1 PEG B 312s 186 ASN B 35 ASN.? 17.32 O2 CAC A 313 coo 32.88 50.55 24.33 31.89 51.78 26.65 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 27.04 52.42 22.30 26.88 49.99 27.00 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 36.98 50.30 37.29 35.85 50.29 35.50 5.40 -3.36 18.41 3.28 -3.68 18.28 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 5 3 # 5 146 TYR B 80 TYR~? 5.35 CL CL B 310 150 LYS B 16 LYS~? 9.68 ZN ZN B 304 186 ASN B 43 ASN^? 8.09 CL CL B 308 coo 32.88 50.55 24.33 31.89 51.78 26.65 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 27.04 52.42 22.30 26.88 49.99 27.00 14.27 -25.10 0.23 14.58 -27.01 3.12 coo 36.98 50.30 37.29 35.85 50.29 35.50 17.50 -9.23 -1.99 17.56 -8.09 -0.19 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 5 hits 1dhr_c00 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 2 TYR^? -4.58 O2 CAC A 313s A 183 LYS A 95 LYS.? 9.36 CL CL B 309 A 278 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 19.43 18.53 42.32 17.66 18.80 40.15 10.20 -0.74 -0.90 7.99 0.53 0.19 coo 21.92 15.80 36.19 17.64 19.44 36.35 10.49 -7.40 -1.88 7.13 -10.96 -4.27 coo 15.46 19.03 31.40 15.01 18.25 33.31 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR A 3 TYR^? 10.95 ZN ZN A 303 A 183 LYS A 95 LYS.? 9.36 CL CL B 309 A 278 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 19.43 18.53 42.32 17.66 18.80 40.15 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 21.92 15.80 36.19 17.64 19.44 36.35 10.49 -7.40 -1.88 7.13 -10.96 -4.27 coo 15.46 19.03 31.40 15.01 18.25 33.31 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 1do8_c00 MALIC ENZYME user 3 3 # 3 A 112 TYR B 2 TYR^? 13.50 CL CL A 306 A 183 LYS B 95 LYS.? 9.10 CL CL A 306 A 278 ASP A 48 ASP.? -15.94 CL CL A 307s coo 19.43 18.53 42.32 17.66 18.80 40.15 15.58 -0.36 14.99 13.00 0.51 15.42 coo 21.92 15.80 36.19 17.64 19.44 36.35 20.80 3.86 14.18 20.78 8.31 16.72 coo 15.46 19.03 31.40 15.01 18.25 33.31 26.96 2.23 21.50 26.58 3.74 22.88 1do8_c00 source 1do8 MALIC ENZYME : 3 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 2 TYR^? -4.58 O2 CAC A 313s B 183 LYS A 95 LYS.? 9.36 CL CL B 309 B 278 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 58.62 15.99 58.34 60.98 14.60 58.93 10.20 -0.74 -0.90 7.99 0.53 0.19 coo 60.11 10.60 53.63 62.59 10.74 58.67 10.49 -7.40 -1.88 7.13 -10.96 -4.27 coo 66.50 7.32 58.45 66.26 9.42 58.23 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR A 3 TYR^? 10.95 ZN ZN A 303 B 183 LYS A 95 LYS.? 9.36 CL CL B 309 B 278 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 58.62 15.99 58.34 60.98 14.60 58.93 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 60.11 10.60 53.63 62.59 10.74 58.67 10.49 -7.40 -1.88 7.13 -10.96 -4.27 coo 66.50 7.32 58.45 66.26 9.42 58.23 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 1do8_c01 MALIC ENZYME user 3 3 # 3 B 112 TYR B 2 TYR^? 13.50 CL CL A 306 B 183 LYS B 95 LYS.? 9.10 CL CL A 306 B 278 ASP A 48 ASP.? -15.94 CL CL A 307s coo 58.62 15.99 58.34 60.98 14.60 58.93 15.58 -0.36 14.99 13.00 0.51 15.42 coo 60.11 10.60 53.63 62.59 10.74 58.67 20.80 3.86 14.18 20.78 8.31 16.72 coo 66.50 7.32 58.45 66.26 9.42 58.23 26.96 2.23 21.50 26.58 3.74 22.88 ULMN 3 1do8_c01 MALIC ENZYME user 4 3 # 4 B 112 TYR B 3 TYR^? 11.16 C1 PEG B 312 B 183 LYS B 95 LYS.? 9.10 CL CL A 306 B 278 ASP A 48 ASP.? -15.94 CL CL A 307s coo 58.62 15.99 58.34 60.98 14.60 58.93 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 60.11 10.60 53.63 62.59 10.74 58.67 20.80 3.86 14.18 20.78 8.31 16.72 coo 66.50 7.32 58.45 66.26 9.42 58.23 26.96 2.23 21.50 26.58 3.74 22.88 1do8_c01 source 1do8 MALIC ENZYME : 4 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 2 TYR^? -4.58 O2 CAC A 313s C 183 LYS A 95 LYS.? 9.36 CL CL B 309 C 278 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 10.20 -0.74 -0.90 7.99 0.53 0.19 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 10.49 -7.40 -1.88 7.13 -10.96 -4.27 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR A 3 TYR^? 10.95 ZN ZN A 303 C 183 LYS A 95 LYS.? 9.36 CL CL B 309 C 278 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 10.49 -7.40 -1.88 7.13 -10.96 -4.27 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 1do8_c02 MALIC ENZYME user 3 3 # 3 C 112 TYR B 2 TYR^? 13.50 CL CL A 306 C 183 LYS B 95 LYS.? 9.10 CL CL A 306 C 278 ASP A 48 ASP.? -15.94 CL CL A 307s coo 76.02 -16.57 8.89 78.24 -15.17 9.87 15.58 -0.36 14.99 13.00 0.51 15.42 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 20.80 3.86 14.18 20.78 8.31 16.72 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 26.96 2.23 21.50 26.58 3.74 22.88 1do8_c02 source 1do8 MALIC ENZYME : 3 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 2 TYR^? -4.58 O2 CAC A 313s D 183 LYS A 95 LYS.? 9.36 CL CL B 309 D 278 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 10.20 -0.74 -0.90 7.99 0.53 0.19 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 10.49 -7.40 -1.88 7.13 -10.96 -4.27 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR A 3 TYR^? 10.95 ZN ZN A 303 D 183 LYS A 95 LYS.? 9.36 CL CL B 309 D 278 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 10.49 -7.40 -1.88 7.13 -10.96 -4.27 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 1do8_c03 MALIC ENZYME user 3 3 # 3 D 112 TYR B 2 TYR^? 13.50 CL CL A 306 D 183 LYS B 95 LYS.? 9.10 CL CL A 306 D 278 ASP A 48 ASP.? -15.94 CL CL A 307s coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 15.58 -0.36 14.99 13.00 0.51 15.42 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 20.80 3.86 14.18 20.78 8.31 16.72 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 26.96 2.23 21.50 26.58 3.74 22.88 1do8_c03 source 1do8 MALIC ENZYME : 3 hits 1do8_c03 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 96 LYS.? 5.78 O2 CAC A 313 B 215 LYS A 92 LYS^? 11.11 CL CL B 310 B 277 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 6.78 45.91 16.15 7.82 40.81 15.84 8.76 -5.89 1.16 6.19 -2.58 4.65 coo 17.88 38.77 19.81 16.38 34.23 17.24 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 20.33 37.78 11.20 16.77 34.53 13.47 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS B 96 LYS.? 11.54 CL CL A 306 B 215 LYS B 92 LYS^? 11.01 CL CL A 307 B 277 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 6.78 45.91 16.15 7.82 40.81 15.84 17.33 4.64 12.77 13.37 4.64 15.16 coo 17.88 38.77 19.81 16.38 34.23 17.24 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 20.33 37.78 11.20 16.77 34.53 13.47 23.06 -12.55 15.81 27.03 -9.57 14.36 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 2 hits 1e19_c01 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 80 TYR~? 5.67 CL CL A 307 A 40 ASP A 88 ASP^? 16.22 CL CL A 305 A 103 ASP A 9 ASP^? 7.20 CL CL A 307 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 28.47 9.96 3.42 27.66 10.97 5.91 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR B 80 TYR~? 5.35 CL CL B 310 A 40 ASP B 88 ASP^? 4.66 O4 PEG B 312 A 103 ASP B 9 ASP^? 7.08 CL CL B 310 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 20.52 -16.92 -1.41 18.60 -16.56 -0.65 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 2 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 80 TYR~? 5.67 CL CL A 307 B 40 ASP A 88 ASP^? 16.22 CL CL A 305 B 103 ASP A 9 ASP^? 7.20 CL CL A 307 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 28.47 9.96 3.42 27.66 10.97 5.91 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 80 TYR~? 5.35 CL CL B 310 B 40 ASP B 88 ASP^? 4.66 O4 PEG B 312 B 103 ASP B 9 ASP^? 7.08 CL CL B 310 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 20.52 -16.92 -1.41 18.60 -16.56 -0.65 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 2 hits 1e3v_c03 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 70 ALA~? 8.84 ZN ZN A 303 A 136 TYR A 3 TYR^? 10.95 ZN ZN A 303 A 140 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 55.90 7.49 23.83 56.71 8.23 22.76 17.79 4.61 -10.66 16.34 5.04 -10.74 coo 59.38 10.02 17.51 59.95 9.89 20.21 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 59.52 3.69 18.67 62.31 6.19 22.58 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA A 83 ALA~? 12.04 CL CL A 307 A 136 TYR A 80 TYR~? 5.67 CL CL A 307 A 140 LYS A 16 LYS~? 15.92 CL CL A 307 coo 55.90 7.49 23.83 56.71 8.23 22.76 33.83 12.87 0.31 32.89 13.15 1.44 coo 59.38 10.02 17.51 59.95 9.89 20.21 28.47 9.96 3.42 27.66 10.97 5.91 coo 59.52 3.69 18.67 62.31 6.19 22.58 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 3 3 # 3 A 107 ALA B 70 ALA~? 11.11 C1 PEG B 312 A 136 TYR B 3 TYR^? 11.16 C1 PEG B 312 A 140 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 55.90 7.49 23.83 56.71 8.23 22.76 20.76 -11.38 20.58 19.79 -10.65 21.49 coo 59.38 10.02 17.51 59.95 9.89 20.21 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 59.52 3.69 18.67 62.31 6.19 22.58 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 4 3 # 4 A 107 ALA B 83 ALA~? 8.27 ZN ZN B 304 A 136 TYR B 80 TYR~? 5.35 CL CL B 310 A 140 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 55.90 7.49 23.83 56.71 8.23 22.76 17.90 -25.48 5.48 16.55 -24.98 4.93 coo 59.38 10.02 17.51 59.95 9.89 20.21 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 59.52 3.69 18.67 62.31 6.19 22.58 14.27 -25.10 0.23 14.58 -27.01 3.12 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 4 hits 1e7q_c01 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 177 ASP A 78 ASP~? 6.31 CL CL A 305 A 203 LYS A 16 LYS~? 15.92 CL CL A 307 coo 8.74 45.76 47.19 9.33 46.93 45.56 24.25 11.32 4.20 23.54 9.34 4.43 coo 11.68 42.31 52.96 12.05 43.92 51.65 25.71 9.07 -1.28 24.93 9.58 0.62 coo 18.07 52.81 49.62 14.17 49.99 48.07 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 177 ASP A 78 ASP~? 6.31 CL CL A 305 A 203 LYS A 29 LYS~? -2.69 OH6A1PE A 311s coo 8.74 45.76 47.19 9.33 46.93 45.56 24.25 11.32 4.20 23.54 9.34 4.43 coo 11.68 42.31 52.96 12.05 43.92 51.65 25.71 9.07 -1.28 24.93 9.58 0.62 coo 18.07 52.81 49.62 14.17 49.99 48.07 14.86 14.41 3.43 16.20 19.44 6.35 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 3 3 # 3 A 99 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 177 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 203 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 8.74 45.76 47.19 9.33 46.93 45.56 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 11.68 42.31 52.96 12.05 43.92 51.65 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 18.07 52.81 49.62 14.17 49.99 48.07 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 4 3 # 4 A 99 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 177 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 203 LYS B 29 LYS~? 10.16 CL CL B 309 coo 8.74 45.76 47.19 9.33 46.93 45.56 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 11.68 42.31 52.96 12.05 43.92 51.65 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 18.07 52.81 49.62 14.17 49.99 48.07 5.16 -12.71 12.47 1.26 -15.97 8.59 1ecx_c02 source 1ecx AMINOTRANSFERASE : 4 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS A 24 HIS~? 3.26 ZN ZN A 301s B 177 ASP A 78 ASP~? 6.31 CL CL A 305 B 203 LYS A 16 LYS~? 15.92 CL CL A 307 coo 14.87 88.04 21.51 13.64 87.90 19.81 24.25 11.32 4.20 23.54 9.34 4.43 coo 15.87 92.46 27.37 14.46 91.76 25.94 25.71 9.07 -1.28 24.93 9.58 0.62 coo 3.60 91.42 23.52 8.20 89.55 22.63 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 2 3 # 2 B 99 HIS A 24 HIS~? 3.26 ZN ZN A 301s B 177 ASP A 78 ASP~? 6.31 CL CL A 305 B 203 LYS A 29 LYS~? -2.69 OH6A1PE A 311s coo 14.87 88.04 21.51 13.64 87.90 19.81 24.25 11.32 4.20 23.54 9.34 4.43 coo 15.87 92.46 27.37 14.46 91.76 25.94 25.71 9.07 -1.28 24.93 9.58 0.62 coo 3.60 91.42 23.52 8.20 89.55 22.63 14.86 14.41 3.43 16.20 19.44 6.35 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 3 3 # 3 B 99 HIS B 24 HIS~? 3.28 ZN ZN B 302s B 177 ASP B 78 ASP~? 6.36 ZN ZN B 302 B 203 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 14.87 88.04 21.51 13.64 87.90 19.81 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 15.87 92.46 27.37 14.46 91.76 25.94 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 3.60 91.42 23.52 8.20 89.55 22.63 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 4 3 # 4 B 99 HIS B 24 HIS~? 3.28 ZN ZN B 302s B 177 ASP B 78 ASP~? 6.36 ZN ZN B 302 B 203 LYS B 29 LYS~? 10.16 CL CL B 309 coo 14.87 88.04 21.51 13.64 87.90 19.81 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 15.87 92.46 27.37 14.46 91.76 25.94 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 3.60 91.42 23.52 8.20 89.55 22.63 5.16 -12.71 12.47 1.26 -15.97 8.59 1ecx_c03 source 1ecx AMINOTRANSFERASE : 4 hits 1ecx_c03 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 197 ASP A 78 ASP~? 6.31 CL CL A 305 A 223 LYS A 16 LYS~? 15.92 CL CL A 307 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 24.25 11.32 4.20 23.54 9.34 4.43 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 25.71 9.07 -1.28 24.93 9.58 0.62 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 34.52 13.28 7.19 39.00 11.44 3.22 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 1 hits 1elq_c02 naa= 3 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 1 3 # 1 150 ASP A 78 ASP~? 6.31 CL CL A 305 153 ARG A 27 ARG~? 9.04 CL CL A 305 177 HIS A 24 HIS~? 3.26 ZN ZN A 301s coo 6.83 2.75 19.17 7.40 0.75 19.11 25.71 9.07 -1.28 24.93 9.58 0.62 coo 1.78 0.50 17.43 2.55 -2.31 16.44 21.75 13.08 -2.42 22.26 10.12 -3.14 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 24.25 11.32 4.20 23.54 9.34 4.43 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 2 3 # 2 150 ASP B 78 ASP~? 6.36 ZN ZN B 302 153 ARG B 27 ARG~? 9.37 CL CL B 308 177 HIS B 24 HIS~? 3.28 ZN ZN B 302s coo 6.83 2.75 19.17 7.40 0.75 19.11 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 1.78 0.50 17.43 2.55 -2.31 16.44 12.55 -18.09 13.90 15.25 -16.65 13.55 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 11.77 -17.25 6.59 12.69 -15.38 6.18 1emd_c01 source 1emd MALATE DEHYDROGENASE (E.C.1.1.1.37) : 2 hits 1emd_c01 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 54 ALA~? 15.05 CL CL A 307 A 257 ALA A 45 ALA.? 12.68 CL CL A 307 A 328 ASP A 9 ASP^? 7.20 CL CL A 307 coo 39.84 24.12 8.44 38.50 24.23 9.11 34.63 3.90 17.29 33.94 2.78 18.03 coo 43.22 26.73 5.37 41.81 27.09 5.79 30.85 -0.04 14.74 32.25 0.57 14.48 coo 38.17 34.10 6.67 37.72 32.06 6.84 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 54 ALA~? 15.05 CL CL A 307 A 257 ALA A 45 ALA.? 12.68 CL CL A 307 A 328 ASP A 47 ASP.? 12.21 O1 PEG B 312 coo 39.84 24.12 8.44 38.50 24.23 9.11 34.63 3.90 17.29 33.94 2.78 18.03 coo 43.22 26.73 5.37 41.81 27.09 5.79 30.85 -0.04 14.74 32.25 0.57 14.48 coo 38.17 34.10 6.67 37.72 32.06 6.84 26.48 -3.27 20.58 24.45 -3.78 20.72 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 54 ALA~? 15.05 CL CL A 307 A 257 ALA A 45 ALA.? 12.68 CL CL A 307 A 328 ASP A 48 ASP.? -15.94 CL CL A 307s coo 39.84 24.12 8.44 38.50 24.23 9.11 34.63 3.90 17.29 33.94 2.78 18.03 coo 43.22 26.73 5.37 41.81 27.09 5.79 30.85 -0.04 14.74 32.25 0.57 14.48 coo 38.17 34.10 6.67 37.72 32.06 6.84 26.96 2.23 21.50 26.58 3.74 22.88 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 70 ALA~? 8.84 ZN ZN A 303 A 257 ALA A 71 ALA~? 12.17 ZN ZN A 303 A 328 ASP B 47 ASP.? 11.08 ZN ZN A 303 coo 39.84 24.12 8.44 38.50 24.23 9.11 17.79 4.61 -10.66 16.34 5.04 -10.74 coo 43.22 26.73 5.37 41.81 27.09 5.79 18.56 3.18 -7.16 18.06 1.87 -6.63 coo 38.17 34.10 6.67 37.72 32.06 6.84 15.08 -4.94 -11.66 14.38 -3.13 -10.90 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA A 71 ALA~? 12.17 ZN ZN A 303 A 257 ALA A 70 ALA~? 8.84 ZN ZN A 303 A 328 ASP B 47 ASP.? 11.08 ZN ZN A 303 coo 39.84 24.12 8.44 38.50 24.23 9.11 18.56 3.18 -7.16 18.06 1.87 -6.63 coo 43.22 26.73 5.37 41.81 27.09 5.79 17.79 4.61 -10.66 16.34 5.04 -10.74 coo 38.17 34.10 6.67 37.72 32.06 6.84 15.08 -4.94 -11.66 14.38 -3.13 -10.90 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA A 75 ALA~? 9.75 CL CL A 305 A 257 ALA A 76 ALA~? 13.94 CL CL A 305 A 328 ASP A 88 ASP^? 16.22 CL CL A 305 coo 39.84 24.12 8.44 38.50 24.23 9.11 23.53 5.60 -4.32 23.61 4.10 -4.21 coo 43.22 26.73 5.37 41.81 27.09 5.79 26.46 6.65 -6.52 26.58 6.29 -8.00 coo 38.17 34.10 6.67 37.72 32.06 6.84 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA A 76 ALA~? 13.94 CL CL A 305 A 257 ALA A 75 ALA~? 9.75 CL CL A 305 A 328 ASP A 88 ASP^? 16.22 CL CL A 305 coo 39.84 24.12 8.44 38.50 24.23 9.11 26.46 6.65 -6.52 26.58 6.29 -8.00 coo 43.22 26.73 5.37 41.81 27.09 5.79 23.53 5.60 -4.32 23.61 4.10 -4.21 coo 38.17 34.10 6.67 37.72 32.06 6.84 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA B 54 ALA~? 14.55 CL CL B 310 A 257 ALA B 45 ALA.? 12.47 CL CL B 310 A 328 ASP B 9 ASP^? 7.08 CL CL B 310 coo 39.84 24.12 8.44 38.50 24.23 9.11 15.06 -16.25 -11.15 15.03 -14.81 -11.68 coo 43.22 26.73 5.37 41.81 27.09 5.79 17.71 -11.65 -8.32 18.01 -13.13 -8.63 coo 38.17 34.10 6.67 37.72 32.06 6.84 20.52 -16.92 -1.41 18.60 -16.56 -0.65 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA B 54 ALA~? 14.55 CL CL B 310 A 257 ALA B 45 ALA.? 12.47 CL CL B 310 A 328 ASP B 47 ASP.? 11.08 ZN ZN A 303 coo 39.84 24.12 8.44 38.50 24.23 9.11 15.06 -16.25 -11.15 15.03 -14.81 -11.68 coo 43.22 26.73 5.37 41.81 27.09 5.79 17.71 -11.65 -8.32 18.01 -13.13 -8.63 coo 38.17 34.10 6.67 37.72 32.06 6.84 15.08 -4.94 -11.66 14.38 -3.13 -10.90 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA B 54 ALA~? 14.55 CL CL B 310 A 257 ALA B 45 ALA.? 12.47 CL CL B 310 A 328 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 39.84 24.12 8.44 38.50 24.23 9.11 15.06 -16.25 -11.15 15.03 -14.81 -11.68 coo 43.22 26.73 5.37 41.81 27.09 5.79 17.71 -11.65 -8.32 18.01 -13.13 -8.63 coo 38.17 34.10 6.67 37.72 32.06 6.84 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA B 70 ALA~? 11.11 C1 PEG B 312 A 257 ALA B 71 ALA~? 8.09 C1 PEG B 312 A 328 ASP A 47 ASP.? 12.21 O1 PEG B 312 coo 39.84 24.12 8.44 38.50 24.23 9.11 20.76 -11.38 20.58 19.79 -10.65 21.49 coo 43.22 26.73 5.37 41.81 27.09 5.79 20.29 -10.20 16.98 20.65 -8.82 16.46 coo 38.17 34.10 6.67 37.72 32.06 6.84 26.48 -3.27 20.58 24.45 -3.78 20.72 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA B 71 ALA~? 8.09 C1 PEG B 312 A 257 ALA B 70 ALA~? 11.11 C1 PEG B 312 A 328 ASP A 47 ASP.? 12.21 O1 PEG B 312 coo 39.84 24.12 8.44 38.50 24.23 9.11 20.29 -10.20 16.98 20.65 -8.82 16.46 coo 43.22 26.73 5.37 41.81 27.09 5.79 20.76 -11.38 20.58 19.79 -10.65 21.49 coo 38.17 34.10 6.67 37.72 32.06 6.84 26.48 -3.27 20.58 24.45 -3.78 20.72 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 12 hits 1eo7_c00 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 16 LYS~? 15.92 CL CL A 307 A 193 GLU A 22 GLU~? -5.00 C13 1PE A 311s A 217 VAL A 20 VAL~? 10.30 CL CL A 307 coo 2.10 10.68 61.44 -2.14 13.16 60.61 34.52 13.28 7.19 39.00 11.44 3.22 coo -5.33 11.71 69.72 -4.62 11.92 67.73 23.55 20.26 6.43 24.10 22.30 6.48 coo 0.07 12.29 66.53 -0.24 11.95 64.38 29.36 15.83 5.12 30.39 15.03 3.31 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS B 16 LYS~? 9.68 ZN ZN B 304 A 193 GLU B 22 GLU~? 10.35 CL CL B 309 A 217 VAL B 20 VAL~? 8.62 ZN ZN B 304 coo 2.10 10.68 61.44 -2.14 13.16 60.61 14.27 -25.10 0.23 14.58 -27.01 3.12 coo -5.33 11.71 69.72 -4.62 11.92 67.73 3.91 -22.17 5.69 2.98 -20.35 5.17 coo 0.07 12.29 66.53 -0.24 11.95 64.38 10.47 -24.03 5.16 12.49 -24.63 5.71 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 2 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 57 THR^? 10.92 CL CL A 307 A 159 LYS B 92 LYS^? 11.01 CL CL A 307 A 193 GLU A 49 GLU.? 12.26 CL CL A 306 coo -2.58 16.31 54.79 -4.02 14.93 55.64 30.98 0.89 9.38 30.52 -0.91 10.45 coo 2.10 10.68 61.44 -2.14 13.16 60.61 25.00 -4.81 12.30 28.64 -2.55 7.65 coo -5.33 11.71 69.72 -4.62 11.92 67.73 21.20 3.66 19.03 19.27 4.46 18.88 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR B 57 THR^? 10.93 CL CL B 310 A 159 LYS A 92 LYS^? 11.11 CL CL B 310 A 193 GLU B 49 GLU.? 12.07 C2 CAC A 313 coo -2.58 16.31 54.79 -4.02 14.93 55.64 19.99 -13.42 -3.76 20.40 -11.62 -4.84 coo 2.10 10.68 61.44 -2.14 13.16 60.61 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo -5.33 11.71 69.72 -4.62 11.92 67.73 7.03 -7.10 -6.90 6.04 -5.38 -6.16 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR B 60 THR^? 7.41 CL CL B 308 A 159 LYS A 92 LYS^? 11.11 CL CL B 310 A 193 GLU B 49 GLU.? 12.07 C2 CAC A 313 coo -2.58 16.31 54.79 -4.02 14.93 55.64 17.06 -8.12 4.50 17.74 -6.27 3.55 coo 2.10 10.68 61.44 -2.14 13.16 60.61 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo -5.33 11.71 69.72 -4.62 11.92 67.73 7.03 -7.10 -6.90 6.04 -5.38 -6.16 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 3 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 47 ASP.? 12.21 O1 PEG B 312 260 GLU A 49 GLU.? 12.26 CL CL A 306 370 TYR B 2 TYR^? 13.50 CL CL A 306 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 21.20 3.66 19.03 19.27 4.46 18.88 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 15.58 -0.36 14.99 13.00 0.51 15.42 1euu_c00 source 1euu SIALIDASE : 1 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 66 GLU.? -2.36 ZN ZN A 303s A 260 ARG A 27 ARG~? 9.04 CL CL A 305 A 270 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 50.99 29.43 12.86 52.11 29.45 14.65 11.68 6.52 -11.11 9.60 6.56 -10.92 coo 39.80 27.50 22.98 42.20 26.56 21.34 21.75 13.08 -2.42 22.26 10.12 -3.14 coo 48.83 21.70 19.50 47.44 24.99 15.25 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU A 82 GLU~? -16.67 C13 1PE A 311s A 260 ARG A 21 ARG~? 8.34 C22 1PE A 311s A 270 LYS A 16 LYS~? 15.92 CL CL A 307 coo 50.99 29.43 12.86 52.11 29.45 14.65 33.07 14.53 -4.24 32.37 16.29 -5.09 coo 39.80 27.50 22.98 42.20 26.56 21.34 25.14 13.51 10.69 25.11 15.00 13.42 coo 48.83 21.70 19.50 47.44 24.99 15.25 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU B 66 GLU.? -18.09 C1 PEG B 312s A 260 ARG B 27 ARG~? 9.37 CL CL B 308 A 270 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 50.99 29.43 12.86 52.11 29.45 14.65 16.63 -8.08 24.80 15.43 -6.55 25.64 coo 39.80 27.50 22.98 42.20 26.56 21.34 12.55 -18.09 13.90 15.25 -16.65 13.55 coo 48.83 21.70 19.50 47.44 24.99 15.25 23.06 -12.55 15.81 27.03 -9.57 14.36 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 3 hits 1euy_c00 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 6 PHE^? 10.79 CL CL A 305 A 210 ASP A 9 ASP^? 7.20 CL CL A 307 A 244 LYS B 95 LYS.? 9.10 CL CL A 306 coo 9.23 46.77 25.11 11.48 48.39 24.76 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 10.51 37.86 19.71 9.07 39.38 20.04 32.44 3.50 6.30 30.77 4.75 6.60 coo -1.20 42.34 17.67 3.19 45.13 19.06 20.80 3.86 14.18 20.78 8.31 16.72 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 6 PHE^? 10.79 CL CL A 305 A 210 ASP A 88 ASP^? 16.22 CL CL A 305 A 244 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 9.23 46.77 25.11 11.48 48.39 24.76 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 10.51 37.86 19.71 9.07 39.38 20.04 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo -1.20 42.34 17.67 3.19 45.13 19.06 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 6 PHE^? 10.79 CL CL A 305 A 210 ASP B 88 ASP^? 4.66 O4 PEG B 312 A 244 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 9.23 46.77 25.11 11.48 48.39 24.76 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 10.51 37.86 19.71 9.07 39.38 20.04 27.27 -14.86 3.96 28.42 -13.55 5.17 coo -1.20 42.34 17.67 3.19 45.13 19.06 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE A 65 PHE.? 9.58 C2 CAC A 313 A 210 ASP A 78 ASP~? 6.31 CL CL A 305 A 244 LYS A 29 LYS~? -2.69 OH6A1PE A 311s coo 9.23 46.77 25.11 11.48 48.39 24.76 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 10.51 37.86 19.71 9.07 39.38 20.04 25.71 9.07 -1.28 24.93 9.58 0.62 coo -1.20 42.34 17.67 3.19 45.13 19.06 14.86 14.41 3.43 16.20 19.44 6.35 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE A 65 PHE.? 9.58 C2 CAC A 313 A 210 ASP B 47 ASP.? 11.08 ZN ZN A 303 A 244 LYS A 95 LYS.? 9.36 CL CL B 309 coo 9.23 46.77 25.11 11.48 48.39 24.76 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 10.51 37.86 19.71 9.07 39.38 20.04 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -1.20 42.34 17.67 3.19 45.13 19.06 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE A 65 PHE.? 9.58 C2 CAC A 313 A 210 ASP B 47 ASP.? 11.08 ZN ZN A 303 A 244 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo 9.23 46.77 25.11 11.48 48.39 24.76 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 10.51 37.86 19.71 9.07 39.38 20.04 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -1.20 42.34 17.67 3.19 45.13 19.06 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE A 94 PHE^? 7.85 CL CL B 308 A 210 ASP B 47 ASP.? 11.08 ZN ZN A 303 A 244 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 9.23 46.77 25.11 11.48 48.39 24.76 13.53 -4.89 0.44 12.53 -5.50 2.96 coo 10.51 37.86 19.71 9.07 39.38 20.04 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -1.20 42.34 17.67 3.19 45.13 19.06 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE B 6 PHE^? 11.00 CL CL B 308 A 210 ASP B 9 ASP^? 7.08 CL CL B 310 A 244 LYS A 95 LYS.? 9.36 CL CL B 309 coo 9.23 46.77 25.11 11.48 48.39 24.76 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 10.51 37.86 19.71 9.07 39.38 20.04 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo -1.20 42.34 17.67 3.19 45.13 19.06 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE B 6 PHE^? 11.00 CL CL B 308 A 210 ASP B 88 ASP^? 4.66 O4 PEG B 312 A 244 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 9.23 46.77 25.11 11.48 48.39 24.76 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 10.51 37.86 19.71 9.07 39.38 20.04 27.27 -14.86 3.96 28.42 -13.55 5.17 coo -1.20 42.34 17.67 3.19 45.13 19.06 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 112 PHE B 65 PHE.? 11.19 C1 PEG B 312 A 210 ASP A 47 ASP.? 12.21 O1 PEG B 312 A 244 LYS B 95 LYS.? 9.10 CL CL A 306 coo 9.23 46.77 25.11 11.48 48.39 24.76 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 10.51 37.86 19.71 9.07 39.38 20.04 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -1.20 42.34 17.67 3.19 45.13 19.06 20.80 3.86 14.18 20.78 8.31 16.72 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 112 PHE B 65 PHE.? 11.19 C1 PEG B 312 A 210 ASP A 47 ASP.? 12.21 O1 PEG B 312 A 244 LYS B 96 LYS.? 11.54 CL CL A 306 coo 9.23 46.77 25.11 11.48 48.39 24.76 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 10.51 37.86 19.71 9.07 39.38 20.04 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -1.20 42.34 17.67 3.19 45.13 19.06 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 112 PHE B 65 PHE.? 11.19 C1 PEG B 312 A 210 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 244 LYS B 29 LYS~? 10.16 CL CL B 309 coo 9.23 46.77 25.11 11.48 48.39 24.76 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 10.51 37.86 19.71 9.07 39.38 20.04 16.87 -17.86 9.95 15.14 -17.20 8.90 coo -1.20 42.34 17.67 3.19 45.13 19.06 5.16 -12.71 12.47 1.26 -15.97 8.59 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 112 PHE B 94 PHE^? 7.88 CL CL A 305 A 210 ASP A 47 ASP.? 12.21 O1 PEG B 312 A 244 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 9.23 46.77 25.11 11.48 48.39 24.76 19.59 0.56 11.28 18.19 2.21 9.54 coo 10.51 37.86 19.71 9.07 39.38 20.04 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -1.20 42.34 17.67 3.19 45.13 19.06 23.06 -12.55 15.81 27.03 -9.57 14.36 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 13 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 6 PHE^? 10.79 CL CL A 305 B 210 ASP A 9 ASP^? 7.20 CL CL A 307 B 244 LYS B 95 LYS.? 9.10 CL CL A 306 coo 8.76 47.85 34.91 11.08 46.36 35.41 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 9.06 56.85 40.30 7.71 55.27 39.90 32.44 3.50 6.30 30.77 4.75 6.60 coo -2.38 51.82 41.62 2.07 49.19 40.42 20.80 3.86 14.18 20.78 8.31 16.72 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 6 PHE^? 10.79 CL CL A 305 B 210 ASP A 88 ASP^? 16.22 CL CL A 305 B 244 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 8.76 47.85 34.91 11.08 46.36 35.41 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 9.06 56.85 40.30 7.71 55.27 39.90 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo -2.38 51.82 41.62 2.07 49.19 40.42 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 6 PHE^? 10.79 CL CL A 305 B 210 ASP B 88 ASP^? 4.66 O4 PEG B 312 B 244 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 8.76 47.85 34.91 11.08 46.36 35.41 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 9.06 56.85 40.30 7.71 55.27 39.90 27.27 -14.86 3.96 28.42 -13.55 5.17 coo -2.38 51.82 41.62 2.07 49.19 40.42 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE A 65 PHE.? 9.58 C2 CAC A 313 B 210 ASP A 78 ASP~? 6.31 CL CL A 305 B 244 LYS A 29 LYS~? -2.69 OH6A1PE A 311s coo 8.76 47.85 34.91 11.08 46.36 35.41 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 9.06 56.85 40.30 7.71 55.27 39.90 25.71 9.07 -1.28 24.93 9.58 0.62 coo -2.38 51.82 41.62 2.07 49.19 40.42 14.86 14.41 3.43 16.20 19.44 6.35 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE A 65 PHE.? 9.58 C2 CAC A 313 B 210 ASP B 47 ASP.? 11.08 ZN ZN A 303 B 244 LYS A 95 LYS.? 9.36 CL CL B 309 coo 8.76 47.85 34.91 11.08 46.36 35.41 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 9.06 56.85 40.30 7.71 55.27 39.90 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -2.38 51.82 41.62 2.07 49.19 40.42 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE A 65 PHE.? 9.58 C2 CAC A 313 B 210 ASP B 47 ASP.? 11.08 ZN ZN A 303 B 244 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo 8.76 47.85 34.91 11.08 46.36 35.41 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 9.06 56.85 40.30 7.71 55.27 39.90 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -2.38 51.82 41.62 2.07 49.19 40.42 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE A 94 PHE^? 7.85 CL CL B 308 B 210 ASP B 47 ASP.? 11.08 ZN ZN A 303 B 244 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 8.76 47.85 34.91 11.08 46.36 35.41 13.53 -4.89 0.44 12.53 -5.50 2.96 coo 9.06 56.85 40.30 7.71 55.27 39.90 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -2.38 51.82 41.62 2.07 49.19 40.42 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE B 6 PHE^? 11.00 CL CL B 308 B 210 ASP B 9 ASP^? 7.08 CL CL B 310 B 244 LYS A 95 LYS.? 9.36 CL CL B 309 coo 8.76 47.85 34.91 11.08 46.36 35.41 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 9.06 56.85 40.30 7.71 55.27 39.90 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo -2.38 51.82 41.62 2.07 49.19 40.42 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE B 6 PHE^? 11.00 CL CL B 308 B 210 ASP B 88 ASP^? 4.66 O4 PEG B 312 B 244 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 8.76 47.85 34.91 11.08 46.36 35.41 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 9.06 56.85 40.30 7.71 55.27 39.90 27.27 -14.86 3.96 28.42 -13.55 5.17 coo -2.38 51.82 41.62 2.07 49.19 40.42 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 112 PHE B 65 PHE.? 11.19 C1 PEG B 312 B 210 ASP A 47 ASP.? 12.21 O1 PEG B 312 B 244 LYS B 95 LYS.? 9.10 CL CL A 306 coo 8.76 47.85 34.91 11.08 46.36 35.41 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 9.06 56.85 40.30 7.71 55.27 39.90 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -2.38 51.82 41.62 2.07 49.19 40.42 20.80 3.86 14.18 20.78 8.31 16.72 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 112 PHE B 65 PHE.? 11.19 C1 PEG B 312 B 210 ASP A 47 ASP.? 12.21 O1 PEG B 312 B 244 LYS B 96 LYS.? 11.54 CL CL A 306 coo 8.76 47.85 34.91 11.08 46.36 35.41 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 9.06 56.85 40.30 7.71 55.27 39.90 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -2.38 51.82 41.62 2.07 49.19 40.42 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 112 PHE B 65 PHE.? 11.19 C1 PEG B 312 B 210 ASP B 78 ASP~? 6.36 ZN ZN B 302 B 244 LYS B 29 LYS~? 10.16 CL CL B 309 coo 8.76 47.85 34.91 11.08 46.36 35.41 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 9.06 56.85 40.30 7.71 55.27 39.90 16.87 -17.86 9.95 15.14 -17.20 8.90 coo -2.38 51.82 41.62 2.07 49.19 40.42 5.16 -12.71 12.47 1.26 -15.97 8.59 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 112 PHE B 94 PHE^? 7.88 CL CL A 305 B 210 ASP A 47 ASP.? 12.21 O1 PEG B 312 B 244 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 8.76 47.85 34.91 11.08 46.36 35.41 19.59 0.56 11.28 18.19 2.21 9.54 coo 9.06 56.85 40.30 7.71 55.27 39.90 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -2.38 51.82 41.62 2.07 49.19 40.42 23.06 -12.55 15.81 27.03 -9.57 14.36 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 13 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 210 ASP A 78 ASP~? 6.31 CL CL A 305 A 244 LYS A 16 LYS~? 15.92 CL CL A 307 coo 11.28 44.53 18.60 9.91 46.00 19.20 24.25 11.32 4.20 23.54 9.34 4.43 coo 10.51 37.86 19.71 9.07 39.38 20.04 25.71 9.07 -1.28 24.93 9.58 0.62 coo -1.20 42.34 17.67 3.19 45.13 19.06 34.52 13.28 7.19 39.00 11.44 3.22 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 1 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 24 HIS~? 3.26 ZN ZN A 301s B 210 ASP A 78 ASP~? 6.31 CL CL A 305 B 244 LYS A 16 LYS~? 15.92 CL CL A 307 coo 10.08 50.18 41.78 8.91 48.61 41.04 24.25 11.32 4.20 23.54 9.34 4.43 coo 9.06 56.85 40.30 7.71 55.27 39.90 25.71 9.07 -1.28 24.93 9.58 0.62 coo -2.38 51.82 41.62 2.07 49.19 40.42 34.52 13.28 7.19 39.00 11.44 3.22 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 1 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 2 TYR^? -4.58 O2 CAC A 313s A 142 LEU A 37 LEU^? -6.67 O1 CAC A 313s A 165 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 12.54 7.66 2.93 14.55 7.55 3.70 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR A 3 TYR^? 10.95 ZN ZN A 303 A 142 LEU A 38 LEU^? -4.59 O2 CAC A 313s A 165 LYS A 92 LYS^? 11.11 CL CL B 310 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 11.19 1.94 4.03 10.80 0.06 5.11 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR B 2 TYR^? 13.50 CL CL A 306 A 142 LEU B 37 LEU^? 8.67 CL CL B 308 A 165 LYS B 96 LYS.? 11.54 CL CL A 306 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 15.58 -0.36 14.99 13.00 0.51 15.42 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 9.07 -6.74 12.55 9.82 -7.92 10.89 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR B 3 TYR^? 11.16 C1 PEG B 312 A 142 LEU B 38 LEU^? 10.11 O2 CAC A 313 A 165 LYS B 92 LYS^? 11.01 CL CL A 307 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 11.93 -1.82 11.09 12.47 0.10 10.29 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 137 TYR B 80 TYR~? 5.35 CL CL B 310 A 142 LEU B 25 LEU~? 5.32 CL CL B 309 A 165 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 15.15 -19.22 4.72 12.71 -19.06 3.39 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 6.36 -16.53 7.28 6.24 -15.77 5.24 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 14.27 -25.10 0.23 14.58 -27.01 3.12 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 2 TYR^? -4.58 O2 CAC A 313s B 142 LEU A 37 LEU^? -6.67 O1 CAC A 313s B 165 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 12.54 7.66 2.93 14.55 7.55 3.70 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR A 3 TYR^? 10.95 ZN ZN A 303 B 142 LEU A 38 LEU^? -4.59 O2 CAC A 313s B 165 LYS A 92 LYS^? 11.11 CL CL B 310 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 11.19 1.94 4.03 10.80 0.06 5.11 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR A 80 TYR~? 5.67 CL CL A 307 B 142 LEU A 25 LEU~? 4.38 C22 1PE A 311 B 165 LYS A 16 LYS~? 15.92 CL CL A 307 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 28.47 9.96 3.42 27.66 10.97 5.91 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 20.72 14.86 6.54 21.02 13.91 8.48 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR B 2 TYR^? 13.50 CL CL A 306 B 142 LEU B 37 LEU^? 8.67 CL CL B 308 B 165 LYS B 96 LYS.? 11.54 CL CL A 306 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 15.58 -0.36 14.99 13.00 0.51 15.42 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 9.07 -6.74 12.55 9.82 -7.92 10.89 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 137 TYR B 3 TYR^? 11.16 C1 PEG B 312 B 142 LEU B 38 LEU^? 10.11 O2 CAC A 313 B 165 LYS B 92 LYS^? 11.01 CL CL A 307 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 11.93 -1.82 11.09 12.47 0.10 10.29 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 137 TYR B 80 TYR~? 5.35 CL CL B 310 B 142 LEU B 25 LEU~? 5.32 CL CL B 309 B 165 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 15.15 -19.22 4.72 12.71 -19.06 3.39 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 6.36 -16.53 7.28 6.24 -15.77 5.24 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 14.27 -25.10 0.23 14.58 -27.01 3.12 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 2 TYR^? -4.58 O2 CAC A 313s C 142 LEU A 37 LEU^? -6.67 O1 CAC A 313s C 165 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 12.54 7.66 2.93 14.55 7.55 3.70 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR A 3 TYR^? 10.95 ZN ZN A 303 C 142 LEU A 38 LEU^? -4.59 O2 CAC A 313s C 165 LYS A 92 LYS^? 11.11 CL CL B 310 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 11.19 1.94 4.03 10.80 0.06 5.11 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR B 2 TYR^? 13.50 CL CL A 306 C 142 LEU B 37 LEU^? 8.67 CL CL B 308 C 165 LYS B 96 LYS.? 11.54 CL CL A 306 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 15.58 -0.36 14.99 13.00 0.51 15.42 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 9.07 -6.74 12.55 9.82 -7.92 10.89 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR B 3 TYR^? 11.16 C1 PEG B 312 C 142 LEU B 38 LEU^? 10.11 O2 CAC A 313 C 165 LYS B 92 LYS^? 11.01 CL CL A 307 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 11.93 -1.82 11.09 12.47 0.10 10.29 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 137 TYR B 80 TYR~? 5.35 CL CL B 310 C 142 LEU B 25 LEU~? 5.32 CL CL B 309 C 165 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 15.15 -19.22 4.72 12.71 -19.06 3.39 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 6.36 -16.53 7.28 6.24 -15.77 5.24 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 14.27 -25.10 0.23 14.58 -27.01 3.12 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 2 TYR^? -4.58 O2 CAC A 313s D 142 LEU A 37 LEU^? -6.67 O1 CAC A 313s D 165 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 12.54 7.66 2.93 14.55 7.55 3.70 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR A 3 TYR^? 10.95 ZN ZN A 303 D 142 LEU A 38 LEU^? -4.59 O2 CAC A 313s D 165 LYS A 92 LYS^? 11.11 CL CL B 310 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 11.19 1.94 4.03 10.80 0.06 5.11 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR A 80 TYR~? 5.67 CL CL A 307 D 142 LEU A 25 LEU~? 4.38 C22 1PE A 311 D 165 LYS A 16 LYS~? 15.92 CL CL A 307 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 28.47 9.96 3.42 27.66 10.97 5.91 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 20.72 14.86 6.54 21.02 13.91 8.48 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR B 2 TYR^? 13.50 CL CL A 306 D 142 LEU B 37 LEU^? 8.67 CL CL B 308 D 165 LYS B 96 LYS.? 11.54 CL CL A 306 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 15.58 -0.36 14.99 13.00 0.51 15.42 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 9.07 -6.74 12.55 9.82 -7.92 10.89 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 137 TYR B 3 TYR^? 11.16 C1 PEG B 312 D 142 LEU B 38 LEU^? 10.11 O2 CAC A 313 D 165 LYS B 92 LYS^? 11.01 CL CL A 307 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 11.93 -1.82 11.09 12.47 0.10 10.29 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 137 TYR B 80 TYR~? 5.35 CL CL B 310 D 142 LEU B 25 LEU~? 5.32 CL CL B 309 D 165 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 15.15 -19.22 4.72 12.71 -19.06 3.39 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 6.36 -16.53 7.28 6.24 -15.77 5.24 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 14.27 -25.10 0.23 14.58 -27.01 3.12 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 59 SER^? 3.89 CL CL A 305s A 48 THR A 60 THR^? 7.28 CL CL A 305 A 165 LYS A 92 LYS^? 11.11 CL CL B 310 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 24.86 2.91 6.28 24.83 4.11 4.27 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 21.60 1.19 5.39 21.17 -0.74 6.30 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 19.55 -4.78 -4.39 22.13 -9.97 -1.89 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 59 SER^? 3.89 CL CL A 305s B 48 THR A 60 THR^? 7.28 CL CL A 305 B 165 LYS A 92 LYS^? 11.11 CL CL B 310 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 24.86 2.91 6.28 24.83 4.11 4.27 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 21.60 1.19 5.39 21.17 -0.74 6.30 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER B 59 SER^? 3.99 CL CL B 308s B 48 THR B 60 THR^? 7.41 CL CL B 308 B 165 LYS B 92 LYS^? 11.01 CL CL A 307 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 17.09 -11.30 2.44 17.22 -12.60 4.35 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 17.06 -8.12 4.50 17.74 -6.27 3.55 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 25.00 -4.81 12.30 28.64 -2.55 7.65 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 59 SER^? 3.89 CL CL A 305s C 48 THR A 60 THR^? 7.28 CL CL A 305 C 165 LYS A 92 LYS^? 11.11 CL CL B 310 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 24.86 2.91 6.28 24.83 4.11 4.27 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 21.60 1.19 5.39 21.17 -0.74 6.30 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 19.55 -4.78 -4.39 22.13 -9.97 -1.89 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c06 naa= 3 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 1 3 # 1 B 267 ASP A 78 ASP~? 6.31 CL CL A 305 B 268 HIS A 24 HIS~? 3.26 ZN ZN A 301s B 334 TYR A 86 TYR^? 7.10 CL CL A 305 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 25.71 9.07 -1.28 24.93 9.58 0.62 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 24.25 11.32 4.20 23.54 9.34 4.43 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 29.34 5.60 1.24 26.89 6.10 2.52 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 2 3 # 2 B 267 ASP B 78 ASP~? 6.36 ZN ZN B 302 B 268 HIS B 24 HIS~? 3.28 ZN ZN B 302s B 334 TYR B 86 TYR^? 6.73 CL CL B 310 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 19.96 -17.22 4.85 17.58 -15.73 4.95 1fgj_c01 source 1fgj HYDROXYLAMINE OXIDOREDUCTASE : 2 hits 1fgj_c01 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 82 GLU~? -16.67 C13 1PE A 311s A 319 ASP A 78 ASP~? 6.31 CL CL A 305 A 359 ARG A 27 ARG~? 9.04 CL CL A 305 coo 14.41 12.40 16.42 12.92 13.74 15.71 33.07 14.53 -4.24 32.37 16.29 -5.09 coo 12.25 13.04 23.85 11.56 15.02 23.93 25.71 9.07 -1.28 24.93 9.58 0.62 coo 10.89 14.95 28.28 12.39 12.53 29.31 21.75 13.08 -2.42 22.26 10.12 -3.14 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 1 hits 1fr8_c00 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP A 78 ASP~? 6.31 CL CL A 305 A 64 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 155 ASN A 43 ASN^? 7.86 CL CL A 307 coo 3.12 38.70 24.20 3.24 38.59 26.33 25.71 9.07 -1.28 24.93 9.58 0.62 coo 1.90 38.00 29.77 3.91 38.35 29.95 24.25 11.32 4.20 23.54 9.34 4.43 coo 9.89 36.55 37.38 9.27 37.99 36.08 25.90 0.17 10.25 24.19 -0.21 9.00 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 64 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 155 ASN B 43 ASN^? 8.09 CL CL B 308 coo 3.12 38.70 24.20 3.24 38.59 26.33 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 1.90 38.00 29.77 3.91 38.35 29.95 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 9.89 36.55 37.38 9.27 37.99 36.08 17.50 -9.23 -1.99 17.56 -8.09 -0.19 1gns_c00 source 1gns SUBTILISIN BPN' : 2 hits 1gns_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 6 PHE^? 10.79 CL CL A 305 A 298 ASP A 88 ASP^? 16.22 CL CL A 305 A 329 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 2.59 0.29 25.55 4.65 0.18 25.07 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 12.42 6.10 23.27 9.95 1.57 20.16 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE A 56 PHE^? 7.07 CL CL A 307 A 298 ASP A 9 ASP^? 7.20 CL CL A 307 A 329 LYS A 16 LYS~? 15.92 CL CL A 307 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 28.85 5.55 12.29 27.69 7.22 14.19 coo 2.59 0.29 25.55 4.65 0.18 25.07 32.44 3.50 6.30 30.77 4.75 6.60 coo 12.42 6.10 23.27 9.95 1.57 20.16 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE A 56 PHE^? 7.07 CL CL A 307 A 298 ASP A 9 ASP^? 7.20 CL CL A 307 A 329 LYS B 92 LYS^? 11.01 CL CL A 307 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 28.85 5.55 12.29 27.69 7.22 14.19 coo 2.59 0.29 25.55 4.65 0.18 25.07 32.44 3.50 6.30 30.77 4.75 6.60 coo 12.42 6.10 23.27 9.95 1.57 20.16 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE A 56 PHE^? 7.07 CL CL A 307 A 298 ASP A 48 ASP.? -15.94 CL CL A 307s A 329 LYS B 92 LYS^? 11.01 CL CL A 307 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 28.85 5.55 12.29 27.69 7.22 14.19 coo 2.59 0.29 25.55 4.65 0.18 25.07 26.96 2.23 21.50 26.58 3.74 22.88 coo 12.42 6.10 23.27 9.95 1.57 20.16 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE A 56 PHE^? 7.07 CL CL A 307 A 298 ASP A 48 ASP.? -15.94 CL CL A 307s A 329 LYS B 96 LYS.? 11.54 CL CL A 306 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 28.85 5.55 12.29 27.69 7.22 14.19 coo 2.59 0.29 25.55 4.65 0.18 25.07 26.96 2.23 21.50 26.58 3.74 22.88 coo 12.42 6.10 23.27 9.95 1.57 20.16 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE A 65 PHE.? 9.58 C2 CAC A 313 A 298 ASP B 47 ASP.? 11.08 ZN ZN A 303 A 329 LYS A 95 LYS.? 9.36 CL CL B 309 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 2.59 0.29 25.55 4.65 0.18 25.07 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 12.42 6.10 23.27 9.95 1.57 20.16 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 A 189 PHE B 6 PHE^? 11.00 CL CL B 308 A 298 ASP B 88 ASP^? 4.66 O4 PEG B 312 A 329 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 6.56 -4.17 18.88 9.26 -4.62 19.48 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 2.59 0.29 25.55 4.65 0.18 25.07 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 12.42 6.10 23.27 9.95 1.57 20.16 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 A 189 PHE B 56 PHE^? 6.57 CL CL B 310 A 298 ASP B 9 ASP^? 7.08 CL CL B 310 A 329 LYS A 92 LYS^? 11.11 CL CL B 310 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 2.59 0.29 25.55 4.65 0.18 25.07 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 12.42 6.10 23.27 9.95 1.57 20.16 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 A 189 PHE B 56 PHE^? 6.57 CL CL B 310 A 298 ASP B 9 ASP^? 7.08 CL CL B 310 A 329 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 2.59 0.29 25.55 4.65 0.18 25.07 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 12.42 6.10 23.27 9.95 1.57 20.16 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 A 189 PHE B 56 PHE^? 6.57 CL CL B 310 A 298 ASP B 48 ASP.? 14.63 ZN ZN A 303 A 329 LYS A 92 LYS^? 11.11 CL CL B 310 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 2.59 0.29 25.55 4.65 0.18 25.07 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 12.42 6.10 23.27 9.95 1.57 20.16 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 A 189 PHE B 56 PHE^? 6.57 CL CL B 310 A 298 ASP B 48 ASP.? 14.63 ZN ZN A 303 A 329 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 2.59 0.29 25.55 4.65 0.18 25.07 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 12.42 6.10 23.27 9.95 1.57 20.16 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 A 189 PHE B 65 PHE.? 11.19 C1 PEG B 312 A 298 ASP A 47 ASP.? 12.21 O1 PEG B 312 A 329 LYS B 95 LYS.? 9.10 CL CL A 306 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 2.59 0.29 25.55 4.65 0.18 25.07 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 12.42 6.10 23.27 9.95 1.57 20.16 20.80 3.86 14.18 20.78 8.31 16.72 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 12 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 6 PHE^? 10.79 CL CL A 305 B 298 ASP A 88 ASP^? 16.22 CL CL A 305 B 329 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE A 56 PHE^? 7.07 CL CL A 307 B 298 ASP A 9 ASP^? 7.20 CL CL A 307 B 329 LYS A 16 LYS~? 15.92 CL CL A 307 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 28.85 5.55 12.29 27.69 7.22 14.19 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 32.44 3.50 6.30 30.77 4.75 6.60 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE A 56 PHE^? 7.07 CL CL A 307 B 298 ASP A 9 ASP^? 7.20 CL CL A 307 B 329 LYS B 92 LYS^? 11.01 CL CL A 307 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 28.85 5.55 12.29 27.69 7.22 14.19 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 32.44 3.50 6.30 30.77 4.75 6.60 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE A 56 PHE^? 7.07 CL CL A 307 B 298 ASP A 48 ASP.? -15.94 CL CL A 307s B 329 LYS B 92 LYS^? 11.01 CL CL A 307 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 28.85 5.55 12.29 27.69 7.22 14.19 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 26.96 2.23 21.50 26.58 3.74 22.88 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE A 56 PHE^? 7.07 CL CL A 307 B 298 ASP A 48 ASP.? -15.94 CL CL A 307s B 329 LYS B 96 LYS.? 11.54 CL CL A 306 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 28.85 5.55 12.29 27.69 7.22 14.19 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 26.96 2.23 21.50 26.58 3.74 22.88 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE A 65 PHE.? 9.58 C2 CAC A 313 B 298 ASP B 47 ASP.? 11.08 ZN ZN A 303 B 329 LYS A 95 LYS.? 9.36 CL CL B 309 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 B 189 PHE B 6 PHE^? 11.00 CL CL B 308 B 298 ASP B 88 ASP^? 4.66 O4 PEG B 312 B 329 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 20.14 -12.51 41.29 18.81 -10.14 40.57 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 B 189 PHE B 56 PHE^? 6.57 CL CL B 310 B 298 ASP B 9 ASP^? 7.08 CL CL B 310 B 329 LYS A 92 LYS^? 11.11 CL CL B 310 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 B 189 PHE B 56 PHE^? 6.57 CL CL B 310 B 298 ASP B 9 ASP^? 7.08 CL CL B 310 B 329 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 B 189 PHE B 56 PHE^? 6.57 CL CL B 310 B 298 ASP B 48 ASP.? 14.63 ZN ZN A 303 B 329 LYS A 92 LYS^? 11.11 CL CL B 310 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 B 189 PHE B 56 PHE^? 6.57 CL CL B 310 B 298 ASP B 48 ASP.? 14.63 ZN ZN A 303 B 329 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 B 189 PHE B 65 PHE.? 11.19 C1 PEG B 312 B 298 ASP A 47 ASP.? 12.21 O1 PEG B 312 B 329 LYS B 95 LYS.? 9.10 CL CL A 306 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 20.80 3.86 14.18 20.78 8.31 16.72 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 12 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 6 PHE^? 10.79 CL CL A 305 C 298 ASP A 88 ASP^? 16.22 CL CL A 305 C 329 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 17.41 60.57 64.39 18.40 58.12 65.34 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 24.10 66.43 63.33 24.18 64.30 63.40 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 27.64 56.61 58.17 22.18 57.92 60.36 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE A 56 PHE^? 7.07 CL CL A 307 C 298 ASP A 9 ASP^? 7.20 CL CL A 307 C 329 LYS A 16 LYS~? 15.92 CL CL A 307 coo 17.41 60.57 64.39 18.40 58.12 65.34 28.85 5.55 12.29 27.69 7.22 14.19 coo 24.10 66.43 63.33 24.18 64.30 63.40 32.44 3.50 6.30 30.77 4.75 6.60 coo 27.64 56.61 58.17 22.18 57.92 60.36 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE A 56 PHE^? 7.07 CL CL A 307 C 298 ASP A 9 ASP^? 7.20 CL CL A 307 C 329 LYS B 92 LYS^? 11.01 CL CL A 307 coo 17.41 60.57 64.39 18.40 58.12 65.34 28.85 5.55 12.29 27.69 7.22 14.19 coo 24.10 66.43 63.33 24.18 64.30 63.40 32.44 3.50 6.30 30.77 4.75 6.60 coo 27.64 56.61 58.17 22.18 57.92 60.36 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE A 56 PHE^? 7.07 CL CL A 307 C 298 ASP A 48 ASP.? -15.94 CL CL A 307s C 329 LYS B 92 LYS^? 11.01 CL CL A 307 coo 17.41 60.57 64.39 18.40 58.12 65.34 28.85 5.55 12.29 27.69 7.22 14.19 coo 24.10 66.43 63.33 24.18 64.30 63.40 26.96 2.23 21.50 26.58 3.74 22.88 coo 27.64 56.61 58.17 22.18 57.92 60.36 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE A 56 PHE^? 7.07 CL CL A 307 C 298 ASP A 48 ASP.? -15.94 CL CL A 307s C 329 LYS B 96 LYS.? 11.54 CL CL A 306 coo 17.41 60.57 64.39 18.40 58.12 65.34 28.85 5.55 12.29 27.69 7.22 14.19 coo 24.10 66.43 63.33 24.18 64.30 63.40 26.96 2.23 21.50 26.58 3.74 22.88 coo 27.64 56.61 58.17 22.18 57.92 60.36 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE A 65 PHE.? 9.58 C2 CAC A 313 C 298 ASP B 47 ASP.? 11.08 ZN ZN A 303 C 329 LYS A 95 LYS.? 9.36 CL CL B 309 coo 17.41 60.57 64.39 18.40 58.12 65.34 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 24.10 66.43 63.33 24.18 64.30 63.40 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 27.64 56.61 58.17 22.18 57.92 60.36 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 C 189 PHE B 6 PHE^? 11.00 CL CL B 308 C 298 ASP B 88 ASP^? 4.66 O4 PEG B 312 C 329 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 17.41 60.57 64.39 18.40 58.12 65.34 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 24.10 66.43 63.33 24.18 64.30 63.40 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 27.64 56.61 58.17 22.18 57.92 60.36 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 C 189 PHE B 56 PHE^? 6.57 CL CL B 310 C 298 ASP B 9 ASP^? 7.08 CL CL B 310 C 329 LYS A 92 LYS^? 11.11 CL CL B 310 coo 17.41 60.57 64.39 18.40 58.12 65.34 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 24.10 66.43 63.33 24.18 64.30 63.40 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 27.64 56.61 58.17 22.18 57.92 60.36 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 C 189 PHE B 56 PHE^? 6.57 CL CL B 310 C 298 ASP B 9 ASP^? 7.08 CL CL B 310 C 329 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 17.41 60.57 64.39 18.40 58.12 65.34 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 24.10 66.43 63.33 24.18 64.30 63.40 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 27.64 56.61 58.17 22.18 57.92 60.36 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 C 189 PHE B 56 PHE^? 6.57 CL CL B 310 C 298 ASP B 48 ASP.? 14.63 ZN ZN A 303 C 329 LYS A 92 LYS^? 11.11 CL CL B 310 coo 17.41 60.57 64.39 18.40 58.12 65.34 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 24.10 66.43 63.33 24.18 64.30 63.40 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 27.64 56.61 58.17 22.18 57.92 60.36 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 C 189 PHE B 56 PHE^? 6.57 CL CL B 310 C 298 ASP B 48 ASP.? 14.63 ZN ZN A 303 C 329 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo 17.41 60.57 64.39 18.40 58.12 65.34 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 24.10 66.43 63.33 24.18 64.30 63.40 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 27.64 56.61 58.17 22.18 57.92 60.36 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 C 189 PHE B 65 PHE.? 11.19 C1 PEG B 312 C 298 ASP A 47 ASP.? 12.21 O1 PEG B 312 C 329 LYS B 95 LYS.? 9.10 CL CL A 306 coo 17.41 60.57 64.39 18.40 58.12 65.34 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 24.10 66.43 63.33 24.18 64.30 63.40 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 27.64 56.61 58.17 22.18 57.92 60.36 20.80 3.86 14.18 20.78 8.31 16.72 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 12 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 6 PHE^? 10.79 CL CL A 305 D 298 ASP A 88 ASP^? 16.22 CL CL A 305 D 329 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 35.44 53.35 83.81 35.65 54.53 81.28 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 29.72 46.46 83.60 30.79 47.36 81.99 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 36.89 44.91 74.55 37.33 48.94 79.01 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE A 56 PHE^? 7.07 CL CL A 307 D 298 ASP A 9 ASP^? 7.20 CL CL A 307 D 329 LYS A 16 LYS~? 15.92 CL CL A 307 coo 35.44 53.35 83.81 35.65 54.53 81.28 28.85 5.55 12.29 27.69 7.22 14.19 coo 29.72 46.46 83.60 30.79 47.36 81.99 32.44 3.50 6.30 30.77 4.75 6.60 coo 36.89 44.91 74.55 37.33 48.94 79.01 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE A 56 PHE^? 7.07 CL CL A 307 D 298 ASP A 9 ASP^? 7.20 CL CL A 307 D 329 LYS B 92 LYS^? 11.01 CL CL A 307 coo 35.44 53.35 83.81 35.65 54.53 81.28 28.85 5.55 12.29 27.69 7.22 14.19 coo 29.72 46.46 83.60 30.79 47.36 81.99 32.44 3.50 6.30 30.77 4.75 6.60 coo 36.89 44.91 74.55 37.33 48.94 79.01 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE A 56 PHE^? 7.07 CL CL A 307 D 298 ASP A 48 ASP.? -15.94 CL CL A 307s D 329 LYS B 92 LYS^? 11.01 CL CL A 307 coo 35.44 53.35 83.81 35.65 54.53 81.28 28.85 5.55 12.29 27.69 7.22 14.19 coo 29.72 46.46 83.60 30.79 47.36 81.99 26.96 2.23 21.50 26.58 3.74 22.88 coo 36.89 44.91 74.55 37.33 48.94 79.01 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE A 56 PHE^? 7.07 CL CL A 307 D 298 ASP A 48 ASP.? -15.94 CL CL A 307s D 329 LYS B 96 LYS.? 11.54 CL CL A 306 coo 35.44 53.35 83.81 35.65 54.53 81.28 28.85 5.55 12.29 27.69 7.22 14.19 coo 29.72 46.46 83.60 30.79 47.36 81.99 26.96 2.23 21.50 26.58 3.74 22.88 coo 36.89 44.91 74.55 37.33 48.94 79.01 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE A 65 PHE.? 9.58 C2 CAC A 313 D 298 ASP B 47 ASP.? 11.08 ZN ZN A 303 D 329 LYS A 95 LYS.? 9.36 CL CL B 309 coo 35.44 53.35 83.81 35.65 54.53 81.28 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 29.72 46.46 83.60 30.79 47.36 81.99 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 36.89 44.91 74.55 37.33 48.94 79.01 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 D 189 PHE B 6 PHE^? 11.00 CL CL B 308 D 298 ASP B 88 ASP^? 4.66 O4 PEG B 312 D 329 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 35.44 53.35 83.81 35.65 54.53 81.28 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 29.72 46.46 83.60 30.79 47.36 81.99 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 36.89 44.91 74.55 37.33 48.94 79.01 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 D 189 PHE B 56 PHE^? 6.57 CL CL B 310 D 298 ASP B 9 ASP^? 7.08 CL CL B 310 D 329 LYS A 92 LYS^? 11.11 CL CL B 310 coo 35.44 53.35 83.81 35.65 54.53 81.28 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 29.72 46.46 83.60 30.79 47.36 81.99 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 36.89 44.91 74.55 37.33 48.94 79.01 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 D 189 PHE B 56 PHE^? 6.57 CL CL B 310 D 298 ASP B 9 ASP^? 7.08 CL CL B 310 D 329 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 35.44 53.35 83.81 35.65 54.53 81.28 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 29.72 46.46 83.60 30.79 47.36 81.99 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 36.89 44.91 74.55 37.33 48.94 79.01 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 D 189 PHE B 56 PHE^? 6.57 CL CL B 310 D 298 ASP B 48 ASP.? 14.63 ZN ZN A 303 D 329 LYS A 92 LYS^? 11.11 CL CL B 310 coo 35.44 53.35 83.81 35.65 54.53 81.28 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 29.72 46.46 83.60 30.79 47.36 81.99 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 36.89 44.91 74.55 37.33 48.94 79.01 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 D 189 PHE B 56 PHE^? 6.57 CL CL B 310 D 298 ASP B 48 ASP.? 14.63 ZN ZN A 303 D 329 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo 35.44 53.35 83.81 35.65 54.53 81.28 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 29.72 46.46 83.60 30.79 47.36 81.99 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 36.89 44.91 74.55 37.33 48.94 79.01 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 D 189 PHE B 65 PHE.? 11.19 C1 PEG B 312 D 298 ASP A 47 ASP.? 12.21 O1 PEG B 312 D 329 LYS B 95 LYS.? 9.10 CL CL A 306 coo 35.44 53.35 83.81 35.65 54.53 81.28 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 29.72 46.46 83.60 30.79 47.36 81.99 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 36.89 44.91 74.55 37.33 48.94 79.01 20.80 3.86 14.18 20.78 8.31 16.72 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 12 hits 1gtx_c03 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 200 ASP A 78 ASP~? 6.31 CL CL A 305 A 226 LYS A 16 LYS~? 15.92 CL CL A 307 coo 23.24 46.58 4.39 24.43 46.59 2.66 24.25 11.32 4.20 23.54 9.34 4.43 coo 24.51 43.28 11.18 25.17 44.50 9.58 25.71 9.07 -1.28 24.93 9.58 0.62 coo 34.47 51.09 7.19 28.58 51.18 7.53 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 200 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 226 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 23.24 46.58 4.39 24.43 46.59 2.66 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 24.51 43.28 11.18 25.17 44.50 9.58 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 14.27 -25.10 0.23 14.58 -27.01 3.12 1i29_c01 source 1i29 CSDB : 2 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 20 VAL~? 10.30 CL CL A 307 A 200 ASP A 9 ASP^? 7.20 CL CL A 307 A 226 LYS B 92 LYS^? 11.01 CL CL A 307 coo 19.13 38.05 1.41 19.72 38.80 -0.53 29.36 15.83 5.12 30.39 15.03 3.31 coo 24.51 43.28 11.18 25.17 44.50 9.58 32.44 3.50 6.30 30.77 4.75 6.60 coo 34.47 51.09 7.19 28.58 51.18 7.53 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 61 VAL^? -4.65 CL CL A 305s A 200 ASP A 78 ASP~? 6.31 CL CL A 305 A 226 LYS A 16 LYS~? 15.92 CL CL A 307 coo 19.13 38.05 1.41 19.72 38.80 -0.53 18.76 2.71 3.31 18.98 4.59 2.19 coo 24.51 43.28 11.18 25.17 44.50 9.58 25.71 9.07 -1.28 24.93 9.58 0.62 coo 34.47 51.09 7.19 28.58 51.18 7.53 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 85 VAL.? 9.29 CL CL A 307 A 200 ASP A 88 ASP^? 16.22 CL CL A 305 A 226 LYS A 92 LYS^? 11.11 CL CL B 310 coo 19.13 38.05 1.41 19.72 38.80 -0.53 33.38 8.09 3.34 32.11 9.08 4.82 coo 24.51 43.28 11.18 25.17 44.50 9.58 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 34.47 51.09 7.19 28.58 51.18 7.53 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 91 VAL^? 12.24 CL CL A 305 A 200 ASP A 78 ASP~? 6.31 CL CL A 305 A 226 LYS A 16 LYS~? 15.92 CL CL A 307 coo 19.13 38.05 1.41 19.72 38.80 -0.53 22.22 -2.10 -4.10 21.90 -0.15 -5.01 coo 24.51 43.28 11.18 25.17 44.50 9.58 25.71 9.07 -1.28 24.93 9.58 0.62 coo 34.47 51.09 7.19 28.58 51.18 7.53 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL A 91 VAL^? 12.24 CL CL A 305 A 200 ASP A 78 ASP~? 6.31 CL CL A 305 A 226 LYS A 29 LYS~? -2.69 OH6A1PE A 311s coo 19.13 38.05 1.41 19.72 38.80 -0.53 22.22 -2.10 -4.10 21.90 -0.15 -5.01 coo 24.51 43.28 11.18 25.17 44.50 9.58 25.71 9.07 -1.28 24.93 9.58 0.62 coo 34.47 51.09 7.19 28.58 51.18 7.53 14.86 14.41 3.43 16.20 19.44 6.35 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL B 61 VAL^? -4.80 CL CL B 308s A 200 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 226 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 19.13 38.05 1.41 19.72 38.80 -0.53 15.52 -7.71 7.99 14.85 -9.45 9.15 coo 24.51 43.28 11.18 25.17 44.50 9.58 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL B 85 VAL.? 8.78 CL CL B 310 A 200 ASP B 88 ASP^? 4.66 O4 PEG B 312 A 226 LYS B 92 LYS^? 11.01 CL CL A 307 coo 19.13 38.05 1.41 19.72 38.80 -0.53 19.27 -21.29 1.90 17.18 -20.68 1.63 coo 24.51 43.28 11.18 25.17 44.50 9.58 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 34.47 51.09 7.19 28.58 51.18 7.53 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL B 91 VAL^? 5.09 C1 PEG B 312 A 200 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 226 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 19.13 38.05 1.41 19.72 38.80 -0.53 24.34 -8.45 11.38 23.20 -9.72 12.73 coo 24.51 43.28 11.18 25.17 44.50 9.58 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1i29_c03 CSDB user 9 3 # 9 A 128 VAL B 91 VAL^? 5.09 C1 PEG B 312 A 200 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 226 LYS B 29 LYS~? 10.16 CL CL B 309 coo 19.13 38.05 1.41 19.72 38.80 -0.53 24.34 -8.45 11.38 23.20 -9.72 12.73 coo 24.51 43.28 11.18 25.17 44.50 9.58 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 5.16 -12.71 12.47 1.26 -15.97 8.59 1i29_c03 source 1i29 CSDB : 9 hits 1i29_c03 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 52 SER~? 16.21 CL CL A 307 A 173 ARG A 21 ARG~? 8.34 C22 1PE A 311s A 211 ASP A 48 ASP.? -15.94 CL CL A 307s coo 22.72 76.24 0.23 24.60 76.86 -1.25 31.84 7.85 19.89 31.12 7.70 22.23 coo 18.77 77.82 11.69 20.55 80.22 10.73 25.14 13.51 10.69 25.11 15.00 13.42 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 26.96 2.23 21.50 26.58 3.74 22.88 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER A 59 SER^? 3.89 CL CL A 305s A 173 ARG A 27 ARG~? 9.04 CL CL A 305 A 211 ASP A 9 ASP^? 7.20 CL CL A 307 coo 22.72 76.24 0.23 24.60 76.86 -1.25 24.86 2.91 6.28 24.83 4.11 4.27 coo 18.77 77.82 11.69 20.55 80.22 10.73 21.75 13.08 -2.42 22.26 10.12 -3.14 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1ig8_c00 HEXOKINASE PII user 3 3 # 3 A 158 SER B 59 SER^? 3.99 CL CL B 308s A 173 ARG B 27 ARG~? 9.37 CL CL B 308 A 211 ASP B 9 ASP^? 7.08 CL CL B 310 coo 22.72 76.24 0.23 24.60 76.86 -1.25 17.09 -11.30 2.44 17.22 -12.60 4.35 coo 18.77 77.82 11.69 20.55 80.22 10.73 12.55 -18.09 13.90 15.25 -16.65 13.55 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 20.52 -16.92 -1.41 18.60 -16.56 -0.65 1ig8_c00 source 1ig8 HEXOKINASE PII : 3 hits 1ig8_c00 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 48 ASP.? -15.94 CL CL A 307s A 204 GLU A 49 GLU.? 12.26 CL CL A 306 A 279 TYR B 3 TYR^? 11.16 C1 PEG B 312 coo 5.85 5.60 30.32 5.00 7.49 29.88 26.96 2.23 21.50 26.58 3.74 22.88 coo 7.79 1.83 27.81 9.08 3.25 26.92 21.20 3.66 19.03 19.27 4.46 18.88 coo 8.22 7.77 18.64 7.58 8.47 21.28 20.49 -5.14 16.12 21.33 -4.29 18.62 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP B 48 ASP.? 14.63 ZN ZN A 303 A 204 GLU B 49 GLU.? 12.07 C2 CAC A 313 A 279 TYR A 2 TYR^? -4.58 O2 CAC A 313s coo 5.85 5.60 30.32 5.00 7.49 29.88 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 7.79 1.83 27.81 9.08 3.25 26.92 7.03 -7.10 -6.90 6.04 -5.38 -6.16 coo 8.22 7.77 18.64 7.58 8.47 21.28 10.20 -0.74 -0.90 7.99 0.53 0.19 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 3 3 # 3 A 202 ASP B 48 ASP.? 14.63 ZN ZN A 303 A 204 GLU B 49 GLU.? 12.07 C2 CAC A 313 A 279 TYR A 3 TYR^? 10.95 ZN ZN A 303 coo 5.85 5.60 30.32 5.00 7.49 29.88 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 7.79 1.83 27.81 9.08 3.25 26.92 7.03 -7.10 -6.90 6.04 -5.38 -6.16 coo 8.22 7.77 18.64 7.58 8.47 21.28 15.55 -0.59 -5.31 14.15 -1.10 -7.68 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 3 hits 1itx_c00 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU B 66 GLU.? -18.09 C1 PEG B 312s A 61 GLU A 49 GLU.? 12.26 CL CL A 306 A 162 HIS B 0 HIS.? -19.60 C1 PEG B 312s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 16.63 -8.08 24.80 15.43 -6.55 25.64 coo -4.89 20.85 5.22 -3.95 21.69 6.91 21.20 3.66 19.03 19.27 4.46 18.88 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 14.07 -2.85 23.00 13.20 -3.63 24.76 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU B 66 GLU.? -18.09 C1 PEG B 312s A 61 GLU B 34 GLU~? 16.28 CL CL B 308 A 162 HIS B 0 HIS.? -19.60 C1 PEG B 312s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 16.63 -8.08 24.80 15.43 -6.55 25.64 coo -4.89 20.85 5.22 -3.95 21.69 6.91 6.76 -9.82 20.52 8.48 -10.92 21.08 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 14.07 -2.85 23.00 13.20 -3.63 24.76 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 2 hits 1j53_c00 naa= 3 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 1 3 # 1 A 488 ARG A 17 ARG~? -3.60 CL CL A 307s A 590 ARG A 21 ARG~? 8.34 C22 1PE A 311s A 632 HIS A 24 HIS~? 3.26 ZN ZN A 301s coo 19.23 7.38 20.83 18.34 7.79 23.74 29.80 8.18 9.40 27.73 6.82 7.62 coo 23.20 10.66 21.48 21.07 10.68 23.70 25.14 13.51 10.69 25.11 15.00 13.42 coo 20.55 9.13 29.66 21.88 8.70 28.08 24.25 11.32 4.20 23.54 9.34 4.43 1k4t_c00 source 1k4t 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-3' : 1 hits 1k4t_c00 naa= 3 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 1 3 # 1 A 290 ARG A 27 ARG~? 9.04 CL CL A 305 A 351 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 386 LEU A 28 LEU~? 5.10 CL CL A 306s coo 57.36 53.34 128.83 58.45 50.56 128.34 21.75 13.08 -2.42 22.26 10.12 -3.14 coo 60.60 50.64 133.59 60.63 48.82 132.56 24.25 11.32 4.20 23.54 9.34 4.43 coo 63.28 54.23 126.45 63.53 52.07 126.70 17.78 10.94 3.74 19.04 9.32 2.94 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 2 3 # 2 A 290 ARG B 27 ARG~? 9.37 CL CL B 308 A 351 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 386 LEU B 28 LEU~? 5.18 CL CL B 309 coo 57.36 53.34 128.83 58.45 50.56 128.34 12.55 -18.09 13.90 15.25 -16.65 13.55 coo 60.60 50.64 133.59 60.63 48.82 132.56 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 63.28 54.23 126.45 63.53 52.07 126.70 9.08 -12.49 10.11 10.99 -12.16 9.14 1knp_c00 source 1knp L-ASPARTATE OXIDASE : 2 hits 1knp_c00 naa= 3 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 1 3 # 1 166 ASP A 78 ASP~? 6.31 CL CL A 305 169 ARG A 27 ARG~? 9.04 CL CL A 305 193 HIS A 24 HIS~? 3.26 ZN ZN A 301s coo 20.88 15.91 3.60 20.25 17.72 4.50 25.71 9.07 -1.28 24.93 9.58 0.62 coo 17.70 17.91 -0.80 15.74 19.74 0.84 21.75 13.08 -2.42 22.26 10.12 -3.14 coo 18.81 19.85 7.63 17.55 19.89 5.97 24.25 11.32 4.20 23.54 9.34 4.43 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 2 3 # 2 166 ASP B 78 ASP~? 6.36 ZN ZN B 302 169 ARG B 27 ARG~? 9.37 CL CL B 308 193 HIS B 24 HIS~? 3.28 ZN ZN B 302s coo 20.88 15.91 3.60 20.25 17.72 4.50 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 17.70 17.91 -0.80 15.74 19.74 0.84 12.55 -18.09 13.90 15.25 -16.65 13.55 coo 18.81 19.85 7.63 17.55 19.89 5.97 11.77 -17.25 6.59 12.69 -15.38 6.18 1ldm_c01 source 1ldm M4 LACTATE DEHYDROGENASE : 2 hits 1ldm_c01 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 7 ALA^? 6.91 CL CL A 305 A 317 GLY A 58 GLY^? 7.04 CL CL A 307 A 318 ASP A 9 ASP^? 7.20 CL CL A 307 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 26.94 1.12 2.04 26.75 2.62 2.11 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 28.51 2.01 6.75 28.22 2.24 7.53 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 7 ALA^? 7.10 CL CL B 308 A 317 GLY B 58 GLY^? 7.10 CL CL B 310 A 318 ASP B 9 ASP^? 7.08 CL CL B 310 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 21.57 -12.46 4.46 20.42 -13.34 4.87 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 19.36 -13.08 -0.04 18.65 -12.88 -0.47 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 20.52 -16.92 -1.41 18.60 -16.56 -0.65 1lij_c01 source 1lij ADENOSINE KINASE : 2 hits 1lij_c01 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP B 73 ASP~? 8.36 C1 PEG B 312 A 265 GLU B 34 GLU~? 16.28 CL CL B 308 A 369 ASP B 78 ASP~? 6.36 ZN ZN B 302 coo 11.74 38.14 80.19 10.63 36.40 80.65 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 17.36 23.57 72.04 18.68 21.92 71.98 6.76 -9.82 20.52 8.48 -10.92 21.08 coo 12.19 31.08 87.29 11.13 32.66 86.38 16.87 -17.86 9.95 15.14 -17.20 8.90 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 1 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 78 ASP~? 6.31 CL CL A 305 A 279 GLU A 15 GLU~? 17.38 CL CL A 307 A 369 ASP A 73 ASP~? 14.36 ZN ZN A 303 coo 11.74 38.14 80.19 10.63 36.40 80.65 25.71 9.07 -1.28 24.93 9.58 0.62 coo 16.54 46.37 63.94 14.77 45.79 62.95 36.85 15.40 11.10 38.87 16.11 11.22 coo 12.19 31.08 87.29 11.13 32.66 86.38 21.65 6.61 -10.76 21.87 5.79 -12.65 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 78 ASP~? 6.31 CL CL A 305 A 279 GLU A 66 GLU.? -2.36 ZN ZN A 303s A 369 ASP A 9 ASP^? 7.20 CL CL A 307 coo 11.74 38.14 80.19 10.63 36.40 80.65 25.71 9.07 -1.28 24.93 9.58 0.62 coo 16.54 46.37 63.94 14.77 45.79 62.95 11.68 6.52 -11.11 9.60 6.56 -10.92 coo 12.19 31.08 87.29 11.13 32.66 86.38 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 279 GLU B 66 GLU.? -18.09 C1 PEG B 312s A 369 ASP B 9 ASP^? 7.08 CL CL B 310 coo 11.74 38.14 80.19 10.63 36.40 80.65 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 16.54 46.37 63.94 14.77 45.79 62.95 16.63 -8.08 24.80 15.43 -6.55 25.64 coo 12.19 31.08 87.29 11.13 32.66 86.38 20.52 -16.92 -1.41 18.60 -16.56 -0.65 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 3 hits 1m53_c06 naa= 3 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 A 10 ASP A 48 ASP.? -15.94 CL CL A 307s A 168 ASN B 67 ASN~? 12.71 C1 PEG B 312 A 241 HIS B 0 HIS.? -19.60 C1 PEG B 312s coo 2.16 -17.86 7.84 1.13 -18.57 9.58 26.96 2.23 21.50 26.58 3.74 22.88 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 22.54 -6.70 23.21 22.14 -8.65 23.93 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 14.07 -2.85 23.00 13.20 -3.63 24.76 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 A 10 ASP B 48 ASP.? 14.63 ZN ZN A 303 A 168 ASN A 67 ASN~? 8.15 ZN ZN A 303 A 241 HIS A 0 HIS.? -3.23 ZN ZN A 303s coo 2.16 -17.86 7.84 1.13 -18.57 9.58 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 14.02 0.88 -12.67 14.89 2.62 -13.50 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 7.36 3.84 -7.81 6.63 5.12 -9.32 1mas_c00 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 2 hits 1mas_c00 naa= 3 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 B 10 ASP A 48 ASP.? -15.94 CL CL A 307s B 168 ASN B 67 ASN~? 12.71 C1 PEG B 312 B 241 HIS B 0 HIS.? -19.60 C1 PEG B 312s coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 26.96 2.23 21.50 26.58 3.74 22.88 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 22.54 -6.70 23.21 22.14 -8.65 23.93 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 14.07 -2.85 23.00 13.20 -3.63 24.76 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 B 10 ASP B 48 ASP.? 14.63 ZN ZN A 303 B 168 ASN A 67 ASN~? 8.15 ZN ZN A 303 B 241 HIS A 0 HIS.? -3.23 ZN ZN A 303s coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 14.02 0.88 -12.67 14.89 2.62 -13.50 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 7.36 3.84 -7.81 6.63 5.12 -9.32 1mas_c01 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 2 hits 1mas_c01 naa= 3 ULMN 3 1mhl_c01 MYELOPEROXIDASE user 1 3 # 1 B 91 GLN A 64 GLN^? -3.49 C2 CAC A 313s B 95 HIS A 0 HIS.? -3.23 ZN ZN A 303s D 239 ARG A 36 ARG.? -4.82 ZN ZN A 303s coo 26.05 12.11 40.60 26.18 11.51 42.66 9.17 2.67 -2.61 7.16 3.33 -2.48 coo 22.38 10.20 38.43 23.87 9.40 39.55 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 21.64 6.32 39.69 22.65 6.72 36.78 9.84 7.66 -4.50 9.21 7.51 -7.47 1mhl_c01 source 1mhl MYELOPEROXIDASE : 1 hits 1mhl_c01 naa= 3 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 1 3 # 1 92 SER A -1 SER.? 8.59 ZN ZN A 303 201 HIS A 0 HIS.? -3.23 ZN ZN A 303s 250 GLN A 64 GLN^? -3.49 C2 CAC A 313s coo 38.34 0.72 11.82 37.33 1.15 14.05 3.33 0.99 -6.09 2.94 -0.67 -7.87 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 9.17 2.67 -2.61 7.16 3.33 -2.48 1mla_c00 source 1mla MALONYL-COENZYME A ACYL CARRIER PROTEIN TRANSA: 1 hits 1mla_c00 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 9 ASP^? 7.20 CL CL A 307 A 55 TYR A 80 TYR~? 5.67 CL CL A 307 A 84 LYS A 16 LYS~? 15.92 CL CL A 307 coo 11.09 42.89 24.44 11.32 42.06 22.49 32.44 3.50 6.30 30.77 4.75 6.60 coo 4.60 40.33 20.42 7.25 39.50 20.05 28.47 9.96 3.42 27.66 10.97 5.91 coo 9.71 44.83 15.47 10.13 41.43 19.93 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP A 47 ASP.? 12.21 O1 PEG B 312 A 55 TYR B 3 TYR^? 11.16 C1 PEG B 312 A 84 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 11.09 42.89 24.44 11.32 42.06 22.49 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 4.60 40.33 20.42 7.25 39.50 20.05 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 9.71 44.83 15.47 10.13 41.43 19.93 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP A 47 ASP.? 12.21 O1 PEG B 312 A 55 TYR B 3 TYR^? 11.16 C1 PEG B 312 A 84 LYS B 95 LYS.? 9.10 CL CL A 306 coo 11.09 42.89 24.44 11.32 42.06 22.49 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 4.60 40.33 20.42 7.25 39.50 20.05 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 9.71 44.83 15.47 10.13 41.43 19.93 20.80 3.86 14.18 20.78 8.31 16.72 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 3 # 4 A 50 ASP B 9 ASP^? 7.08 CL CL B 310 A 55 TYR B 80 TYR~? 5.35 CL CL B 310 A 84 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 11.09 42.89 24.44 11.32 42.06 22.49 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 4.60 40.33 20.42 7.25 39.50 20.05 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 9.71 44.83 15.47 10.13 41.43 19.93 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 5 3 # 5 A 50 ASP B 47 ASP.? 11.08 ZN ZN A 303 A 55 TYR A 3 TYR^? 10.95 ZN ZN A 303 A 84 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 11.09 42.89 24.44 11.32 42.06 22.49 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 4.60 40.33 20.42 7.25 39.50 20.05 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 9.71 44.83 15.47 10.13 41.43 19.93 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 6 3 # 6 A 50 ASP B 47 ASP.? 11.08 ZN ZN A 303 A 55 TYR A 3 TYR^? 10.95 ZN ZN A 303 A 84 LYS A 95 LYS.? 9.36 CL CL B 309 coo 11.09 42.89 24.44 11.32 42.06 22.49 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 4.60 40.33 20.42 7.25 39.50 20.05 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 9.71 44.83 15.47 10.13 41.43 19.93 10.49 -7.40 -1.88 7.13 -10.96 -4.27 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 6 hits 1mrq_c02 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 197 ASP A 78 ASP~? 6.31 CL CL A 305 A 223 ALA A 63 ALA^? 6.28 C2 CAC A 313 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 24.25 11.32 4.20 23.54 9.34 4.43 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 25.71 9.07 -1.28 24.93 9.58 0.62 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 13.60 3.30 -0.26 14.39 4.56 -0.44 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 197 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 223 ALA B 63 ALA^? 9.65 CL CL B 308 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 11.77 -17.25 6.59 12.69 -15.38 6.18 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 16.87 -17.86 9.95 15.14 -17.20 8.90 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 14.23 -5.36 13.76 13.84 -6.85 13.80 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 2 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 24 HIS~? 3.26 ZN ZN A 301s B 197 ASP A 78 ASP~? 6.31 CL CL A 305 B 223 ALA A 63 ALA^? 6.28 C2 CAC A 313 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 24.25 11.32 4.20 23.54 9.34 4.43 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 25.71 9.07 -1.28 24.93 9.58 0.62 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 13.60 3.30 -0.26 14.39 4.56 -0.44 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS B 24 HIS~? 3.28 ZN ZN B 302s B 197 ASP B 78 ASP~? 6.36 ZN ZN B 302 B 223 ALA B 63 ALA^? 9.65 CL CL B 308 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 11.77 -17.25 6.59 12.69 -15.38 6.18 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 16.87 -17.86 9.95 15.14 -17.20 8.90 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 14.23 -5.36 13.76 13.84 -6.85 13.80 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 2 hits 1n2t_c03 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 92 LYS^? 11.11 CL CL B 310 631 LYS B 16 LYS~? 9.68 ZN ZN B 304 708 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 8.61 33.06 11.15 10.12 29.19 8.82 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo -11.99 27.40 17.14 -13.60 24.52 11.71 14.27 -25.10 0.23 14.58 -27.01 3.12 coo 18.16 32.86 9.85 16.06 28.20 13.56 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS A 92 LYS^? 11.11 CL CL B 310 631 LYS B 29 LYS~? 10.16 CL CL B 309 708 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 8.61 33.06 11.15 10.12 29.19 8.82 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo -11.99 27.40 17.14 -13.60 24.52 11.71 5.16 -12.71 12.47 1.26 -15.97 8.59 coo 18.16 32.86 9.85 16.06 28.20 13.56 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 3 3 # 3 549 LYS B 92 LYS^? 11.01 CL CL A 307 631 LYS A 16 LYS~? 15.92 CL CL A 307 708 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 8.61 33.06 11.15 10.12 29.19 8.82 25.00 -4.81 12.30 28.64 -2.55 7.65 coo -11.99 27.40 17.14 -13.60 24.52 11.71 34.52 13.28 7.19 39.00 11.44 3.22 coo 18.16 32.86 9.85 16.06 28.20 13.56 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 4 3 # 4 549 LYS B 92 LYS^? 11.01 CL CL A 307 631 LYS A 29 LYS~? -2.69 OH6A1PE A 311s 708 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 8.61 33.06 11.15 10.12 29.19 8.82 25.00 -4.81 12.30 28.64 -2.55 7.65 coo -11.99 27.40 17.14 -13.60 24.52 11.71 14.86 14.41 3.43 16.20 19.44 6.35 coo 18.16 32.86 9.85 16.06 28.20 13.56 23.06 -12.55 15.81 27.03 -9.57 14.36 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 4 hits 1nsf_c00 naa= 3 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 B 175 LYS A 96 LYS.? 5.78 O2 CAC A 313 B 208 GLN B 32 GLN~? 10.33 CL CL B 309 B 209 LYS B 29 LYS~? 10.16 CL CL B 309 coo 105.03 46.01 19.55 106.59 42.35 15.55 8.76 -5.89 1.16 6.19 -2.58 4.65 coo 113.93 46.99 13.56 113.37 48.52 14.95 4.16 -7.29 12.58 3.46 -7.62 10.61 coo 115.66 49.12 8.60 111.19 49.52 4.73 5.16 -12.71 12.47 1.26 -15.97 8.59 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 B 175 LYS B 96 LYS.? 11.54 CL CL A 306 B 208 GLN A 32 GLN~? 8.22 OH7A1PE A 311 B 209 LYS A 29 LYS~? -2.69 OH6A1PE A 311s coo 105.03 46.01 19.55 106.59 42.35 15.55 17.33 4.64 12.77 13.37 4.64 15.16 coo 113.93 46.99 13.56 113.37 48.52 14.95 10.42 11.79 5.14 11.19 12.00 7.08 coo 115.66 49.12 8.60 111.19 49.52 4.73 14.86 14.41 3.43 16.20 19.44 6.35 1ohh_c07 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 2 hits 1ohh_c07 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 A 146 TYR B 2 TYR^? 13.50 CL CL A 306 A 177 LYS B 95 LYS.? 9.10 CL CL A 306 coo -3.50 124.89 25.05 -2.25 124.77 23.26 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 1.87 119.38 16.45 1.41 122.11 16.84 15.58 -0.36 14.99 13.00 0.51 15.42 coo -2.59 124.07 12.67 -0.91 126.17 18.42 20.80 3.86 14.18 20.78 8.31 16.72 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 A 146 TYR B 2 TYR^? 13.50 CL CL A 306 A 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -3.50 124.89 25.05 -2.25 124.77 23.26 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 1.87 119.38 16.45 1.41 122.11 16.84 15.58 -0.36 14.99 13.00 0.51 15.42 coo -2.59 124.07 12.67 -0.91 126.17 18.42 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP A 48 ASP.? -15.94 CL CL A 307s A 146 TYR B 2 TYR^? 13.50 CL CL A 306 A 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -3.50 124.89 25.05 -2.25 124.77 23.26 26.96 2.23 21.50 26.58 3.74 22.88 coo 1.87 119.38 16.45 1.41 122.11 16.84 15.58 -0.36 14.99 13.00 0.51 15.42 coo -2.59 124.07 12.67 -0.91 126.17 18.42 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 A 24 ASP A 48 ASP.? -15.94 CL CL A 307s A 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 A 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -3.50 124.89 25.05 -2.25 124.77 23.26 26.96 2.23 21.50 26.58 3.74 22.88 coo 1.87 119.38 16.45 1.41 122.11 16.84 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -2.59 124.07 12.67 -0.91 126.17 18.42 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 A 24 ASP A 73 ASP~? 14.36 ZN ZN A 303 A 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 A 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -3.50 124.89 25.05 -2.25 124.77 23.26 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 1.87 119.38 16.45 1.41 122.11 16.84 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -2.59 124.07 12.67 -0.91 126.17 18.42 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 A 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 A 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s A 177 LYS A 95 LYS.? 9.36 CL CL B 309 coo -3.50 124.89 25.05 -2.25 124.77 23.26 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 1.87 119.38 16.45 1.41 122.11 16.84 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -2.59 124.07 12.67 -0.91 126.17 18.42 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 A 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 A 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s A 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -3.50 124.89 25.05 -2.25 124.77 23.26 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 1.87 119.38 16.45 1.41 122.11 16.84 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -2.59 124.07 12.67 -0.91 126.17 18.42 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 A 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 A 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s A 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -3.50 124.89 25.05 -2.25 124.77 23.26 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 1.87 119.38 16.45 1.41 122.11 16.84 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -2.59 124.07 12.67 -0.91 126.17 18.42 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 A 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 A 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 A 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -3.50 124.89 25.05 -2.25 124.77 23.26 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 1.87 119.38 16.45 1.41 122.11 16.84 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -2.59 124.07 12.67 -0.91 126.17 18.42 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 A 24 ASP B 73 ASP~? 8.36 C1 PEG B 312 A 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 A 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -3.50 124.89 25.05 -2.25 124.77 23.26 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 1.87 119.38 16.45 1.41 122.11 16.84 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -2.59 124.07 12.67 -0.91 126.17 18.42 25.00 -4.81 12.30 28.64 -2.55 7.65 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 10 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 B 146 TYR B 2 TYR^? 13.50 CL CL A 306 B 177 LYS B 95 LYS.? 9.10 CL CL A 306 coo -7.43 109.06 51.23 -5.84 110.54 50.86 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 0.22 114.56 44.62 -0.76 115.18 47.18 15.58 -0.36 14.99 13.00 0.51 15.42 coo -4.18 120.17 46.85 -4.02 115.31 51.00 20.80 3.86 14.18 20.78 8.31 16.72 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 B 146 TYR B 2 TYR^? 13.50 CL CL A 306 B 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -7.43 109.06 51.23 -5.84 110.54 50.86 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 0.22 114.56 44.62 -0.76 115.18 47.18 15.58 -0.36 14.99 13.00 0.51 15.42 coo -4.18 120.17 46.85 -4.02 115.31 51.00 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP A 48 ASP.? -15.94 CL CL A 307s B 146 TYR B 2 TYR^? 13.50 CL CL A 306 B 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -7.43 109.06 51.23 -5.84 110.54 50.86 26.96 2.23 21.50 26.58 3.74 22.88 coo 0.22 114.56 44.62 -0.76 115.18 47.18 15.58 -0.36 14.99 13.00 0.51 15.42 coo -4.18 120.17 46.85 -4.02 115.31 51.00 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 B 24 ASP A 48 ASP.? -15.94 CL CL A 307s B 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 B 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -7.43 109.06 51.23 -5.84 110.54 50.86 26.96 2.23 21.50 26.58 3.74 22.88 coo 0.22 114.56 44.62 -0.76 115.18 47.18 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -4.18 120.17 46.85 -4.02 115.31 51.00 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 B 24 ASP A 73 ASP~? 14.36 ZN ZN A 303 B 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 B 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -7.43 109.06 51.23 -5.84 110.54 50.86 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 0.22 114.56 44.62 -0.76 115.18 47.18 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -4.18 120.17 46.85 -4.02 115.31 51.00 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 B 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 B 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s B 177 LYS A 95 LYS.? 9.36 CL CL B 309 coo -7.43 109.06 51.23 -5.84 110.54 50.86 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 0.22 114.56 44.62 -0.76 115.18 47.18 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -4.18 120.17 46.85 -4.02 115.31 51.00 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 B 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 B 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s B 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -7.43 109.06 51.23 -5.84 110.54 50.86 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 0.22 114.56 44.62 -0.76 115.18 47.18 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -4.18 120.17 46.85 -4.02 115.31 51.00 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 B 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 B 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s B 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -7.43 109.06 51.23 -5.84 110.54 50.86 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 0.22 114.56 44.62 -0.76 115.18 47.18 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -4.18 120.17 46.85 -4.02 115.31 51.00 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 B 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 B 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 B 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -7.43 109.06 51.23 -5.84 110.54 50.86 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 0.22 114.56 44.62 -0.76 115.18 47.18 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -4.18 120.17 46.85 -4.02 115.31 51.00 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 B 24 ASP B 73 ASP~? 8.36 C1 PEG B 312 B 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 B 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -7.43 109.06 51.23 -5.84 110.54 50.86 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 0.22 114.56 44.62 -0.76 115.18 47.18 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -4.18 120.17 46.85 -4.02 115.31 51.00 25.00 -4.81 12.30 28.64 -2.55 7.65 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 10 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 C 146 TYR B 2 TYR^? 13.50 CL CL A 306 C 177 LYS B 95 LYS.? 9.10 CL CL A 306 coo -13.49 79.65 43.90 -12.13 80.29 45.45 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -5.65 86.78 48.49 -7.16 84.72 49.65 15.58 -0.36 14.99 13.00 0.51 15.42 coo -11.22 87.18 53.49 -10.94 81.64 50.31 20.80 3.86 14.18 20.78 8.31 16.72 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 C 146 TYR B 2 TYR^? 13.50 CL CL A 306 C 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -13.49 79.65 43.90 -12.13 80.29 45.45 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -5.65 86.78 48.49 -7.16 84.72 49.65 15.58 -0.36 14.99 13.00 0.51 15.42 coo -11.22 87.18 53.49 -10.94 81.64 50.31 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP A 48 ASP.? -15.94 CL CL A 307s C 146 TYR B 2 TYR^? 13.50 CL CL A 306 C 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -13.49 79.65 43.90 -12.13 80.29 45.45 26.96 2.23 21.50 26.58 3.74 22.88 coo -5.65 86.78 48.49 -7.16 84.72 49.65 15.58 -0.36 14.99 13.00 0.51 15.42 coo -11.22 87.18 53.49 -10.94 81.64 50.31 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 C 24 ASP A 48 ASP.? -15.94 CL CL A 307s C 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 C 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -13.49 79.65 43.90 -12.13 80.29 45.45 26.96 2.23 21.50 26.58 3.74 22.88 coo -5.65 86.78 48.49 -7.16 84.72 49.65 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -11.22 87.18 53.49 -10.94 81.64 50.31 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 C 24 ASP A 73 ASP~? 14.36 ZN ZN A 303 C 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 C 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -13.49 79.65 43.90 -12.13 80.29 45.45 21.65 6.61 -10.76 21.87 5.79 -12.65 coo -5.65 86.78 48.49 -7.16 84.72 49.65 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -11.22 87.18 53.49 -10.94 81.64 50.31 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 C 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 C 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s C 177 LYS A 95 LYS.? 9.36 CL CL B 309 coo -13.49 79.65 43.90 -12.13 80.29 45.45 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -5.65 86.78 48.49 -7.16 84.72 49.65 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -11.22 87.18 53.49 -10.94 81.64 50.31 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 C 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 C 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s C 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -13.49 79.65 43.90 -12.13 80.29 45.45 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -5.65 86.78 48.49 -7.16 84.72 49.65 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -11.22 87.18 53.49 -10.94 81.64 50.31 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 C 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 C 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s C 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -13.49 79.65 43.90 -12.13 80.29 45.45 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -5.65 86.78 48.49 -7.16 84.72 49.65 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -11.22 87.18 53.49 -10.94 81.64 50.31 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 C 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 C 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 C 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -13.49 79.65 43.90 -12.13 80.29 45.45 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -5.65 86.78 48.49 -7.16 84.72 49.65 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -11.22 87.18 53.49 -10.94 81.64 50.31 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 C 24 ASP B 73 ASP~? 8.36 C1 PEG B 312 C 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 C 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -13.49 79.65 43.90 -12.13 80.29 45.45 21.44 -15.50 19.28 23.24 -15.58 20.39 coo -5.65 86.78 48.49 -7.16 84.72 49.65 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -11.22 87.18 53.49 -10.94 81.64 50.31 25.00 -4.81 12.30 28.64 -2.55 7.65 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 10 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 D 146 TYR B 2 TYR^? 13.50 CL CL A 306 D 177 LYS B 95 LYS.? 9.10 CL CL A 306 coo -13.44 77.36 13.12 -12.53 75.97 14.48 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -7.85 74.44 22.75 -9.22 72.86 20.89 15.58 -0.36 14.99 13.00 0.51 15.42 coo -14.24 70.61 23.48 -12.55 71.73 17.42 20.80 3.86 14.18 20.78 8.31 16.72 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 D 146 TYR B 2 TYR^? 13.50 CL CL A 306 D 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -13.44 77.36 13.12 -12.53 75.97 14.48 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -7.85 74.44 22.75 -9.22 72.86 20.89 15.58 -0.36 14.99 13.00 0.51 15.42 coo -14.24 70.61 23.48 -12.55 71.73 17.42 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP A 48 ASP.? -15.94 CL CL A 307s D 146 TYR B 2 TYR^? 13.50 CL CL A 306 D 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -13.44 77.36 13.12 -12.53 75.97 14.48 26.96 2.23 21.50 26.58 3.74 22.88 coo -7.85 74.44 22.75 -9.22 72.86 20.89 15.58 -0.36 14.99 13.00 0.51 15.42 coo -14.24 70.61 23.48 -12.55 71.73 17.42 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 D 24 ASP A 48 ASP.? -15.94 CL CL A 307s D 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 D 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -13.44 77.36 13.12 -12.53 75.97 14.48 26.96 2.23 21.50 26.58 3.74 22.88 coo -7.85 74.44 22.75 -9.22 72.86 20.89 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -14.24 70.61 23.48 -12.55 71.73 17.42 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 D 24 ASP A 73 ASP~? 14.36 ZN ZN A 303 D 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 D 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -13.44 77.36 13.12 -12.53 75.97 14.48 21.65 6.61 -10.76 21.87 5.79 -12.65 coo -7.85 74.44 22.75 -9.22 72.86 20.89 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -14.24 70.61 23.48 -12.55 71.73 17.42 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 D 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 D 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s D 177 LYS A 95 LYS.? 9.36 CL CL B 309 coo -13.44 77.36 13.12 -12.53 75.97 14.48 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -7.85 74.44 22.75 -9.22 72.86 20.89 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -14.24 70.61 23.48 -12.55 71.73 17.42 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 D 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 D 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s D 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -13.44 77.36 13.12 -12.53 75.97 14.48 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -7.85 74.44 22.75 -9.22 72.86 20.89 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -14.24 70.61 23.48 -12.55 71.73 17.42 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 D 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 D 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s D 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -13.44 77.36 13.12 -12.53 75.97 14.48 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -7.85 74.44 22.75 -9.22 72.86 20.89 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -14.24 70.61 23.48 -12.55 71.73 17.42 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 D 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 D 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 D 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -13.44 77.36 13.12 -12.53 75.97 14.48 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -7.85 74.44 22.75 -9.22 72.86 20.89 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -14.24 70.61 23.48 -12.55 71.73 17.42 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 D 24 ASP B 73 ASP~? 8.36 C1 PEG B 312 D 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 D 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -13.44 77.36 13.12 -12.53 75.97 14.48 21.44 -15.50 19.28 23.24 -15.58 20.39 coo -7.85 74.44 22.75 -9.22 72.86 20.89 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -14.24 70.61 23.48 -12.55 71.73 17.42 25.00 -4.81 12.30 28.64 -2.55 7.65 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 10 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 E 146 TYR B 2 TYR^? 13.50 CL CL A 306 E 177 LYS B 95 LYS.? 9.10 CL CL A 306 coo -7.12 105.25 1.43 -6.30 103.34 0.77 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -3.11 94.55 3.01 -3.83 95.92 0.66 15.58 -0.36 14.99 13.00 0.51 15.42 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 20.80 3.86 14.18 20.78 8.31 16.72 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 E 146 TYR B 2 TYR^? 13.50 CL CL A 306 E 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -7.12 105.25 1.43 -6.30 103.34 0.77 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -3.11 94.55 3.01 -3.83 95.92 0.66 15.58 -0.36 14.99 13.00 0.51 15.42 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP A 48 ASP.? -15.94 CL CL A 307s E 146 TYR B 2 TYR^? 13.50 CL CL A 306 E 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -7.12 105.25 1.43 -6.30 103.34 0.77 26.96 2.23 21.50 26.58 3.74 22.88 coo -3.11 94.55 3.01 -3.83 95.92 0.66 15.58 -0.36 14.99 13.00 0.51 15.42 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 E 24 ASP A 48 ASP.? -15.94 CL CL A 307s E 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 E 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -7.12 105.25 1.43 -6.30 103.34 0.77 26.96 2.23 21.50 26.58 3.74 22.88 coo -3.11 94.55 3.01 -3.83 95.92 0.66 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 E 24 ASP A 73 ASP~? 14.36 ZN ZN A 303 E 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 E 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -7.12 105.25 1.43 -6.30 103.34 0.77 21.65 6.61 -10.76 21.87 5.79 -12.65 coo -3.11 94.55 3.01 -3.83 95.92 0.66 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 E 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 E 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s E 177 LYS A 95 LYS.? 9.36 CL CL B 309 coo -7.12 105.25 1.43 -6.30 103.34 0.77 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -3.11 94.55 3.01 -3.83 95.92 0.66 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 E 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 E 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s E 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -7.12 105.25 1.43 -6.30 103.34 0.77 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -3.11 94.55 3.01 -3.83 95.92 0.66 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 E 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 E 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s E 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -7.12 105.25 1.43 -6.30 103.34 0.77 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -3.11 94.55 3.01 -3.83 95.92 0.66 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 E 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 E 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 E 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -7.12 105.25 1.43 -6.30 103.34 0.77 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -3.11 94.55 3.01 -3.83 95.92 0.66 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 E 24 ASP B 73 ASP~? 8.36 C1 PEG B 312 E 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 E 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -7.12 105.25 1.43 -6.30 103.34 0.77 21.44 -15.50 19.28 23.24 -15.58 20.39 coo -3.11 94.55 3.01 -3.83 95.92 0.66 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 25.00 -4.81 12.30 28.64 -2.55 7.65 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 10 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 F 146 TYR B 2 TYR^? 13.50 CL CL A 306 F 177 LYS B 95 LYS.? 9.10 CL CL A 306 coo -44.75 128.15 10.28 -45.68 129.67 11.55 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -50.43 131.90 19.60 -49.04 133.31 17.60 15.58 -0.36 14.99 13.00 0.51 15.42 coo -44.10 135.86 19.99 -45.67 134.21 14.07 20.80 3.86 14.18 20.78 8.31 16.72 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 F 146 TYR B 2 TYR^? 13.50 CL CL A 306 F 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -44.75 128.15 10.28 -45.68 129.67 11.55 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -50.43 131.90 19.60 -49.04 133.31 17.60 15.58 -0.36 14.99 13.00 0.51 15.42 coo -44.10 135.86 19.99 -45.67 134.21 14.07 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP A 48 ASP.? -15.94 CL CL A 307s F 146 TYR B 2 TYR^? 13.50 CL CL A 306 F 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -44.75 128.15 10.28 -45.68 129.67 11.55 26.96 2.23 21.50 26.58 3.74 22.88 coo -50.43 131.90 19.60 -49.04 133.31 17.60 15.58 -0.36 14.99 13.00 0.51 15.42 coo -44.10 135.86 19.99 -45.67 134.21 14.07 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 F 24 ASP A 48 ASP.? -15.94 CL CL A 307s F 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 F 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -44.75 128.15 10.28 -45.68 129.67 11.55 26.96 2.23 21.50 26.58 3.74 22.88 coo -50.43 131.90 19.60 -49.04 133.31 17.60 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -44.10 135.86 19.99 -45.67 134.21 14.07 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 F 24 ASP A 73 ASP~? 14.36 ZN ZN A 303 F 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 F 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -44.75 128.15 10.28 -45.68 129.67 11.55 21.65 6.61 -10.76 21.87 5.79 -12.65 coo -50.43 131.90 19.60 -49.04 133.31 17.60 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -44.10 135.86 19.99 -45.67 134.21 14.07 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 F 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 F 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s F 177 LYS A 95 LYS.? 9.36 CL CL B 309 coo -44.75 128.15 10.28 -45.68 129.67 11.55 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -50.43 131.90 19.60 -49.04 133.31 17.60 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -44.10 135.86 19.99 -45.67 134.21 14.07 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 F 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 F 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s F 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -44.75 128.15 10.28 -45.68 129.67 11.55 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -50.43 131.90 19.60 -49.04 133.31 17.60 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -44.10 135.86 19.99 -45.67 134.21 14.07 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 F 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 F 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s F 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -44.75 128.15 10.28 -45.68 129.67 11.55 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -50.43 131.90 19.60 -49.04 133.31 17.60 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -44.10 135.86 19.99 -45.67 134.21 14.07 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 F 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 F 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 F 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -44.75 128.15 10.28 -45.68 129.67 11.55 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -50.43 131.90 19.60 -49.04 133.31 17.60 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -44.10 135.86 19.99 -45.67 134.21 14.07 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 F 24 ASP B 73 ASP~? 8.36 C1 PEG B 312 F 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 F 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -44.75 128.15 10.28 -45.68 129.67 11.55 21.44 -15.50 19.28 23.24 -15.58 20.39 coo -50.43 131.90 19.60 -49.04 133.31 17.60 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -44.10 135.86 19.99 -45.67 134.21 14.07 25.00 -4.81 12.30 28.64 -2.55 7.65 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 10 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 G 146 TYR B 2 TYR^? 13.50 CL CL A 306 G 177 LYS B 95 LYS.? 9.10 CL CL A 306 coo -44.97 128.78 41.20 -46.32 128.26 42.83 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -52.83 122.13 46.42 -51.31 124.30 47.39 15.58 -0.36 14.99 13.00 0.51 15.42 coo -47.30 122.24 51.49 -47.46 127.44 47.81 20.80 3.86 14.18 20.78 8.31 16.72 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 G 146 TYR B 2 TYR^? 13.50 CL CL A 306 G 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -44.97 128.78 41.20 -46.32 128.26 42.83 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -52.83 122.13 46.42 -51.31 124.30 47.39 15.58 -0.36 14.99 13.00 0.51 15.42 coo -47.30 122.24 51.49 -47.46 127.44 47.81 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP A 48 ASP.? -15.94 CL CL A 307s G 146 TYR B 2 TYR^? 13.50 CL CL A 306 G 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -44.97 128.78 41.20 -46.32 128.26 42.83 26.96 2.23 21.50 26.58 3.74 22.88 coo -52.83 122.13 46.42 -51.31 124.30 47.39 15.58 -0.36 14.99 13.00 0.51 15.42 coo -47.30 122.24 51.49 -47.46 127.44 47.81 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 G 24 ASP A 48 ASP.? -15.94 CL CL A 307s G 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 G 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -44.97 128.78 41.20 -46.32 128.26 42.83 26.96 2.23 21.50 26.58 3.74 22.88 coo -52.83 122.13 46.42 -51.31 124.30 47.39 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -47.30 122.24 51.49 -47.46 127.44 47.81 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 G 24 ASP A 73 ASP~? 14.36 ZN ZN A 303 G 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 G 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -44.97 128.78 41.20 -46.32 128.26 42.83 21.65 6.61 -10.76 21.87 5.79 -12.65 coo -52.83 122.13 46.42 -51.31 124.30 47.39 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -47.30 122.24 51.49 -47.46 127.44 47.81 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 G 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 G 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s G 177 LYS A 95 LYS.? 9.36 CL CL B 309 coo -44.97 128.78 41.20 -46.32 128.26 42.83 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -52.83 122.13 46.42 -51.31 124.30 47.39 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -47.30 122.24 51.49 -47.46 127.44 47.81 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 G 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 G 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s G 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -44.97 128.78 41.20 -46.32 128.26 42.83 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -52.83 122.13 46.42 -51.31 124.30 47.39 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -47.30 122.24 51.49 -47.46 127.44 47.81 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 G 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 G 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s G 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -44.97 128.78 41.20 -46.32 128.26 42.83 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -52.83 122.13 46.42 -51.31 124.30 47.39 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -47.30 122.24 51.49 -47.46 127.44 47.81 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 G 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 G 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 G 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -44.97 128.78 41.20 -46.32 128.26 42.83 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -52.83 122.13 46.42 -51.31 124.30 47.39 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -47.30 122.24 51.49 -47.46 127.44 47.81 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 G 24 ASP B 73 ASP~? 8.36 C1 PEG B 312 G 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 G 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -44.97 128.78 41.20 -46.32 128.26 42.83 21.44 -15.50 19.28 23.24 -15.58 20.39 coo -52.83 122.13 46.42 -51.31 124.30 47.39 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -47.30 122.24 51.49 -47.46 127.44 47.81 25.00 -4.81 12.30 28.64 -2.55 7.65 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 10 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 H 146 TYR B 2 TYR^? 13.50 CL CL A 306 H 177 LYS B 95 LYS.? 9.10 CL CL A 306 coo -51.11 100.30 51.41 -52.67 98.82 51.12 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -58.70 94.17 45.32 -57.76 93.82 47.92 15.58 -0.36 14.99 13.00 0.51 15.42 coo -54.32 88.79 48.13 -54.61 94.04 51.74 20.80 3.86 14.18 20.78 8.31 16.72 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 H 146 TYR B 2 TYR^? 13.50 CL CL A 306 H 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -51.11 100.30 51.41 -52.67 98.82 51.12 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -58.70 94.17 45.32 -57.76 93.82 47.92 15.58 -0.36 14.99 13.00 0.51 15.42 coo -54.32 88.79 48.13 -54.61 94.04 51.74 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP A 48 ASP.? -15.94 CL CL A 307s H 146 TYR B 2 TYR^? 13.50 CL CL A 306 H 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -51.11 100.30 51.41 -52.67 98.82 51.12 26.96 2.23 21.50 26.58 3.74 22.88 coo -58.70 94.17 45.32 -57.76 93.82 47.92 15.58 -0.36 14.99 13.00 0.51 15.42 coo -54.32 88.79 48.13 -54.61 94.04 51.74 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 H 24 ASP A 48 ASP.? -15.94 CL CL A 307s H 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 H 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -51.11 100.30 51.41 -52.67 98.82 51.12 26.96 2.23 21.50 26.58 3.74 22.88 coo -58.70 94.17 45.32 -57.76 93.82 47.92 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -54.32 88.79 48.13 -54.61 94.04 51.74 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 H 24 ASP A 73 ASP~? 14.36 ZN ZN A 303 H 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 H 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -51.11 100.30 51.41 -52.67 98.82 51.12 21.65 6.61 -10.76 21.87 5.79 -12.65 coo -58.70 94.17 45.32 -57.76 93.82 47.92 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -54.32 88.79 48.13 -54.61 94.04 51.74 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 H 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 H 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s H 177 LYS A 95 LYS.? 9.36 CL CL B 309 coo -51.11 100.30 51.41 -52.67 98.82 51.12 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -58.70 94.17 45.32 -57.76 93.82 47.92 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -54.32 88.79 48.13 -54.61 94.04 51.74 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 H 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 H 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s H 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -51.11 100.30 51.41 -52.67 98.82 51.12 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -58.70 94.17 45.32 -57.76 93.82 47.92 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -54.32 88.79 48.13 -54.61 94.04 51.74 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 H 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 H 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s H 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -51.11 100.30 51.41 -52.67 98.82 51.12 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -58.70 94.17 45.32 -57.76 93.82 47.92 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -54.32 88.79 48.13 -54.61 94.04 51.74 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 H 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 H 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 H 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -51.11 100.30 51.41 -52.67 98.82 51.12 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -58.70 94.17 45.32 -57.76 93.82 47.92 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -54.32 88.79 48.13 -54.61 94.04 51.74 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 H 24 ASP B 73 ASP~? 8.36 C1 PEG B 312 H 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 H 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -51.11 100.30 51.41 -52.67 98.82 51.12 21.44 -15.50 19.28 23.24 -15.58 20.39 coo -58.70 94.17 45.32 -57.76 93.82 47.92 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -54.32 88.79 48.13 -54.61 94.04 51.74 25.00 -4.81 12.30 28.64 -2.55 7.65 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 10 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 I 146 TYR B 2 TYR^? 13.50 CL CL A 306 I 177 LYS B 95 LYS.? 9.10 CL CL A 306 coo -54.65 81.97 26.87 -55.88 81.89 25.07 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -59.92 86.62 17.74 -59.42 83.94 18.40 15.58 -0.36 14.99 13.00 0.51 15.42 coo -55.38 81.61 14.50 -57.11 80.05 20.41 20.80 3.86 14.18 20.78 8.31 16.72 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 I 146 TYR B 2 TYR^? 13.50 CL CL A 306 I 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -54.65 81.97 26.87 -55.88 81.89 25.07 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -59.92 86.62 17.74 -59.42 83.94 18.40 15.58 -0.36 14.99 13.00 0.51 15.42 coo -55.38 81.61 14.50 -57.11 80.05 20.41 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP A 48 ASP.? -15.94 CL CL A 307s I 146 TYR B 2 TYR^? 13.50 CL CL A 306 I 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -54.65 81.97 26.87 -55.88 81.89 25.07 26.96 2.23 21.50 26.58 3.74 22.88 coo -59.92 86.62 17.74 -59.42 83.94 18.40 15.58 -0.36 14.99 13.00 0.51 15.42 coo -55.38 81.61 14.50 -57.11 80.05 20.41 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 I 24 ASP A 48 ASP.? -15.94 CL CL A 307s I 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 I 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -54.65 81.97 26.87 -55.88 81.89 25.07 26.96 2.23 21.50 26.58 3.74 22.88 coo -59.92 86.62 17.74 -59.42 83.94 18.40 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -55.38 81.61 14.50 -57.11 80.05 20.41 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 I 24 ASP A 73 ASP~? 14.36 ZN ZN A 303 I 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 I 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -54.65 81.97 26.87 -55.88 81.89 25.07 21.65 6.61 -10.76 21.87 5.79 -12.65 coo -59.92 86.62 17.74 -59.42 83.94 18.40 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -55.38 81.61 14.50 -57.11 80.05 20.41 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 I 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 I 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s I 177 LYS A 95 LYS.? 9.36 CL CL B 309 coo -54.65 81.97 26.87 -55.88 81.89 25.07 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -59.92 86.62 17.74 -59.42 83.94 18.40 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -55.38 81.61 14.50 -57.11 80.05 20.41 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 I 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 I 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s I 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -54.65 81.97 26.87 -55.88 81.89 25.07 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -59.92 86.62 17.74 -59.42 83.94 18.40 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -55.38 81.61 14.50 -57.11 80.05 20.41 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 I 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 I 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s I 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -54.65 81.97 26.87 -55.88 81.89 25.07 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -59.92 86.62 17.74 -59.42 83.94 18.40 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -55.38 81.61 14.50 -57.11 80.05 20.41 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 I 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 I 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 I 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -54.65 81.97 26.87 -55.88 81.89 25.07 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -59.92 86.62 17.74 -59.42 83.94 18.40 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -55.38 81.61 14.50 -57.11 80.05 20.41 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 I 24 ASP B 73 ASP~? 8.36 C1 PEG B 312 I 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 I 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -54.65 81.97 26.87 -55.88 81.89 25.07 21.44 -15.50 19.28 23.24 -15.58 20.39 coo -59.92 86.62 17.74 -59.42 83.94 18.40 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -55.38 81.61 14.50 -57.11 80.05 20.41 25.00 -4.81 12.30 28.64 -2.55 7.65 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 10 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 J 146 TYR B 2 TYR^? 13.50 CL CL A 306 J 177 LYS B 95 LYS.? 9.10 CL CL A 306 coo -50.64 99.08 1.52 -51.52 100.83 0.67 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 15.58 -0.36 14.99 13.00 0.51 15.42 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 20.80 3.86 14.18 20.78 8.31 16.72 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP A 47 ASP.? 12.21 O1 PEG B 312 J 146 TYR B 2 TYR^? 13.50 CL CL A 306 J 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -50.64 99.08 1.52 -51.52 100.83 0.67 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 15.58 -0.36 14.99 13.00 0.51 15.42 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP A 48 ASP.? -15.94 CL CL A 307s J 146 TYR B 2 TYR^? 13.50 CL CL A 306 J 177 LYS B 96 LYS.? 11.54 CL CL A 306 coo -50.64 99.08 1.52 -51.52 100.83 0.67 26.96 2.23 21.50 26.58 3.74 22.88 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 15.58 -0.36 14.99 13.00 0.51 15.42 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 J 24 ASP A 48 ASP.? -15.94 CL CL A 307s J 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 J 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -50.64 99.08 1.52 -51.52 100.83 0.67 26.96 2.23 21.50 26.58 3.74 22.88 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 J 24 ASP A 73 ASP~? 14.36 ZN ZN A 303 J 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 J 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -50.64 99.08 1.52 -51.52 100.83 0.67 21.65 6.61 -10.76 21.87 5.79 -12.65 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 J 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 J 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s J 177 LYS A 95 LYS.? 9.36 CL CL B 309 coo -50.64 99.08 1.52 -51.52 100.83 0.67 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 J 24 ASP B 47 ASP.? 11.08 ZN ZN A 303 J 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s J 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -50.64 99.08 1.52 -51.52 100.83 0.67 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 J 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 J 146 TYR A 2 TYR^? -4.58 O2 CAC A 313s J 177 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo -50.64 99.08 1.52 -51.52 100.83 0.67 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 J 24 ASP B 48 ASP.? 14.63 ZN ZN A 303 J 146 TYR A 3 TYR^? 10.95 ZN ZN A 303 J 177 LYS A 92 LYS^? 11.11 CL CL B 310 coo -50.64 99.08 1.52 -51.52 100.83 0.67 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 J 24 ASP B 73 ASP~? 8.36 C1 PEG B 312 J 146 TYR B 3 TYR^? 11.16 C1 PEG B 312 J 177 LYS B 92 LYS^? 11.01 CL CL A 307 coo -50.64 99.08 1.52 -51.52 100.83 0.67 21.44 -15.50 19.28 23.24 -15.58 20.39 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 25.00 -4.81 12.30 28.64 -2.55 7.65 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 10 hits 1ok4_c09 naa= 3 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 1 3 # 1 1 8 TYR A 2 TYR^? -4.58 O2 CAC A 313s 1 14 ARG A 36 ARG.? -4.82 ZN ZN A 303s 1 104 TRP A 74 TRP~? 8.77 CL CL A 305 coo -6.26 36.66 22.35 -5.62 38.66 24.20 10.20 -0.74 -0.90 7.99 0.53 0.19 coo -1.84 42.97 23.45 -1.37 45.90 22.68 9.84 7.66 -4.50 9.21 7.51 -7.47 coo -2.17 45.44 30.78 -5.80 46.76 31.55 18.76 9.45 -4.73 19.86 8.05 -1.25 1pd2_c02 source 1pd2 HEMATOPOIETIC PROSTAGLADIN D SYNTHASE : 1 hits 1pd2_c02 naa= 3 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 1 3 # 1 2 8 TYR A 2 TYR^? -4.58 O2 CAC A 313s 2 14 ARG A 36 ARG.? -4.82 ZN ZN A 303s 2 104 TRP A 74 TRP~? 8.77 CL CL A 305 coo 14.82 62.39 20.28 14.73 60.21 22.02 10.20 -0.74 -0.90 7.99 0.53 0.19 coo 10.81 55.96 22.08 10.04 53.12 21.26 9.84 7.66 -4.50 9.21 7.51 -7.47 coo 13.42 52.88 28.75 17.04 51.48 28.24 18.76 9.45 -4.73 19.86 8.05 -1.25 1pd2_c03 source 1pd2 HEMATOPOIETIC PROSTAGLADIN D SYNTHASE : 1 hits 1pd2_c03 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 63 ALA^? 6.28 C2 CAC A 313 A 126 LEU A 31 LEU~? 8.17 C2 CAC A 313 A 158 GLU A 34 GLU~? 9.95 C2 CAC A 313 coo -2.29 37.66 144.73 -1.46 37.12 145.87 13.60 3.30 -0.26 14.39 4.56 -0.44 coo -4.62 32.83 147.14 -5.50 32.85 149.12 14.00 9.74 -0.22 15.06 8.67 -1.77 coo -0.83 29.57 149.77 -0.39 31.47 148.95 10.18 12.55 -3.49 11.83 11.91 -4.60 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA B 26 ALA~? 10.59 CL CL B 309 A 126 LEU B 25 LEU~? 5.32 CL CL B 309 A 158 GLU B 22 GLU~? 10.35 CL CL B 309 coo -2.29 37.66 144.73 -1.46 37.12 145.87 6.34 -17.54 11.68 6.25 -18.99 12.16 coo -4.62 32.83 147.14 -5.50 32.85 149.12 6.36 -16.53 7.28 6.24 -15.77 5.24 coo -0.83 29.57 149.77 -0.39 31.47 148.95 3.91 -22.17 5.69 2.98 -20.35 5.17 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA B 63 ALA^? 9.65 CL CL B 308 A 126 LEU B 31 LEU~? 10.17 CL CL B 308 A 158 GLU B 34 GLU~? 16.28 CL CL B 308 coo -2.29 37.66 144.73 -1.46 37.12 145.87 14.23 -5.36 13.76 13.84 -6.85 13.80 coo -4.62 32.83 147.14 -5.50 32.85 149.12 9.79 -9.88 15.03 11.78 -10.48 15.51 coo -0.83 29.57 149.77 -0.39 31.47 148.95 6.76 -9.82 20.52 8.48 -10.92 21.08 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 3 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 63 ALA^? 6.28 C2 CAC A 313 B 126 LEU A 31 LEU~? 8.17 C2 CAC A 313 B 158 GLU A 34 GLU~? 9.95 C2 CAC A 313 coo -39.79 4.61 147.27 -39.61 5.56 148.47 13.60 3.30 -0.26 14.39 4.56 -0.44 coo -34.22 5.06 149.25 -33.65 4.24 151.15 14.00 9.74 -0.22 15.06 8.67 -1.77 coo -33.03 9.93 151.71 -34.98 9.38 151.11 10.18 12.55 -3.49 11.83 11.91 -4.60 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA B 26 ALA~? 10.59 CL CL B 309 B 126 LEU B 25 LEU~? 5.32 CL CL B 309 B 158 GLU B 22 GLU~? 10.35 CL CL B 309 coo -39.79 4.61 147.27 -39.61 5.56 148.47 6.34 -17.54 11.68 6.25 -18.99 12.16 coo -34.22 5.06 149.25 -33.65 4.24 151.15 6.36 -16.53 7.28 6.24 -15.77 5.24 coo -33.03 9.93 151.71 -34.98 9.38 151.11 3.91 -22.17 5.69 2.98 -20.35 5.17 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA B 63 ALA^? 9.65 CL CL B 308 B 126 LEU B 31 LEU~? 10.17 CL CL B 308 B 158 GLU B 34 GLU~? 16.28 CL CL B 308 coo -39.79 4.61 147.27 -39.61 5.56 148.47 14.23 -5.36 13.76 13.84 -6.85 13.80 coo -34.22 5.06 149.25 -33.65 4.24 151.15 9.79 -9.88 15.03 11.78 -10.48 15.51 coo -33.03 9.93 151.71 -34.98 9.38 151.11 6.76 -9.82 20.52 8.48 -10.92 21.08 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 3 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 63 ALA^? 6.28 C2 CAC A 313 C 126 LEU A 31 LEU~? 8.17 C2 CAC A 313 C 158 GLU A 34 GLU~? 9.95 C2 CAC A 313 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 13.60 3.30 -0.26 14.39 4.56 -0.44 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 14.00 9.74 -0.22 15.06 8.67 -1.77 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 10.18 12.55 -3.49 11.83 11.91 -4.60 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA B 26 ALA~? 10.59 CL CL B 309 C 126 LEU B 25 LEU~? 5.32 CL CL B 309 C 158 GLU B 22 GLU~? 10.35 CL CL B 309 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 6.34 -17.54 11.68 6.25 -18.99 12.16 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 6.36 -16.53 7.28 6.24 -15.77 5.24 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 3.91 -22.17 5.69 2.98 -20.35 5.17 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA B 63 ALA^? 9.65 CL CL B 308 C 126 LEU B 31 LEU~? 10.17 CL CL B 308 C 158 GLU B 34 GLU~? 16.28 CL CL B 308 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 14.23 -5.36 13.76 13.84 -6.85 13.80 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 9.79 -9.88 15.03 11.78 -10.48 15.51 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 6.76 -9.82 20.52 8.48 -10.92 21.08 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 3 hits 1pjh_c02 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 30 GLN~? 9.53 C14 1PE A 311 294 GLU A 66 GLU.? -2.36 ZN ZN A 303s 304 ARG A 27 ARG~? 9.04 CL CL A 305 coo 15.89 18.45 46.53 15.82 16.91 48.02 13.94 15.22 -2.67 15.06 15.53 -4.45 coo 22.84 13.44 52.91 20.84 13.18 52.38 11.68 6.52 -11.11 9.60 6.56 -10.92 coo 8.71 17.11 46.51 7.23 17.64 49.20 21.75 13.08 -2.42 22.26 10.12 -3.14 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN A 64 GLN^? -3.49 C2 CAC A 313s 294 GLU B 49 GLU.? 12.07 C2 CAC A 313 304 ARG A 36 ARG.? -4.82 ZN ZN A 303s coo 15.89 18.45 46.53 15.82 16.91 48.02 9.17 2.67 -2.61 7.16 3.33 -2.48 coo 22.84 13.44 52.91 20.84 13.18 52.38 7.03 -7.10 -6.90 6.04 -5.38 -6.16 coo 8.71 17.11 46.51 7.23 17.64 49.20 9.84 7.66 -4.50 9.21 7.51 -7.47 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 3 3 # 3 111 GLN B 64 GLN^? 16.90 CL CL B 308 294 GLU A 49 GLU.? 12.26 CL CL A 306 304 ARG B 36 ARG.? 14.37 CL CL B 308 coo 15.89 18.45 46.53 15.82 16.91 48.02 13.48 -2.38 17.76 11.93 -1.34 18.68 coo 22.84 13.44 52.91 20.84 13.18 52.38 21.20 3.66 19.03 19.27 4.46 18.88 coo 8.71 17.11 46.51 7.23 17.64 49.20 10.68 -7.55 19.92 12.72 -9.80 19.82 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 3 hits 1pmi_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 36 ARG.? -4.82 ZN ZN A 303s A 479 PHE A 65 PHE.? 9.58 C2 CAC A 313 A 483 GLU A 66 GLU.? -2.36 ZN ZN A 303s coo 17.33 52.29 2.24 18.71 54.03 0.18 9.84 7.66 -4.50 9.21 7.51 -7.47 coo 20.06 57.44 1.28 18.39 56.19 3.12 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 11.68 6.52 -11.11 9.60 6.56 -10.92 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG B 36 ARG.? 14.37 CL CL B 308 A 479 PHE B 65 PHE.? 11.19 C1 PEG B 312 A 483 GLU B 66 GLU.? -18.09 C1 PEG B 312s coo 17.33 52.29 2.24 18.71 54.03 0.18 10.68 -7.55 19.92 12.72 -9.80 19.82 coo 20.06 57.44 1.28 18.39 56.19 3.12 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 16.63 -8.08 24.80 15.43 -6.55 25.64 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 2 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 36 ARG.? -4.82 ZN ZN A 303s B 479 PHE A 65 PHE.? 9.58 C2 CAC A 313 B 483 GLU A 66 GLU.? -2.36 ZN ZN A 303s coo -26.72 93.28 20.13 -28.02 93.55 17.39 9.84 7.66 -4.50 9.21 7.51 -7.47 coo -29.34 90.48 15.69 -27.62 89.95 17.80 15.37 4.31 -5.77 16.86 5.34 -3.63 coo -26.63 95.49 14.65 -25.77 93.77 13.77 11.68 6.52 -11.11 9.60 6.56 -10.92 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG B 36 ARG.? 14.37 CL CL B 308 B 479 PHE B 65 PHE.? 11.19 C1 PEG B 312 B 483 GLU B 66 GLU.? -18.09 C1 PEG B 312s coo -26.72 93.28 20.13 -28.02 93.55 17.39 10.68 -7.55 19.92 12.72 -9.80 19.82 coo -29.34 90.48 15.69 -27.62 89.95 17.80 17.22 -8.48 17.88 16.17 -9.84 15.69 coo -26.63 95.49 14.65 -25.77 93.77 13.77 16.63 -8.08 24.80 15.43 -6.55 25.64 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 2 hits 1pow_c03 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN A 43 ASN^? 7.86 CL CL A 307 A 192 ASP A 78 ASP~? 6.31 CL CL A 305 A 195 HIS A 24 HIS~? 3.26 ZN ZN A 301s coo -4.84 51.77 30.37 -3.89 50.12 29.46 25.90 0.17 10.25 24.19 -0.21 9.00 coo 2.03 47.14 19.75 1.72 46.26 21.64 25.71 9.07 -1.28 24.93 9.58 0.62 coo 1.41 44.84 24.92 -0.49 45.70 25.19 24.25 11.32 4.20 23.54 9.34 4.43 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 1 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN A 43 ASN^? 7.86 CL CL A 307 B 192 ASP A 78 ASP~? 6.31 CL CL A 305 B 195 HIS A 24 HIS~? 3.26 ZN ZN A 301s coo -1.08 51.41 10.34 0.65 52.62 10.17 25.90 0.17 10.25 24.19 -0.21 9.00 coo 11.36 52.33 5.59 10.18 53.87 6.47 25.71 9.07 -1.28 24.93 9.58 0.62 coo 7.99 56.74 7.55 6.88 55.39 8.70 24.25 11.32 4.20 23.54 9.34 4.43 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 1 hits 1pp4_c03 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU A 22 GLU~? -5.00 C13 1PE A 311s A 67 ARG A 21 ARG~? 8.34 C22 1PE A 311s A 86 HIS A 24 HIS~? 3.26 ZN ZN A 301s coo 18.15 3.28 18.56 20.10 2.92 19.20 23.55 20.26 6.43 24.10 22.30 6.48 coo 21.52 6.83 26.64 21.22 5.53 23.85 25.14 13.51 10.69 25.11 15.00 13.42 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 24.25 11.32 4.20 23.54 9.34 4.43 ULMN 3 1pyl_c00 RIBONUCLEASE user 2 3 # 2 A 56 GLU B 82 GLU~? -1.87 ZN ZN B 304s A 67 ARG B 27 ARG~? 9.37 CL CL B 308 A 86 HIS B 24 HIS~? 3.28 ZN ZN B 302s coo 18.15 3.28 18.56 20.10 2.92 19.20 17.85 -26.45 10.11 16.17 -26.92 11.31 coo 21.52 6.83 26.64 21.22 5.53 23.85 12.55 -18.09 13.90 15.25 -16.65 13.55 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 11.77 -17.25 6.59 12.69 -15.38 6.18 1pyl_c00 source 1pyl RIBONUCLEASE : 2 hits 1pyl_c00 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 73 ASP~? 14.36 ZN ZN A 303 A 68 ALA A 70 ALA~? 8.84 ZN ZN A 303 A 72 LEU A 68 LEU~? 13.78 ZN ZN A 303 coo 46.76 7.59 18.65 45.27 6.01 18.52 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 48.88 4.35 16.59 48.73 5.09 15.20 17.79 4.61 -10.66 16.34 5.04 -10.74 coo 53.89 6.25 15.09 52.88 7.92 14.14 17.65 -2.18 -10.41 19.13 -3.35 -9.29 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 73 ASP~? 14.36 ZN ZN A 303 A 68 ALA A 71 ALA~? 12.17 ZN ZN A 303 A 72 LEU A 68 LEU~? 13.78 ZN ZN A 303 coo 46.76 7.59 18.65 45.27 6.01 18.52 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 48.88 4.35 16.59 48.73 5.09 15.20 18.56 3.18 -7.16 18.06 1.87 -6.63 coo 53.89 6.25 15.09 52.88 7.92 14.14 17.65 -2.18 -10.41 19.13 -3.35 -9.29 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP B 73 ASP~? 8.36 C1 PEG B 312 A 68 ALA B 70 ALA~? 11.11 C1 PEG B 312 A 72 LEU B 68 LEU~? 7.97 O1 PEG B 312 coo 46.76 7.59 18.65 45.27 6.01 18.52 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 48.88 4.35 16.59 48.73 5.09 15.20 20.76 -11.38 20.58 19.79 -10.65 21.49 coo 53.89 6.25 15.09 52.88 7.92 14.14 25.24 -6.64 18.79 26.23 -6.64 16.84 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP B 73 ASP~? 8.36 C1 PEG B 312 A 68 ALA B 71 ALA~? 8.09 C1 PEG B 312 A 72 LEU B 68 LEU~? 7.97 O1 PEG B 312 coo 46.76 7.59 18.65 45.27 6.01 18.52 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 48.88 4.35 16.59 48.73 5.09 15.20 20.29 -10.20 16.98 20.65 -8.82 16.46 coo 53.89 6.25 15.09 52.88 7.92 14.14 25.24 -6.64 18.79 26.23 -6.64 16.84 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 4 hits 1q6l_c05 naa= 3 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 1 3 # 1 A 189 SER A -1 SER.? 8.59 ZN ZN A 303 A 310 GLU A 66 GLU.? -2.36 ZN ZN A 303s A 399 HIS A 0 HIS.? -3.23 ZN ZN A 303s coo 2.67 37.96 55.23 1.78 40.01 56.16 3.33 0.99 -6.09 2.94 -0.67 -7.87 coo 6.61 38.44 63.61 6.69 38.31 61.50 11.68 6.52 -11.11 9.60 6.56 -10.92 coo 4.95 41.82 59.53 3.85 40.70 58.14 7.36 3.84 -7.81 6.63 5.12 -9.32 1qe3_c00 source 1qe3 PARA-NITROBENZYL ESTERASE : 1 hits 1qe3_c00 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 0 HIS.? -3.23 ZN ZN A 303s A 236 ASP A 78 ASP~? 6.31 CL CL A 305 A 261 LYS A 16 LYS~? 15.92 CL CL A 307 coo 55.45 46.76 42.08 57.34 46.16 42.75 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 48.87 29.19 44.63 49.10 27.34 43.63 25.71 9.07 -1.28 24.93 9.58 0.62 coo 47.58 17.35 41.83 51.40 20.85 40.83 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 155 HIS B 0 HIS.? -19.60 C1 PEG B 312s A 236 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 261 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 55.45 46.76 42.08 57.34 46.16 42.75 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 48.87 29.19 44.63 49.10 27.34 43.63 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 47.58 17.35 41.83 51.40 20.85 40.83 14.27 -25.10 0.23 14.58 -27.01 3.12 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS B 0 HIS.? -19.60 C1 PEG B 312s B 236 ASP B 78 ASP~? 6.36 ZN ZN B 302 B 261 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 14.27 -25.10 0.23 14.58 -27.01 3.12 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS B 0 HIS.? -19.60 C1 PEG B 312s C 236 ASP B 78 ASP~? 6.36 ZN ZN B 302 C 261 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 55.11 47.10 12.61 53.44 47.85 11.58 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 45.78 31.11 9.51 44.25 30.06 10.53 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 37.54 22.37 12.10 37.83 27.55 13.24 14.27 -25.10 0.23 14.58 -27.01 3.12 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 0 HIS.? -3.23 ZN ZN A 303s D 236 ASP A 78 ASP~? 6.31 CL CL A 305 D 261 LYS A 16 LYS~? 15.92 CL CL A 307 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 25.71 9.07 -1.28 24.93 9.58 0.62 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 155 HIS B 0 HIS.? -19.60 C1 PEG B 312s D 236 ASP B 78 ASP~? 6.36 ZN ZN B 302 D 261 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 14.27 -25.10 0.23 14.58 -27.01 3.12 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 0 HIS.? -3.23 ZN ZN A 303s E 236 ASP A 78 ASP~? 6.31 CL CL A 305 E 261 LYS A 16 LYS~? 15.92 CL CL A 307 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 25.71 9.07 -1.28 24.93 9.58 0.62 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 155 HIS B 0 HIS.? -19.60 C1 PEG B 312s E 236 ASP B 78 ASP~? 6.36 ZN ZN B 302 E 261 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 14.27 -25.10 0.23 14.58 -27.01 3.12 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS B 0 HIS.? -19.60 C1 PEG B 312s F 236 ASP B 78 ASP~? 6.36 ZN ZN B 302 F 261 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 14.27 -25.10 0.23 14.58 -27.01 3.12 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS B 0 HIS.? -19.60 C1 PEG B 312s G 236 ASP B 78 ASP~? 6.36 ZN ZN B 302 G 261 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 14.27 -25.10 0.23 14.58 -27.01 3.12 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 0 HIS.? -3.23 ZN ZN A 303s H 236 ASP A 78 ASP~? 6.31 CL CL A 305 H 261 LYS A 16 LYS~? 15.92 CL CL A 307 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 25.71 9.07 -1.28 24.93 9.58 0.62 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 155 HIS B 0 HIS.? -19.60 C1 PEG B 312s H 236 ASP B 78 ASP~? 6.36 ZN ZN B 302 H 261 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 14.27 -25.10 0.23 14.58 -27.01 3.12 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 86 TYR^? 7.10 CL CL A 305 A 236 ASP A 88 ASP^? 16.22 CL CL A 305 A 261 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 55.48 26.51 40.65 55.39 23.99 39.43 29.34 5.60 1.24 26.89 6.10 2.52 coo 48.87 29.19 44.63 49.10 27.34 43.63 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 47.58 17.35 41.83 51.40 20.85 40.83 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 86 TYR^? 6.73 CL CL B 310 A 236 ASP B 9 ASP^? 7.08 CL CL B 310 A 261 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 55.48 26.51 40.65 55.39 23.99 39.43 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 48.87 29.19 44.63 49.10 27.34 43.63 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 47.58 17.35 41.83 51.40 20.85 40.83 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR B 86 TYR^? 6.73 CL CL B 310 A 236 ASP B 88 ASP^? 4.66 O4 PEG B 312 A 261 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 55.48 26.51 40.65 55.39 23.99 39.43 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 48.87 29.19 44.63 49.10 27.34 43.63 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 47.58 17.35 41.83 51.40 20.85 40.83 23.06 -12.55 15.81 27.03 -9.57 14.36 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 86 TYR^? 7.10 CL CL A 305 B 236 ASP A 88 ASP^? 16.22 CL CL A 305 B 261 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 29.34 5.60 1.24 26.89 6.10 2.52 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 86 TYR^? 6.73 CL CL B 310 B 236 ASP B 9 ASP^? 7.08 CL CL B 310 B 261 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 86 TYR^? 6.73 CL CL B 310 B 236 ASP B 88 ASP^? 4.66 O4 PEG B 312 B 261 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 23.06 -12.55 15.81 27.03 -9.57 14.36 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 86 TYR^? 7.10 CL CL A 305 C 236 ASP A 88 ASP^? 16.22 CL CL A 305 C 261 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 39.51 34.34 13.63 37.63 32.61 14.79 29.34 5.60 1.24 26.89 6.10 2.52 coo 45.78 31.11 9.51 44.25 30.06 10.53 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 37.54 22.37 12.10 37.83 27.55 13.24 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR B 86 TYR^? 6.73 CL CL B 310 C 236 ASP B 9 ASP^? 7.08 CL CL B 310 C 261 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 39.51 34.34 13.63 37.63 32.61 14.79 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 45.78 31.11 9.51 44.25 30.06 10.53 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 37.54 22.37 12.10 37.83 27.55 13.24 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 163 TYR B 86 TYR^? 6.73 CL CL B 310 C 236 ASP B 88 ASP^? 4.66 O4 PEG B 312 C 261 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 39.51 34.34 13.63 37.63 32.61 14.79 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 45.78 31.11 9.51 44.25 30.06 10.53 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 37.54 22.37 12.10 37.83 27.55 13.24 23.06 -12.55 15.81 27.03 -9.57 14.36 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 86 TYR^? 7.10 CL CL A 305 D 236 ASP A 88 ASP^? 16.22 CL CL A 305 D 261 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 29.34 5.60 1.24 26.89 6.10 2.52 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR B 86 TYR^? 6.73 CL CL B 310 D 236 ASP B 9 ASP^? 7.08 CL CL B 310 D 261 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 163 TYR B 86 TYR^? 6.73 CL CL B 310 D 236 ASP B 88 ASP^? 4.66 O4 PEG B 312 D 261 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 21.28 -11.43 41.42 21.14 -8.83 40.39 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 23.06 -12.55 15.81 27.03 -9.57 14.36 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 86 TYR^? 7.10 CL CL A 305 E 236 ASP A 88 ASP^? 16.22 CL CL A 305 E 261 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 29.34 5.60 1.24 26.89 6.10 2.52 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 86 TYR^? 6.73 CL CL B 310 E 236 ASP B 9 ASP^? 7.08 CL CL B 310 E 261 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR B 86 TYR^? 6.73 CL CL B 310 E 236 ASP B 88 ASP^? 4.66 O4 PEG B 312 E 261 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 23.06 -12.55 15.81 27.03 -9.57 14.36 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 86 TYR^? 7.10 CL CL A 305 F 236 ASP A 88 ASP^? 16.22 CL CL A 305 F 261 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 29.34 5.60 1.24 26.89 6.10 2.52 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 86 TYR^? 6.73 CL CL B 310 F 236 ASP B 9 ASP^? 7.08 CL CL B 310 F 261 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR B 86 TYR^? 6.73 CL CL B 310 F 236 ASP B 88 ASP^? 4.66 O4 PEG B 312 F 261 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 23.06 -12.55 15.81 27.03 -9.57 14.36 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 86 TYR^? 7.10 CL CL A 305 G 236 ASP A 88 ASP^? 16.22 CL CL A 305 G 261 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 29.34 5.60 1.24 26.89 6.10 2.52 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR B 86 TYR^? 6.73 CL CL B 310 G 236 ASP B 9 ASP^? 7.08 CL CL B 310 G 261 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 163 TYR B 86 TYR^? 6.73 CL CL B 310 G 236 ASP B 88 ASP^? 4.66 O4 PEG B 312 G 261 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 23.06 -12.55 15.81 27.03 -9.57 14.36 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 86 TYR^? 7.10 CL CL A 305 H 236 ASP A 88 ASP^? 16.22 CL CL A 305 H 261 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 29.34 5.60 1.24 26.89 6.10 2.52 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR B 86 TYR^? 6.73 CL CL B 310 H 236 ASP B 9 ASP^? 7.08 CL CL B 310 H 261 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 163 TYR B 86 TYR^? 6.73 CL CL B 310 H 236 ASP B 88 ASP^? 4.66 O4 PEG B 312 H 261 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 20.90 10.83 -36.23 23.51 10.75 -37.23 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 23.06 -12.55 15.81 27.03 -9.57 14.36 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 17 ARG~? -3.60 CL CL A 307s C 163 TYR A 86 TYR^? 7.10 CL CL A 305 C 236 ASP A 88 ASP^? 16.22 CL CL A 305 coo 39.01 29.77 22.02 37.48 31.30 19.84 29.80 8.18 9.40 27.73 6.82 7.62 coo 39.51 34.34 13.63 37.63 32.61 14.79 29.34 5.60 1.24 26.89 6.10 2.52 coo 45.78 31.11 9.51 44.25 30.06 10.53 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG A 21 ARG~? 8.34 C22 1PE A 311s C 163 TYR A 80 TYR~? 5.67 CL CL A 307 C 236 ASP A 9 ASP^? 7.20 CL CL A 307 coo 39.01 29.77 22.02 37.48 31.30 19.84 25.14 13.51 10.69 25.11 15.00 13.42 coo 39.51 34.34 13.63 37.63 32.61 14.79 28.47 9.96 3.42 27.66 10.97 5.91 coo 45.78 31.11 9.51 44.25 30.06 10.53 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG A 36 ARG.? -4.82 ZN ZN A 303s C 163 TYR A 3 TYR^? 10.95 ZN ZN A 303 C 236 ASP B 47 ASP.? 11.08 ZN ZN A 303 coo 39.01 29.77 22.02 37.48 31.30 19.84 9.84 7.66 -4.50 9.21 7.51 -7.47 coo 39.51 34.34 13.63 37.63 32.61 14.79 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 45.78 31.11 9.51 44.25 30.06 10.53 15.08 -4.94 -11.66 14.38 -3.13 -10.90 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 110 ARG B 17 ARG~? -3.61 CL CL B 310s C 163 TYR B 86 TYR^? 6.73 CL CL B 310 C 236 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 39.01 29.77 22.02 37.48 31.30 19.84 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo 39.51 34.34 13.63 37.63 32.61 14.79 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 45.78 31.11 9.51 44.25 30.06 10.53 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 110 ARG B 21 ARG~? 10.16 CL CL B 310 C 163 TYR B 80 TYR~? 5.35 CL CL B 310 C 236 ASP B 9 ASP^? 7.08 CL CL B 310 coo 39.01 29.77 22.02 37.48 31.30 19.84 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo 39.51 34.34 13.63 37.63 32.61 14.79 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 45.78 31.11 9.51 44.25 30.06 10.53 20.52 -16.92 -1.41 18.60 -16.56 -0.65 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 17 ARG~? -3.60 CL CL A 307s D 163 TYR A 86 TYR^? 7.10 CL CL A 305 D 236 ASP A 88 ASP^? 16.22 CL CL A 305 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 29.80 8.18 9.40 27.73 6.82 7.62 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 29.34 5.60 1.24 26.89 6.10 2.52 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG A 21 ARG~? 8.34 C22 1PE A 311s D 163 TYR A 80 TYR~? 5.67 CL CL A 307 D 236 ASP A 9 ASP^? 7.20 CL CL A 307 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 25.14 13.51 10.69 25.11 15.00 13.42 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 28.47 9.96 3.42 27.66 10.97 5.91 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG A 36 ARG.? -4.82 ZN ZN A 303s D 163 TYR A 3 TYR^? 10.95 ZN ZN A 303 D 236 ASP B 47 ASP.? 11.08 ZN ZN A 303 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 9.84 7.66 -4.50 9.21 7.51 -7.47 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 15.08 -4.94 -11.66 14.38 -3.13 -10.90 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 110 ARG B 17 ARG~? -3.61 CL CL B 310s D 163 TYR B 86 TYR^? 6.73 CL CL B 310 D 236 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 110 ARG B 21 ARG~? 10.16 CL CL B 310 D 163 TYR B 80 TYR~? 5.35 CL CL B 310 D 236 ASP B 9 ASP^? 7.08 CL CL B 310 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 20.52 -16.92 -1.41 18.60 -16.56 -0.65 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 3 TYR^? 10.95 ZN ZN A 303 A 236 ASP B 47 ASP.? 11.08 ZN ZN A 303 C 110 ARG A 36 ARG.? -4.82 ZN ZN A 303s coo 55.48 26.51 40.65 55.39 23.99 39.43 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 48.87 29.19 44.63 49.10 27.34 43.63 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 52.39 23.42 32.10 54.51 23.27 34.29 9.84 7.66 -4.50 9.21 7.51 -7.47 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 80 TYR~? 5.67 CL CL A 307 A 236 ASP A 9 ASP^? 7.20 CL CL A 307 C 110 ARG A 21 ARG~? 8.34 C22 1PE A 311s coo 55.48 26.51 40.65 55.39 23.99 39.43 28.47 9.96 3.42 27.66 10.97 5.91 coo 48.87 29.19 44.63 49.10 27.34 43.63 32.44 3.50 6.30 30.77 4.75 6.60 coo 52.39 23.42 32.10 54.51 23.27 34.29 25.14 13.51 10.69 25.11 15.00 13.42 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR A 86 TYR^? 7.10 CL CL A 305 A 236 ASP A 88 ASP^? 16.22 CL CL A 305 C 110 ARG A 17 ARG~? -3.60 CL CL A 307s coo 55.48 26.51 40.65 55.39 23.99 39.43 29.34 5.60 1.24 26.89 6.10 2.52 coo 48.87 29.19 44.63 49.10 27.34 43.63 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 52.39 23.42 32.10 54.51 23.27 34.29 29.80 8.18 9.40 27.73 6.82 7.62 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR B 80 TYR~? 5.35 CL CL B 310 A 236 ASP B 9 ASP^? 7.08 CL CL B 310 C 110 ARG B 21 ARG~? 10.16 CL CL B 310 coo 55.48 26.51 40.65 55.39 23.99 39.43 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 48.87 29.19 44.63 49.10 27.34 43.63 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 52.39 23.42 32.10 54.51 23.27 34.29 7.31 -19.18 1.19 5.97 -20.30 -1.38 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR B 86 TYR^? 6.73 CL CL B 310 A 236 ASP B 88 ASP^? 4.66 O4 PEG B 312 C 110 ARG B 17 ARG~? -3.61 CL CL B 310s coo 55.48 26.51 40.65 55.39 23.99 39.43 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 48.87 29.19 44.63 49.10 27.34 43.63 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 52.39 23.42 32.10 54.51 23.27 34.29 14.51 -18.33 -1.30 15.06 -15.90 0.47 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 3 TYR^? 10.95 ZN ZN A 303 B 236 ASP B 47 ASP.? 11.08 ZN ZN A 303 D 110 ARG A 36 ARG.? -4.82 ZN ZN A 303s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 9.84 7.66 -4.50 9.21 7.51 -7.47 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 80 TYR~? 5.67 CL CL A 307 B 236 ASP A 9 ASP^? 7.20 CL CL A 307 D 110 ARG A 21 ARG~? 8.34 C22 1PE A 311s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 28.47 9.96 3.42 27.66 10.97 5.91 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 32.44 3.50 6.30 30.77 4.75 6.60 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 25.14 13.51 10.69 25.11 15.00 13.42 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR A 86 TYR^? 7.10 CL CL A 305 B 236 ASP A 88 ASP^? 16.22 CL CL A 305 D 110 ARG A 17 ARG~? -3.60 CL CL A 307s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 29.34 5.60 1.24 26.89 6.10 2.52 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 29.80 8.18 9.40 27.73 6.82 7.62 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR B 80 TYR~? 5.35 CL CL B 310 B 236 ASP B 9 ASP^? 7.08 CL CL B 310 D 110 ARG B 21 ARG~? 10.16 CL CL B 310 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 7.31 -19.18 1.19 5.97 -20.30 -1.38 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR B 86 TYR^? 6.73 CL CL B 310 B 236 ASP B 88 ASP^? 4.66 O4 PEG B 312 D 110 ARG B 17 ARG~? -3.61 CL CL B 310s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 14.51 -18.33 -1.30 15.06 -15.90 0.47 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 17 ARG~? -3.60 CL CL A 307s G 163 TYR A 86 TYR^? 7.10 CL CL A 305 G 236 ASP A 88 ASP^? 16.22 CL CL A 305 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 29.80 8.18 9.40 27.73 6.82 7.62 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 29.34 5.60 1.24 26.89 6.10 2.52 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG A 21 ARG~? 8.34 C22 1PE A 311s G 163 TYR A 80 TYR~? 5.67 CL CL A 307 G 236 ASP A 9 ASP^? 7.20 CL CL A 307 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 25.14 13.51 10.69 25.11 15.00 13.42 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 28.47 9.96 3.42 27.66 10.97 5.91 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG A 36 ARG.? -4.82 ZN ZN A 303s G 163 TYR A 3 TYR^? 10.95 ZN ZN A 303 G 236 ASP B 47 ASP.? 11.08 ZN ZN A 303 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 9.84 7.66 -4.50 9.21 7.51 -7.47 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 15.08 -4.94 -11.66 14.38 -3.13 -10.90 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 110 ARG B 17 ARG~? -3.61 CL CL B 310s G 163 TYR B 86 TYR^? 6.73 CL CL B 310 G 236 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 110 ARG B 21 ARG~? 10.16 CL CL B 310 G 163 TYR B 80 TYR~? 5.35 CL CL B 310 G 236 ASP B 9 ASP^? 7.08 CL CL B 310 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 20.52 -16.92 -1.41 18.60 -16.56 -0.65 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 17 ARG~? -3.60 CL CL A 307s H 163 TYR A 86 TYR^? 7.10 CL CL A 305 H 236 ASP A 88 ASP^? 16.22 CL CL A 305 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 29.80 8.18 9.40 27.73 6.82 7.62 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 29.34 5.60 1.24 26.89 6.10 2.52 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG A 21 ARG~? 8.34 C22 1PE A 311s H 163 TYR A 80 TYR~? 5.67 CL CL A 307 H 236 ASP A 9 ASP^? 7.20 CL CL A 307 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 25.14 13.51 10.69 25.11 15.00 13.42 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 28.47 9.96 3.42 27.66 10.97 5.91 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG A 36 ARG.? -4.82 ZN ZN A 303s H 163 TYR A 3 TYR^? 10.95 ZN ZN A 303 H 236 ASP B 47 ASP.? 11.08 ZN ZN A 303 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 9.84 7.66 -4.50 9.21 7.51 -7.47 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 15.08 -4.94 -11.66 14.38 -3.13 -10.90 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 110 ARG B 17 ARG~? -3.61 CL CL B 310s H 163 TYR B 86 TYR^? 6.73 CL CL B 310 H 236 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 110 ARG B 21 ARG~? 10.16 CL CL B 310 H 163 TYR B 80 TYR~? 5.35 CL CL B 310 H 236 ASP B 9 ASP^? 7.08 CL CL B 310 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 20.52 -16.92 -1.41 18.60 -16.56 -0.65 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 3 TYR^? 10.95 ZN ZN A 303 E 236 ASP B 47 ASP.? 11.08 ZN ZN A 303 G 110 ARG A 36 ARG.? -4.82 ZN ZN A 303s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 9.84 7.66 -4.50 9.21 7.51 -7.47 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 80 TYR~? 5.67 CL CL A 307 E 236 ASP A 9 ASP^? 7.20 CL CL A 307 G 110 ARG A 21 ARG~? 8.34 C22 1PE A 311s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 28.47 9.96 3.42 27.66 10.97 5.91 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 32.44 3.50 6.30 30.77 4.75 6.60 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 25.14 13.51 10.69 25.11 15.00 13.42 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR A 86 TYR^? 7.10 CL CL A 305 E 236 ASP A 88 ASP^? 16.22 CL CL A 305 G 110 ARG A 17 ARG~? -3.60 CL CL A 307s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 29.34 5.60 1.24 26.89 6.10 2.52 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 29.80 8.18 9.40 27.73 6.82 7.62 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR B 80 TYR~? 5.35 CL CL B 310 E 236 ASP B 9 ASP^? 7.08 CL CL B 310 G 110 ARG B 21 ARG~? 10.16 CL CL B 310 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 7.31 -19.18 1.19 5.97 -20.30 -1.38 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR B 86 TYR^? 6.73 CL CL B 310 E 236 ASP B 88 ASP^? 4.66 O4 PEG B 312 G 110 ARG B 17 ARG~? -3.61 CL CL B 310s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 14.51 -18.33 -1.30 15.06 -15.90 0.47 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 3 TYR^? 10.95 ZN ZN A 303 F 236 ASP B 47 ASP.? 11.08 ZN ZN A 303 H 110 ARG A 36 ARG.? -4.82 ZN ZN A 303s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 9.84 7.66 -4.50 9.21 7.51 -7.47 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 80 TYR~? 5.67 CL CL A 307 F 236 ASP A 9 ASP^? 7.20 CL CL A 307 H 110 ARG A 21 ARG~? 8.34 C22 1PE A 311s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 28.47 9.96 3.42 27.66 10.97 5.91 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 32.44 3.50 6.30 30.77 4.75 6.60 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 25.14 13.51 10.69 25.11 15.00 13.42 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR A 86 TYR^? 7.10 CL CL A 305 F 236 ASP A 88 ASP^? 16.22 CL CL A 305 H 110 ARG A 17 ARG~? -3.60 CL CL A 307s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 29.34 5.60 1.24 26.89 6.10 2.52 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 29.80 8.18 9.40 27.73 6.82 7.62 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR B 80 TYR~? 5.35 CL CL B 310 F 236 ASP B 9 ASP^? 7.08 CL CL B 310 H 110 ARG B 21 ARG~? 10.16 CL CL B 310 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 7.31 -19.18 1.19 5.97 -20.30 -1.38 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR B 86 TYR^? 6.73 CL CL B 310 F 236 ASP B 88 ASP^? 4.66 O4 PEG B 312 H 110 ARG B 17 ARG~? -3.61 CL CL B 310s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 14.51 -18.33 -1.30 15.06 -15.90 0.47 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c23 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 9 ASP^? 7.20 CL CL A 307 A 261 ASP A 73 ASP~? 14.36 ZN ZN A 303 A 329 ASP A 88 ASP^? 16.22 CL CL A 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 32.44 3.50 6.30 30.77 4.75 6.60 coo 34.02 79.89 42.60 34.73 78.01 41.86 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 37.87 70.12 31.80 36.61 69.74 30.15 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 9 ASP^? 7.20 CL CL A 307 A 261 ASP B 88 ASP^? 4.66 O4 PEG B 312 A 329 ASP A 88 ASP^? 16.22 CL CL A 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 32.44 3.50 6.30 30.77 4.75 6.60 coo 34.02 79.89 42.60 34.73 78.01 41.86 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 37.87 70.12 31.80 36.61 69.74 30.15 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 78 ASP~? 6.31 CL CL A 305 A 261 ASP B 47 ASP.? 11.08 ZN ZN A 303 A 329 ASP A 73 ASP~? 14.36 ZN ZN A 303 coo 28.46 69.88 26.74 30.40 70.70 26.53 25.71 9.07 -1.28 24.93 9.58 0.62 coo 34.02 79.89 42.60 34.73 78.01 41.86 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 37.87 70.12 31.80 36.61 69.74 30.15 21.65 6.61 -10.76 21.87 5.79 -12.65 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 9 ASP^? 7.08 CL CL B 310 A 261 ASP A 88 ASP^? 16.22 CL CL A 305 A 329 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 28.46 69.88 26.74 30.40 70.70 26.53 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 34.02 79.89 42.60 34.73 78.01 41.86 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 9 ASP^? 7.08 CL CL B 310 A 261 ASP B 73 ASP~? 8.36 C1 PEG B 312 A 329 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 28.46 69.88 26.74 30.40 70.70 26.53 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 34.02 79.89 42.60 34.73 78.01 41.86 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 37.87 70.12 31.80 36.61 69.74 30.15 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 261 ASP A 47 ASP.? 12.21 O1 PEG B 312 A 329 ASP B 73 ASP~? 8.36 C1 PEG B 312 coo 28.46 69.88 26.74 30.40 70.70 26.53 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 34.02 79.89 42.60 34.73 78.01 41.86 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 37.87 70.12 31.80 36.61 69.74 30.15 21.44 -15.50 19.28 23.24 -15.58 20.39 1qho_c05 source 1qho ALPHA-AMYLASE : 6 hits 1qho_c05 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA A 26 ALA~? 3.84 OH4 1PE A 311 H 148 HIS A 24 HIS~? 3.26 ZN ZN A 301s H 163 ASP A 78 ASP~? 6.31 CL CL A 305 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 19.35 16.64 2.62 20.12 17.75 1.91 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 24.25 11.32 4.20 23.54 9.34 4.43 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 25.71 9.07 -1.28 24.93 9.58 0.62 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 H 51 ALA B 26 ALA~? 10.59 CL CL B 309 H 148 HIS B 24 HIS~? 3.28 ZN ZN B 302s H 163 ASP B 78 ASP~? 6.36 ZN ZN B 302 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 6.34 -17.54 11.68 6.25 -18.99 12.16 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 11.77 -17.25 6.59 12.69 -15.38 6.18 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 16.87 -17.86 9.95 15.14 -17.20 8.90 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c07 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 13 THR~? 12.05 CL CL A 307 A 182 TYR A 80 TYR~? 5.67 CL CL A 307 A 186 LYS A 16 LYS~? 15.92 CL CL A 307 coo 69.38 87.38 24.64 71.11 88.47 25.40 36.58 8.43 8.32 36.19 7.36 6.46 coo 73.61 90.42 31.12 71.36 89.66 29.64 28.47 9.96 3.42 27.66 10.97 5.91 coo 73.54 84.00 28.64 69.01 86.68 29.71 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR A 39 THR^? 8.50 CL CL A 305 A 182 TYR B 2 TYR^? 13.50 CL CL A 306 A 186 LYS B 96 LYS.? 11.54 CL CL A 306 coo 69.38 87.38 24.64 71.11 88.47 25.40 14.21 3.91 6.70 14.94 2.35 8.05 coo 73.61 90.42 31.12 71.36 89.66 29.64 15.58 -0.36 14.99 13.00 0.51 15.42 coo 73.54 84.00 28.64 69.01 86.68 29.71 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 3 3 # 3 A 145 THR B 13 THR~? 11.44 CL CL B 310 A 182 TYR B 80 TYR~? 5.35 CL CL B 310 A 186 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 69.38 87.38 24.64 71.11 88.47 25.40 17.86 -22.93 -3.30 19.41 -22.24 -1.96 coo 73.61 90.42 31.12 71.36 89.66 29.64 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 73.54 84.00 28.64 69.01 86.68 29.71 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 4 3 # 4 A 145 THR B 39 THR^? 8.33 O2 CAC A 313 A 182 TYR A 2 TYR^? -4.58 O2 CAC A 313s A 186 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo 69.38 87.38 24.64 71.11 88.47 25.40 10.69 -4.51 7.70 11.48 -3.65 5.83 coo 73.61 90.42 31.12 71.36 89.66 29.64 10.20 -0.74 -0.90 7.99 0.53 0.19 coo 73.54 84.00 28.64 69.01 86.68 29.71 8.76 -5.89 1.16 6.19 -2.58 4.65 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 4 hits 1qrr_c01 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 6 PHE^? 10.79 CL CL A 305 A 201 ASP A 88 ASP^? 16.22 CL CL A 305 A 227 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 23.39 49.81 32.16 21.33 51.68 32.26 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 25.52 45.12 37.98 23.98 46.65 37.85 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 12.68 46.83 36.69 18.26 48.67 34.51 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 56 PHE^? 7.07 CL CL A 307 A 201 ASP A 9 ASP^? 7.20 CL CL A 307 A 227 LYS B 92 LYS^? 11.01 CL CL A 307 coo 23.39 49.81 32.16 21.33 51.68 32.26 28.85 5.55 12.29 27.69 7.22 14.19 coo 25.52 45.12 37.98 23.98 46.65 37.85 32.44 3.50 6.30 30.77 4.75 6.60 coo 12.68 46.83 36.69 18.26 48.67 34.51 25.00 -4.81 12.30 28.64 -2.55 7.65 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE A 65 PHE.? 9.58 C2 CAC A 313 A 201 ASP A 73 ASP~? 14.36 ZN ZN A 303 A 227 LYS A 92 LYS^? 11.11 CL CL B 310 coo 23.39 49.81 32.16 21.33 51.68 32.26 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 25.52 45.12 37.98 23.98 46.65 37.85 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 12.68 46.83 36.69 18.26 48.67 34.51 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE B 6 PHE^? 11.00 CL CL B 308 A 201 ASP B 88 ASP^? 4.66 O4 PEG B 312 A 227 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 23.39 49.81 32.16 21.33 51.68 32.26 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 25.52 45.12 37.98 23.98 46.65 37.85 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 12.68 46.83 36.69 18.26 48.67 34.51 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE B 56 PHE^? 6.57 CL CL B 310 A 201 ASP B 9 ASP^? 7.08 CL CL B 310 A 227 LYS A 92 LYS^? 11.11 CL CL B 310 coo 23.39 49.81 32.16 21.33 51.68 32.26 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 25.52 45.12 37.98 23.98 46.65 37.85 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 12.68 46.83 36.69 18.26 48.67 34.51 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE B 65 PHE.? 11.19 C1 PEG B 312 A 201 ASP B 73 ASP~? 8.36 C1 PEG B 312 A 227 LYS B 92 LYS^? 11.01 CL CL A 307 coo 23.39 49.81 32.16 21.33 51.68 32.26 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 25.52 45.12 37.98 23.98 46.65 37.85 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 12.68 46.83 36.69 18.26 48.67 34.51 25.00 -4.81 12.30 28.64 -2.55 7.65 1qz9_c02 source 1qz9 KYNURENINASE : 6 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 9 ASP^? 7.20 CL CL A 307 A 186 ASN A 12 ASN.? 17.53 CL CL A 307 A 260 ALA A 54 ALA~? 15.05 CL CL A 307 coo 11.81 33.10 11.71 13.07 31.45 11.40 32.44 3.50 6.30 30.77 4.75 6.60 coo 11.43 26.53 7.41 13.01 27.56 8.43 40.38 5.75 9.96 41.03 3.99 10.95 coo 21.53 26.33 6.96 20.26 25.69 7.52 34.63 3.90 17.29 33.94 2.78 18.03 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP A 9 ASP^? 7.20 CL CL A 307 A 186 ASN A 43 ASN^? 7.86 CL CL A 307 A 260 ALA A 40 ALA^? 3.90 CL CL A 305 coo 11.81 33.10 11.71 13.07 31.45 11.40 32.44 3.50 6.30 30.77 4.75 6.60 coo 11.43 26.53 7.41 13.01 27.56 8.43 25.90 0.17 10.25 24.19 -0.21 9.00 coo 21.53 26.33 6.96 20.26 25.69 7.52 17.79 5.14 6.68 17.95 6.32 5.72 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP A 9 ASP^? 7.20 CL CL A 307 A 186 ASN A 43 ASN^? 7.86 CL CL A 307 A 260 ALA A 54 ALA~? 15.05 CL CL A 307 coo 11.81 33.10 11.71 13.07 31.45 11.40 32.44 3.50 6.30 30.77 4.75 6.60 coo 11.43 26.53 7.41 13.01 27.56 8.43 25.90 0.17 10.25 24.19 -0.21 9.00 coo 21.53 26.33 6.96 20.26 25.69 7.52 34.63 3.90 17.29 33.94 2.78 18.03 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP B 9 ASP^? 7.08 CL CL B 310 A 186 ASN B 12 ASN.? 16.85 CL CL B 310 A 260 ALA B 54 ALA~? 14.55 CL CL B 310 coo 11.81 33.10 11.71 13.07 31.45 11.40 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 11.43 26.53 7.41 13.01 27.56 8.43 20.42 -23.48 -7.49 21.29 -22.60 -9.16 coo 21.53 26.33 6.96 20.26 25.69 7.52 15.06 -16.25 -11.15 15.03 -14.81 -11.68 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 5 3 # 5 A 10 ASP B 9 ASP^? 7.08 CL CL B 310 A 186 ASN B 43 ASN^? 8.09 CL CL B 308 A 260 ALA B 40 ALA^? 3.96 CL CL B 308 coo 11.81 33.10 11.71 13.07 31.45 11.40 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 11.43 26.53 7.41 13.01 27.56 8.43 17.50 -9.23 -1.99 17.56 -8.09 -0.19 coo 21.53 26.33 6.96 20.26 25.69 7.52 11.68 -7.85 6.20 11.37 -9.01 7.19 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 6 3 # 6 A 10 ASP B 9 ASP^? 7.08 CL CL B 310 A 186 ASN B 43 ASN^? 8.09 CL CL B 308 A 260 ALA B 54 ALA~? 14.55 CL CL B 310 coo 11.81 33.10 11.71 13.07 31.45 11.40 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 11.43 26.53 7.41 13.01 27.56 8.43 17.50 -9.23 -1.99 17.56 -8.09 -0.19 coo 21.53 26.33 6.96 20.26 25.69 7.52 15.06 -16.25 -11.15 15.03 -14.81 -11.68 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 6 hits 1r4f_c00 naa= 3 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 1 3 # 1 D 129 ARG A 21 ARG~? 8.34 C22 1PE A 311s D 156 TYR A 86 TYR^? 7.10 CL CL A 305 D 188 HIS A 24 HIS~? 3.26 ZN ZN A 301s coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 25.14 13.51 10.69 25.11 15.00 13.42 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 29.34 5.60 1.24 26.89 6.10 2.52 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 24.25 11.32 4.20 23.54 9.34 4.43 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 2 3 # 2 D 129 ARG B 21 ARG~? 10.16 CL CL B 310 D 156 TYR B 86 TYR^? 6.73 CL CL B 310 D 188 HIS B 24 HIS~? 3.28 ZN ZN B 302s coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 19.96 -17.22 4.85 17.58 -15.73 4.95 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 11.77 -17.25 6.59 12.69 -15.38 6.18 1ro7_c03 source 1ro7 ALPHA-2,3/8-SIALYLTRANSFERASE : 2 hits 1ro7_c03 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU B 66 GLU.? -18.09 C1 PEG B 312s A 288 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 329 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 29.27 18.78 14.99 27.16 18.62 14.76 16.63 -8.08 24.80 15.43 -6.55 25.64 coo 49.52 10.06 10.36 50.99 9.65 8.92 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 57.80 12.92 13.83 53.77 8.42 12.15 14.27 -25.10 0.23 14.58 -27.01 3.12 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 1 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU B 66 GLU.? -18.09 C1 PEG B 312s B 288 HIS B 24 HIS~? 3.28 ZN ZN B 302s B 329 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 16.63 -8.08 24.80 15.43 -6.55 25.64 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 14.27 -25.10 0.23 14.58 -27.01 3.12 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 1 hits 1roz_c01 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 24 HIS~? 3.26 ZN ZN A 301s B 102 ASP A 78 ASP~? 6.31 CL CL A 305 B 193 GLY A 41 GLY^? 3.79 CL CL A 306 coo -4.60 27.52 42.88 -4.63 27.41 40.76 24.25 11.32 4.20 23.54 9.34 4.43 coo -0.27 31.24 43.51 -1.49 29.62 42.98 25.71 9.07 -1.28 24.93 9.58 0.62 coo -6.81 22.81 34.74 -6.42 23.54 34.62 20.71 5.55 9.04 20.91 4.99 8.47 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS B 24 HIS~? 3.28 ZN ZN B 302s B 102 ASP B 78 ASP~? 6.36 ZN ZN B 302 B 193 GLY B 41 GLY^? -3.88 CL CL B 309s coo -4.60 27.52 42.88 -4.63 27.41 40.76 11.77 -17.25 6.59 12.69 -15.38 6.18 coo -0.27 31.24 43.51 -1.49 29.62 42.98 16.87 -17.86 9.95 15.14 -17.20 8.90 coo -6.81 22.81 34.74 -6.42 23.54 34.62 11.75 -9.68 2.90 12.54 -9.55 3.14 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 2 hits 1rtf_c06 naa= 3 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 78 ASP~? 6.31 CL CL A 305 64 HIS A 24 HIS~? 3.26 ZN ZN A 301s 221 SER A 59 SER^? 3.89 CL CL A 305s coo 80.16 73.25 62.48 80.01 71.25 61.82 25.71 9.07 -1.28 24.93 9.58 0.62 coo 78.27 67.69 61.83 79.58 67.76 60.19 24.25 11.32 4.20 23.54 9.34 4.43 coo 83.63 66.07 58.16 81.31 66.75 57.98 24.86 2.91 6.28 24.83 4.11 4.27 1sca_c00 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 1 hits 1sca_c00 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 78 ASP~? 6.31 CL CL A 305 64 HIS A 24 HIS~? 3.26 ZN ZN A 301s 155 ASN A 43 ASN^? 7.86 CL CL A 307 coo 80.16 73.25 62.48 80.01 71.25 61.82 25.71 9.07 -1.28 24.93 9.58 0.62 coo 78.27 67.69 61.83 79.58 67.76 60.19 24.25 11.32 4.20 23.54 9.34 4.43 coo 80.34 61.88 52.75 81.25 63.19 54.35 25.90 0.17 10.25 24.19 -0.21 9.00 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 1 hits 1sca_c01 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 102 ASP A 78 ASP~? 6.31 CL CL A 305 A 193 GLY A 41 GLY^? 3.79 CL CL A 306 coo 15.02 29.17 19.44 15.63 29.96 17.60 24.25 11.32 4.20 23.54 9.34 4.43 coo 19.67 30.58 22.61 18.30 29.87 21.17 25.71 9.07 -1.28 24.93 9.58 0.62 coo 14.52 29.10 10.01 15.08 29.66 10.19 20.71 5.55 9.04 20.91 4.99 8.47 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 102 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 193 GLY B 41 GLY^? -3.88 CL CL B 309s coo 15.02 29.17 19.44 15.63 29.96 17.60 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 19.67 30.58 22.61 18.30 29.87 21.17 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 14.52 29.10 10.01 15.08 29.66 10.19 11.75 -9.68 2.90 12.54 -9.55 3.14 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 2 hits 1ssx_c02 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 0 HIS.? -3.23 ZN ZN A 303s B 80 GLU A 66 GLU.? -2.36 ZN ZN A 303s B 223 ARG B 36 ARG.? 14.37 CL CL B 308 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 7.36 3.84 -7.81 6.63 5.12 -9.32 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 11.68 6.52 -11.11 9.60 6.56 -10.92 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 10.68 -7.55 19.92 12.72 -9.80 19.82 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS B 0 HIS.? -19.60 C1 PEG B 312s B 80 GLU B 66 GLU.? -18.09 C1 PEG B 312s B 223 ARG A 36 ARG.? -4.82 ZN ZN A 303s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 14.07 -2.85 23.00 13.20 -3.63 24.76 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 16.63 -8.08 24.80 15.43 -6.55 25.64 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 9.84 7.66 -4.50 9.21 7.51 -7.47 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 2 hits 1t0u_c01 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 7 ALA^? 6.91 CL CL A 305 A 251 GLY A 58 GLY^? 7.04 CL CL A 307 A 252 ASP A 9 ASP^? 7.20 CL CL A 307 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 26.94 1.12 2.04 26.75 2.62 2.11 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 28.51 2.01 6.75 28.22 2.24 7.53 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA B 7 ALA^? 7.10 CL CL B 308 A 251 GLY B 58 GLY^? 7.10 CL CL B 310 A 252 ASP B 9 ASP^? 7.08 CL CL B 310 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 21.57 -12.46 4.46 20.42 -13.34 4.87 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 19.36 -13.08 -0.04 18.65 -12.88 -0.47 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 20.52 -16.92 -1.41 18.60 -16.56 -0.65 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 2 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 7 ALA^? 6.91 CL CL A 305 B 251 GLY A 58 GLY^? 7.04 CL CL A 307 B 252 ASP A 9 ASP^? 7.20 CL CL A 307 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 26.94 1.12 2.04 26.75 2.62 2.11 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 28.51 2.01 6.75 28.22 2.24 7.53 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA B 7 ALA^? 7.10 CL CL B 308 B 251 GLY B 58 GLY^? 7.10 CL CL B 310 B 252 ASP B 9 ASP^? 7.08 CL CL B 310 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 21.57 -12.46 4.46 20.42 -13.34 4.87 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 19.36 -13.08 -0.04 18.65 -12.88 -0.47 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 20.52 -16.92 -1.41 18.60 -16.56 -0.65 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 2 hits 1tz3_c03 naa= 3 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 1 3 # 1 115 LYS A 72 LYS~? 17.83 ZN ZN A 303 138 ASN A 67 ASN~? 8.15 ZN ZN A 303 183 HIS A 0 HIS.? -3.23 ZN ZN A 303s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 14.02 0.88 -12.67 14.89 2.62 -13.50 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 7.36 3.84 -7.81 6.63 5.12 -9.32 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 2 3 # 2 115 LYS B 72 LYS~? -3.48 O1 PEG B 312s 138 ASN B 67 ASN~? 12.71 C1 PEG B 312 183 HIS B 0 HIS.? -19.60 C1 PEG B 312s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 22.54 -6.70 23.21 22.14 -8.65 23.93 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 14.07 -2.85 23.00 13.20 -3.63 24.76 1uag_c01 source 1uag UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLUTAMATE LI: 2 hits 1uag_c01 naa= 3 ULMN 3 1uk7_c00 3.07.01.0009 user 1 3 # 1 A 103 ALA A 26 ALA~? 3.84 OH4 1PE A 311 A 224 ASP A 78 ASP~? 6.31 CL CL A 305 A 252 HIS A 24 HIS~? 3.26 ZN ZN A 301s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 19.35 16.64 2.62 20.12 17.75 1.91 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 25.71 9.07 -1.28 24.93 9.58 0.62 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 24.25 11.32 4.20 23.54 9.34 4.43 ULMN 3 1uk7_c00 3.07.01.0009 user 2 3 # 2 A 103 ALA B 26 ALA~? 10.59 CL CL B 309 A 224 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 252 HIS B 24 HIS~? 3.28 ZN ZN B 302s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 6.34 -17.54 11.68 6.25 -18.99 12.16 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 11.77 -17.25 6.59 12.69 -15.38 6.18 1uk7_c00 source 1uk7 3.07.01.0009 : 2 hits 1uk7_c00 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS A 0 HIS.? -3.23 ZN ZN A 303s 89 GLU A 66 GLU.? -2.36 ZN ZN A 303s 243 ASN B 43 ASN^? 8.09 CL CL B 308 coo 5.83 15.74 17.38 6.41 17.70 17.86 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 3.11 16.19 13.44 4.96 17.09 13.42 11.68 6.52 -11.11 9.60 6.56 -10.92 coo 0.53 21.81 31.33 1.05 20.47 29.70 17.50 -9.23 -1.99 17.56 -8.09 -0.19 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 2 3 # 2 86 HIS A 0 HIS.? -3.23 ZN ZN A 303s 89 GLU A 66 GLU.? -2.36 ZN ZN A 303s 243 ASN B 50 ASN.? 13.34 CL CL B 309 coo 5.83 15.74 17.38 6.41 17.70 17.86 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 3.11 16.19 13.44 4.96 17.09 13.42 11.68 6.52 -11.11 9.60 6.56 -10.92 coo 0.53 21.81 31.33 1.05 20.47 29.70 6.69 -11.33 -9.11 5.16 -10.77 -7.82 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 3 3 # 3 86 HIS B 0 HIS.? -19.60 C1 PEG B 312s 89 GLU B 66 GLU.? -18.09 C1 PEG B 312s 243 ASN A 43 ASN^? 7.86 CL CL A 307 coo 5.83 15.74 17.38 6.41 17.70 17.86 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 3.11 16.19 13.44 4.96 17.09 13.42 16.63 -8.08 24.80 15.43 -6.55 25.64 coo 0.53 21.81 31.33 1.05 20.47 29.70 25.90 0.17 10.25 24.19 -0.21 9.00 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 4 3 # 4 86 HIS B 0 HIS.? -19.60 C1 PEG B 312s 89 GLU B 66 GLU.? -18.09 C1 PEG B 312s 243 ASN A 50 ASN.? 13.13 CL CL A 307 coo 5.83 15.74 17.38 6.41 17.70 17.86 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 3.11 16.19 13.44 4.96 17.09 13.42 16.63 -8.08 24.80 15.43 -6.55 25.64 coo 0.53 21.81 31.33 1.05 20.47 29.70 26.00 7.74 20.99 24.12 8.66 20.66 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 4 hits 1ula_c00 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 78 ASP~? 6.31 CL CL A 305 218 GLU B 66 GLU.? -18.09 C1 PEG B 312s 329 ASP A 9 ASP^? 7.20 CL CL A 307 coo 49.16 35.16 15.19 51.08 34.43 15.65 25.71 9.07 -1.28 24.93 9.58 0.62 coo 70.09 11.71 8.46 70.56 12.89 6.77 16.63 -8.08 24.80 15.43 -6.55 25.64 coo 59.16 37.82 13.95 57.63 37.03 15.12 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 88 ASP^? 16.22 CL CL A 305 218 GLU B 66 GLU.? -18.09 C1 PEG B 312s 329 ASP A 9 ASP^? 7.20 CL CL A 307 coo 49.16 35.16 15.19 51.08 34.43 15.65 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 70.09 11.71 8.46 70.56 12.89 6.77 16.63 -8.08 24.80 15.43 -6.55 25.64 coo 59.16 37.82 13.95 57.63 37.03 15.12 32.44 3.50 6.30 30.77 4.75 6.60 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 78 ASP~? 6.36 ZN ZN B 302 218 GLU A 66 GLU.? -2.36 ZN ZN A 303s 329 ASP B 9 ASP^? 7.08 CL CL B 310 coo 49.16 35.16 15.19 51.08 34.43 15.65 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 70.09 11.71 8.46 70.56 12.89 6.77 11.68 6.52 -11.11 9.60 6.56 -10.92 coo 59.16 37.82 13.95 57.63 37.03 15.12 20.52 -16.92 -1.41 18.60 -16.56 -0.65 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 78 ASP~? 6.36 ZN ZN B 302 218 GLU A 66 GLU.? -2.36 ZN ZN A 303s 329 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 49.16 35.16 15.19 51.08 34.43 15.65 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 70.09 11.71 8.46 70.56 12.89 6.77 11.68 6.52 -11.11 9.60 6.56 -10.92 coo 59.16 37.82 13.95 57.63 37.03 15.12 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 88 ASP^? 4.66 O4 PEG B 312 218 GLU A 66 GLU.? -2.36 ZN ZN A 303s 329 ASP B 9 ASP^? 7.08 CL CL B 310 coo 49.16 35.16 15.19 51.08 34.43 15.65 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 70.09 11.71 8.46 70.56 12.89 6.77 11.68 6.52 -11.11 9.60 6.56 -10.92 coo 59.16 37.82 13.95 57.63 37.03 15.12 20.52 -16.92 -1.41 18.60 -16.56 -0.65 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 5 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 78 ASP~? 6.31 CL CL A 305 242 GLU A 49 GLU.? 12.26 CL CL A 306 329 ASP A 73 ASP~? 14.36 ZN ZN A 303 coo 49.16 35.16 15.19 51.08 34.43 15.65 25.71 9.07 -1.28 24.93 9.58 0.62 coo 30.42 34.74 5.00 29.09 35.09 3.38 21.20 3.66 19.03 19.27 4.46 18.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 21.65 6.61 -10.76 21.87 5.79 -12.65 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 78 ASP~? 6.36 ZN ZN B 302 242 GLU B 49 GLU.? 12.07 C2 CAC A 313 329 ASP B 73 ASP~? 8.36 C1 PEG B 312 coo 49.16 35.16 15.19 51.08 34.43 15.65 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 30.42 34.74 5.00 29.09 35.09 3.38 7.03 -7.10 -6.90 6.04 -5.38 -6.16 coo 59.16 37.82 13.95 57.63 37.03 15.12 21.44 -15.50 19.28 23.24 -15.58 20.39 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 2 hits 1uok_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 12 ASN.? 17.53 CL CL A 307 457 GLY A 55 GLY.? 11.02 CL CL A 307 459 GLU A 53 GLU~? 18.59 CL CL A 307 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 40.38 5.75 9.96 41.03 3.99 10.95 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 32.43 5.49 14.62 32.30 4.76 14.95 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 36.80 8.95 19.88 36.02 9.25 21.82 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 50 ASN.? 13.13 CL CL A 307 457 GLY A 55 GLY.? 11.02 CL CL A 307 459 GLU A 53 GLU~? 18.59 CL CL A 307 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 26.00 7.74 20.99 24.12 8.66 20.66 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 32.43 5.49 14.62 32.30 4.76 14.95 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 36.80 8.95 19.88 36.02 9.25 21.82 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN B 12 ASN.? 16.85 CL CL B 310 457 GLY B 55 GLY.? 10.53 CL CL B 310 459 GLU B 53 GLU~? 18.91 CL CL B 310 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 20.42 -23.48 -7.49 21.29 -22.60 -9.16 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 14.71 -16.40 -7.41 14.86 -15.73 -7.82 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 12.65 -21.17 -12.94 11.35 -22.27 -14.28 1vom_c00 source 1vom MYOSIN : 3 hits 1vom_c00 naa= 3 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 A 100 PHE A 6 PHE^? 10.79 CL CL A 305 A 197 ASN A 43 ASN^? 7.86 CL CL A 307 A 198 PRO A 42 PRO^? -3.67 CL CL A 307s coo 5.24 -2.19 28.74 3.83 -0.30 30.29 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 25.90 0.17 10.25 24.19 -0.21 9.00 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 24.14 6.33 11.54 23.60 4.92 9.86 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 A 100 PHE A 6 PHE^? 10.79 CL CL A 305 A 197 ASN A 43 ASN^? 7.86 CL CL A 307 A 198 PRO B 93 PRO^? 10.62 O1 PEG B 312 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 25.90 0.17 10.25 24.19 -0.21 9.00 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 25.70 -2.58 16.00 24.06 -2.80 14.47 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 A 100 PHE A 56 PHE^? 7.07 CL CL A 307 A 197 ASN A 43 ASN^? 7.86 CL CL A 307 A 198 PRO B 93 PRO^? 10.62 O1 PEG B 312 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 28.85 5.55 12.29 27.69 7.22 14.19 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 25.90 0.17 10.25 24.19 -0.21 9.00 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 25.70 -2.58 16.00 24.06 -2.80 14.47 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 A 100 PHE B 6 PHE^? 11.00 CL CL B 308 A 197 ASN B 43 ASN^? 8.09 CL CL B 308 A 198 PRO A 93 PRO^? 13.00 CL CL B 310 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 17.50 -9.23 -1.99 17.56 -8.09 -0.19 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 16.50 -5.89 -7.34 16.59 -5.00 -5.27 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 5 3 # 5 A 100 PHE B 6 PHE^? 11.00 CL CL B 308 A 197 ASN B 43 ASN^? 8.09 CL CL B 308 A 198 PRO B 42 PRO^? -3.70 CL CL B 310s coo 5.24 -2.19 28.74 3.83 -0.30 30.29 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 17.50 -9.23 -1.99 17.56 -8.09 -0.19 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 11.82 -12.10 -0.68 13.32 -11.08 0.64 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 6 3 # 6 A 100 PHE B 56 PHE^? 6.57 CL CL B 310 A 197 ASN B 43 ASN^? 8.09 CL CL B 308 A 198 PRO A 93 PRO^? 13.00 CL CL B 310 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 17.50 -9.23 -1.99 17.56 -8.09 -0.19 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 16.50 -5.89 -7.34 16.59 -5.00 -5.27 1vq1_c00 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 6 hits 1vq1_c00 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE A 6 PHE^? 10.79 CL CL A 305 B 197 ASN A 43 ASN^? 7.86 CL CL A 307 B 198 PRO A 42 PRO^? -3.67 CL CL A 307s coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 25.90 0.17 10.25 24.19 -0.21 9.00 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 24.14 6.33 11.54 23.60 4.92 9.86 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 B 100 PHE A 6 PHE^? 10.79 CL CL A 305 B 197 ASN A 43 ASN^? 7.86 CL CL A 307 B 198 PRO B 93 PRO^? 10.62 O1 PEG B 312 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 25.90 0.17 10.25 24.19 -0.21 9.00 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 25.70 -2.58 16.00 24.06 -2.80 14.47 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 B 100 PHE A 56 PHE^? 7.07 CL CL A 307 B 197 ASN A 43 ASN^? 7.86 CL CL A 307 B 198 PRO B 93 PRO^? 10.62 O1 PEG B 312 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 28.85 5.55 12.29 27.69 7.22 14.19 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 25.90 0.17 10.25 24.19 -0.21 9.00 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 25.70 -2.58 16.00 24.06 -2.80 14.47 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 B 100 PHE B 6 PHE^? 11.00 CL CL B 308 B 197 ASN B 43 ASN^? 8.09 CL CL B 308 B 198 PRO B 42 PRO^? -3.70 CL CL B 310s coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 17.50 -9.23 -1.99 17.56 -8.09 -0.19 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 11.82 -12.10 -0.68 13.32 -11.08 0.64 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 5 3 # 5 B 100 PHE B 56 PHE^? 6.57 CL CL B 310 B 197 ASN B 43 ASN^? 8.09 CL CL B 308 B 198 PRO A 93 PRO^? 13.00 CL CL B 310 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 17.50 -9.23 -1.99 17.56 -8.09 -0.19 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 16.50 -5.89 -7.34 16.59 -5.00 -5.27 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 5 hits 1vq1_c01 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 3 TYR^? 10.95 ZN ZN A 303 A 40 ASP A 73 ASP~? 14.36 ZN ZN A 303 A 103 LEU A 68 LEU~? 13.78 ZN ZN A 303 coo 12.09 16.13 10.57 11.28 18.80 10.73 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 7.55 25.51 14.34 9.65 25.73 14.24 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 11.83 18.73 16.99 10.99 19.71 15.26 17.65 -2.18 -10.41 19.13 -3.35 -9.29 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 3 TYR^? 10.95 ZN ZN A 303 A 40 ASP B 48 ASP.? 14.63 ZN ZN A 303 A 103 LEU A 68 LEU~? 13.78 ZN ZN A 303 coo 12.09 16.13 10.57 11.28 18.80 10.73 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 7.55 25.51 14.34 9.65 25.73 14.24 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 11.83 18.73 16.99 10.99 19.71 15.26 17.65 -2.18 -10.41 19.13 -3.35 -9.29 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR B 3 TYR^? 11.16 C1 PEG B 312 A 40 ASP A 48 ASP.? -15.94 CL CL A 307s A 103 LEU B 68 LEU~? 7.97 O1 PEG B 312 coo 12.09 16.13 10.57 11.28 18.80 10.73 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 7.55 25.51 14.34 9.65 25.73 14.24 26.96 2.23 21.50 26.58 3.74 22.88 coo 11.83 18.73 16.99 10.99 19.71 15.26 25.24 -6.64 18.79 26.23 -6.64 16.84 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 3 TYR^? 11.16 C1 PEG B 312 A 40 ASP B 73 ASP~? 8.36 C1 PEG B 312 A 103 LEU B 68 LEU~? 7.97 O1 PEG B 312 coo 12.09 16.13 10.57 11.28 18.80 10.73 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 7.55 25.51 14.34 9.65 25.73 14.24 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 11.83 18.73 16.99 10.99 19.71 15.26 25.24 -6.64 18.79 26.23 -6.64 16.84 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 4 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 3 TYR^? 10.95 ZN ZN A 303 B 40 ASP A 73 ASP~? 14.36 ZN ZN A 303 B 103 LEU A 68 LEU~? 13.78 ZN ZN A 303 coo 14.25 20.09 37.35 13.48 17.40 37.38 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 9.39 10.77 34.53 11.50 10.63 34.41 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 12.89 17.60 31.13 12.34 16.51 32.90 17.65 -2.18 -10.41 19.13 -3.35 -9.29 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 3 TYR^? 10.95 ZN ZN A 303 B 40 ASP B 48 ASP.? 14.63 ZN ZN A 303 B 103 LEU A 68 LEU~? 13.78 ZN ZN A 303 coo 14.25 20.09 37.35 13.48 17.40 37.38 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 9.39 10.77 34.53 11.50 10.63 34.41 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 12.89 17.60 31.13 12.34 16.51 32.90 17.65 -2.18 -10.41 19.13 -3.35 -9.29 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR B 3 TYR^? 11.16 C1 PEG B 312 B 40 ASP A 48 ASP.? -15.94 CL CL A 307s B 103 LEU B 68 LEU~? 7.97 O1 PEG B 312 coo 14.25 20.09 37.35 13.48 17.40 37.38 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 9.39 10.77 34.53 11.50 10.63 34.41 26.96 2.23 21.50 26.58 3.74 22.88 coo 12.89 17.60 31.13 12.34 16.51 32.90 25.24 -6.64 18.79 26.23 -6.64 16.84 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 3 TYR^? 11.16 C1 PEG B 312 B 40 ASP B 73 ASP~? 8.36 C1 PEG B 312 B 103 LEU B 68 LEU~? 7.97 O1 PEG B 312 coo 14.25 20.09 37.35 13.48 17.40 37.38 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 9.39 10.77 34.53 11.50 10.63 34.41 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 12.89 17.60 31.13 12.34 16.51 32.90 25.24 -6.64 18.79 26.23 -6.64 16.84 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 4 hits 1vzz_c01 naa= 3 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 105 ALA A 26 ALA~? 3.84 OH4 1PE A 311 A 244 ASP A 78 ASP~? 6.31 CL CL A 305 A 271 HIS A 24 HIS~? 3.26 ZN ZN A 301s coo 15.05 3.71 6.93 14.58 4.88 7.78 19.35 16.64 2.62 20.12 17.75 1.91 coo 9.85 8.15 0.76 10.61 7.04 2.39 25.71 9.07 -1.28 24.93 9.58 0.62 coo 10.61 7.65 6.01 12.39 6.55 6.23 24.25 11.32 4.20 23.54 9.34 4.43 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 105 ALA B 26 ALA~? 10.59 CL CL B 309 A 244 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 271 HIS B 24 HIS~? 3.28 ZN ZN B 302s coo 15.05 3.71 6.93 14.58 4.88 7.78 6.34 -17.54 11.68 6.25 -18.99 12.16 coo 9.85 8.15 0.76 10.61 7.04 2.39 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 10.61 7.65 6.01 12.39 6.55 6.23 11.77 -17.25 6.59 12.69 -15.38 6.18 1xqw_c00 source 1xqw PROLINE IMINOPEPTIDASE : 2 hits 1xqw_c00 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 19 ALA~? 13.01 C23 1PE A 311 B 126 ARG A 17 ARG~? -3.60 CL CL A 307s B 138 GLU A 22 GLU~? -5.00 C13 1PE A 311s coo 2.11 4.00 19.31 3.14 4.86 19.99 31.39 17.11 8.09 32.81 17.33 7.60 coo 2.45 5.53 11.28 3.59 7.56 13.29 29.80 8.18 9.40 27.73 6.82 7.62 coo 6.10 2.00 25.24 6.12 1.84 23.13 23.55 20.26 6.43 24.10 22.30 6.48 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA B 19 ALA~? 11.52 ZN ZN B 304 B 126 ARG B 17 ARG~? -3.61 CL CL B 310s B 138 GLU B 22 GLU~? 10.35 CL CL B 309 coo 2.11 4.00 19.31 3.14 4.86 19.99 9.94 -25.99 1.93 11.15 -26.95 1.94 coo 2.45 5.53 11.28 3.59 7.56 13.29 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo 6.10 2.00 25.24 6.12 1.84 23.13 3.91 -22.17 5.69 2.98 -20.35 5.17 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 19 ALA~? 13.01 C23 1PE A 311 C 126 ARG A 17 ARG~? -3.60 CL CL A 307s C 138 GLU A 22 GLU~? -5.00 C13 1PE A 311s coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 31.39 17.11 8.09 32.81 17.33 7.60 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 29.80 8.18 9.40 27.73 6.82 7.62 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 23.55 20.26 6.43 24.10 22.30 6.48 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA B 19 ALA~? 11.52 ZN ZN B 304 C 126 ARG B 17 ARG~? -3.61 CL CL B 310s C 138 GLU B 22 GLU~? 10.35 CL CL B 309 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 9.94 -25.99 1.93 11.15 -26.95 1.94 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 3.91 -22.17 5.69 2.98 -20.35 5.17 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 19 ALA~? 13.01 C23 1PE A 311 D 126 ARG A 17 ARG~? -3.60 CL CL A 307s D 138 GLU A 22 GLU~? -5.00 C13 1PE A 311s coo 2.08 -1.49 62.94 3.12 -2.39 62.28 31.39 17.11 8.09 32.81 17.33 7.60 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 29.80 8.18 9.40 27.73 6.82 7.62 coo 6.23 0.50 57.10 5.93 0.72 59.19 23.55 20.26 6.43 24.10 22.30 6.48 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA B 19 ALA~? 11.52 ZN ZN B 304 D 126 ARG B 17 ARG~? -3.61 CL CL B 310s D 138 GLU B 22 GLU~? 10.35 CL CL B 309 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 9.94 -25.99 1.93 11.15 -26.95 1.94 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo 6.23 0.50 57.10 5.93 0.72 59.19 3.91 -22.17 5.69 2.98 -20.35 5.17 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 19 ALA~? 13.01 C23 1PE A 311 E 126 ARG A 17 ARG~? -3.60 CL CL A 307s E 138 GLU A 22 GLU~? -5.00 C13 1PE A 311s coo -4.56 10.03 62.36 -4.38 11.31 61.55 31.39 17.11 8.09 32.81 17.33 7.60 coo -3.02 12.00 70.07 -1.94 13.84 67.82 29.80 8.18 9.40 27.73 6.82 7.62 coo -8.67 12.22 56.54 -8.68 12.09 58.65 23.55 20.26 6.43 24.10 22.30 6.48 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA B 19 ALA~? 11.52 ZN ZN B 304 E 126 ARG B 17 ARG~? -3.61 CL CL B 310s E 138 GLU B 22 GLU~? 10.35 CL CL B 309 coo -4.56 10.03 62.36 -4.38 11.31 61.55 9.94 -25.99 1.93 11.15 -26.95 1.94 coo -3.02 12.00 70.07 -1.94 13.84 67.82 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo -8.67 12.22 56.54 -8.68 12.09 58.65 3.91 -22.17 5.69 2.98 -20.35 5.17 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 19 ALA~? 13.01 C23 1PE A 311 F 126 ARG A 17 ARG~? -3.60 CL CL A 307s F 138 GLU A 22 GLU~? -5.00 C13 1PE A 311s coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 31.39 17.11 8.09 32.81 17.33 7.60 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 29.80 8.18 9.40 27.73 6.82 7.62 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 23.55 20.26 6.43 24.10 22.30 6.48 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA B 19 ALA~? 11.52 ZN ZN B 304 F 126 ARG B 17 ARG~? -3.61 CL CL B 310s F 138 GLU B 22 GLU~? 10.35 CL CL B 309 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 9.94 -25.99 1.93 11.15 -26.95 1.94 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 3.91 -22.17 5.69 2.98 -20.35 5.17 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 41 GLY^? 3.79 CL CL A 306 B 175 ARG A 17 ARG~? -3.60 CL CL A 307s B 242 TYR A 86 TYR^? 7.10 CL CL A 305 coo 99.45 58.28 3.33 99.57 58.61 4.10 20.71 5.55 9.04 20.91 4.99 8.47 coo 106.37 63.53 0.89 108.02 63.40 -1.62 29.80 8.18 9.40 27.73 6.82 7.62 coo 100.93 69.04 4.38 99.52 68.48 2.09 29.34 5.60 1.24 26.89 6.10 2.52 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 41 GLY^? 3.79 CL CL A 306 B 175 ARG A 21 ARG~? 8.34 C22 1PE A 311s B 242 TYR A 80 TYR~? 5.67 CL CL A 307 coo 99.45 58.28 3.33 99.57 58.61 4.10 20.71 5.55 9.04 20.91 4.99 8.47 coo 106.37 63.53 0.89 108.02 63.40 -1.62 25.14 13.51 10.69 25.11 15.00 13.42 coo 100.93 69.04 4.38 99.52 68.48 2.09 28.47 9.96 3.42 27.66 10.97 5.91 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY B 41 GLY^? -3.88 CL CL B 309s B 175 ARG B 17 ARG~? -3.61 CL CL B 310s B 242 TYR B 86 TYR^? 6.73 CL CL B 310 coo 99.45 58.28 3.33 99.57 58.61 4.10 11.75 -9.68 2.90 12.54 -9.55 3.14 coo 106.37 63.53 0.89 108.02 63.40 -1.62 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo 100.93 69.04 4.38 99.52 68.48 2.09 19.96 -17.22 4.85 17.58 -15.73 4.95 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY B 41 GLY^? -3.88 CL CL B 309s B 175 ARG B 21 ARG~? 10.16 CL CL B 310 B 242 TYR B 80 TYR~? 5.35 CL CL B 310 coo 99.45 58.28 3.33 99.57 58.61 4.10 11.75 -9.68 2.90 12.54 -9.55 3.14 coo 106.37 63.53 0.89 108.02 63.40 -1.62 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo 100.93 69.04 4.38 99.52 68.48 2.09 15.15 -19.22 4.72 12.71 -19.06 3.39 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 4 hits 1xva_c03 naa= 3 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 3 # 1 142 TRP B 74 TRP~? 9.22 CL CL B 308 223 ASP B 73 ASP~? 8.36 C1 PEG B 312 258 ALA B 7 ALA^? 7.10 CL CL B 308 coo 128.40 33.01 26.67 128.12 36.28 28.81 14.76 -14.11 16.53 14.47 -13.16 12.72 coo 127.91 41.73 23.55 129.18 40.35 24.44 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 141.00 37.49 25.74 139.80 37.53 24.78 21.57 -12.46 4.46 20.42 -13.34 4.87 2aat_c01 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 1 hits 2aat_c01 naa= 3 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 A 105 ASN B 43 ASN^? 8.09 CL CL B 308 A 106 PRO A 93 PRO^? 13.00 CL CL B 310 A 108 TYR A 3 TYR^? 10.95 ZN ZN A 303 coo 34.91 38.94 20.48 33.53 38.20 19.00 17.50 -9.23 -1.99 17.56 -8.09 -0.19 coo 36.18 33.51 20.99 37.11 35.33 20.14 16.50 -5.89 -7.34 16.59 -5.00 -5.27 coo 33.01 33.46 15.68 31.96 34.97 17.80 15.55 -0.59 -5.31 14.15 -1.10 -7.68 2adm_c00 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 1 hits 2adm_c00 naa= 3 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 B 105 ASN A 43 ASN^? 7.86 CL CL A 307 B 106 PRO B 93 PRO^? 10.62 O1 PEG B 312 B 108 TYR B 3 TYR^? 11.16 C1 PEG B 312 coo 5.98 38.14 46.94 7.30 38.92 45.46 25.90 0.17 10.25 24.19 -0.21 9.00 coo 4.66 43.53 47.47 3.74 41.73 46.59 25.70 -2.58 16.00 24.06 -2.80 14.47 coo 7.86 43.80 42.15 8.87 42.26 44.27 20.49 -5.14 16.12 21.33 -4.29 18.62 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 2 3 # 2 B 105 ASN B 43 ASN^? 8.09 CL CL B 308 B 106 PRO A 93 PRO^? 13.00 CL CL B 310 B 108 TYR A 3 TYR^? 10.95 ZN ZN A 303 coo 5.98 38.14 46.94 7.30 38.92 45.46 17.50 -9.23 -1.99 17.56 -8.09 -0.19 coo 4.66 43.53 47.47 3.74 41.73 46.59 16.50 -5.89 -7.34 16.59 -5.00 -5.27 coo 7.86 43.80 42.15 8.87 42.26 44.27 15.55 -0.59 -5.31 14.15 -1.10 -7.68 2adm_c01 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 2 hits 2adm_c01 naa= 3 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 0 HIS.? -3.23 ZN ZN A 303s B 50 GLU B 49 GLU.? 12.07 C2 CAC A 313 B 113 GLN A 64 GLN^? -3.49 C2 CAC A 313s coo 37.74 -17.01 11.59 38.11 -17.83 13.49 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 7.03 -7.10 -6.90 6.04 -5.38 -6.16 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 9.17 2.67 -2.61 7.16 3.33 -2.48 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS B 0 HIS.? -19.60 C1 PEG B 312s B 50 GLU A 49 GLU.? 12.26 CL CL A 306 B 113 GLN B 64 GLN^? 16.90 CL CL B 308 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 21.20 3.66 19.03 19.27 4.46 18.88 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 13.48 -2.38 17.76 11.93 -1.34 18.68 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS B 0 HIS.? -19.60 C1 PEG B 312s B 50 GLU B 34 GLU~? 16.28 CL CL B 308 B 113 GLN B 64 GLN^? 16.90 CL CL B 308 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 6.76 -9.82 20.52 8.48 -10.92 21.08 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 13.48 -2.38 17.76 11.93 -1.34 18.68 2ag0_c04 source 2ag0 BENZALDEHYDE LYASE : 3 hits 2ag0_c04 naa= 3 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 0 HIS.? -3.23 ZN ZN A 303s B 50 GLU B 49 GLU.? 12.07 C2 CAC A 313 B 113 GLN A 64 GLN^? -3.49 C2 CAC A 313s coo 37.74 -17.01 11.59 38.11 -17.83 13.49 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 7.03 -7.10 -6.90 6.04 -5.38 -6.16 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 9.17 2.67 -2.61 7.16 3.33 -2.48 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS B 0 HIS.? -19.60 C1 PEG B 312s B 50 GLU A 49 GLU.? 12.26 CL CL A 306 B 113 GLN B 64 GLN^? 16.90 CL CL B 308 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 21.20 3.66 19.03 19.27 4.46 18.88 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 13.48 -2.38 17.76 11.93 -1.34 18.68 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS B 0 HIS.? -19.60 C1 PEG B 312s B 50 GLU B 34 GLU~? 16.28 CL CL B 308 B 113 GLN B 64 GLN^? 16.90 CL CL B 308 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 6.76 -9.82 20.52 8.48 -10.92 21.08 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 13.48 -2.38 17.76 11.93 -1.34 18.68 2ag0_c08 source 2ag0 BENZALDEHYDE LYASE : 3 hits 2ag0_c08 naa= 3 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 1 3 # 1 A 29 HIS A 0 HIS.? -3.23 ZN ZN A 303s A 50 GLU B 49 GLU.? 12.07 C2 CAC A 313 A 113 GLN A 64 GLN^? -3.49 C2 CAC A 313s coo 73.37 -13.43 4.64 73.06 -11.77 3.39 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 7.03 -7.10 -6.90 6.04 -5.38 -6.16 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 9.17 2.67 -2.61 7.16 3.33 -2.48 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 2 3 # 2 A 29 HIS B 0 HIS.? -19.60 C1 PEG B 312s A 50 GLU A 49 GLU.? 12.26 CL CL A 306 A 113 GLN B 64 GLN^? 16.90 CL CL B 308 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 21.20 3.66 19.03 19.27 4.46 18.88 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 13.48 -2.38 17.76 11.93 -1.34 18.68 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 3 3 # 3 A 29 HIS B 0 HIS.? -19.60 C1 PEG B 312s A 50 GLU B 34 GLU~? 16.28 CL CL B 308 A 113 GLN B 64 GLN^? 16.90 CL CL B 308 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 6.76 -9.82 20.52 8.48 -10.92 21.08 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 13.48 -2.38 17.76 11.93 -1.34 18.68 2ag0_c09 source 2ag0 BENZALDEHYDE LYASE : 3 hits 2ag0_c09 naa= 3 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 1 3 # 1 C 29 HIS A 0 HIS.? -3.23 ZN ZN A 303s C 50 GLU B 49 GLU.? 12.07 C2 CAC A 313 C 113 GLN A 64 GLN^? -3.49 C2 CAC A 313s coo 74.92 8.52 28.42 74.88 6.86 29.70 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 65.25 15.95 28.73 65.73 15.63 30.78 7.03 -7.10 -6.90 6.04 -5.38 -6.16 coo 70.80 6.73 32.72 71.88 8.55 32.53 9.17 2.67 -2.61 7.16 3.33 -2.48 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 2 3 # 2 C 29 HIS B 0 HIS.? -19.60 C1 PEG B 312s C 50 GLU A 49 GLU.? 12.26 CL CL A 306 C 113 GLN B 64 GLN^? 16.90 CL CL B 308 coo 74.92 8.52 28.42 74.88 6.86 29.70 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 65.25 15.95 28.73 65.73 15.63 30.78 21.20 3.66 19.03 19.27 4.46 18.88 coo 70.80 6.73 32.72 71.88 8.55 32.53 13.48 -2.38 17.76 11.93 -1.34 18.68 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 3 3 # 3 C 29 HIS B 0 HIS.? -19.60 C1 PEG B 312s C 50 GLU B 34 GLU~? 16.28 CL CL B 308 C 113 GLN B 64 GLN^? 16.90 CL CL B 308 coo 74.92 8.52 28.42 74.88 6.86 29.70 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 65.25 15.95 28.73 65.73 15.63 30.78 6.76 -9.82 20.52 8.48 -10.92 21.08 coo 70.80 6.73 32.72 71.88 8.55 32.53 13.48 -2.38 17.76 11.93 -1.34 18.68 2ag0_c10 source 2ag0 BENZALDEHYDE LYASE : 3 hits 2ag0_c10 naa= 3 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 1 3 # 1 D 29 HIS A 0 HIS.? -3.23 ZN ZN A 303s D 50 GLU B 49 GLU.? 12.07 C2 CAC A 313 D 113 GLN A 64 GLN^? -3.49 C2 CAC A 313s coo 38.66 11.31 27.15 38.67 12.13 25.22 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 48.72 12.85 33.83 48.36 14.77 32.95 7.03 -7.10 -6.90 6.04 -5.38 -6.16 coo 42.85 14.77 24.15 41.85 15.11 26.02 9.17 2.67 -2.61 7.16 3.33 -2.48 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 2 3 # 2 D 29 HIS B 0 HIS.? -19.60 C1 PEG B 312s D 50 GLU A 49 GLU.? 12.26 CL CL A 306 D 113 GLN B 64 GLN^? 16.90 CL CL B 308 coo 38.66 11.31 27.15 38.67 12.13 25.22 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 48.72 12.85 33.83 48.36 14.77 32.95 21.20 3.66 19.03 19.27 4.46 18.88 coo 42.85 14.77 24.15 41.85 15.11 26.02 13.48 -2.38 17.76 11.93 -1.34 18.68 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 3 3 # 3 D 29 HIS B 0 HIS.? -19.60 C1 PEG B 312s D 50 GLU B 34 GLU~? 16.28 CL CL B 308 D 113 GLN B 64 GLN^? 16.90 CL CL B 308 coo 38.66 11.31 27.15 38.67 12.13 25.22 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 48.72 12.85 33.83 48.36 14.77 32.95 6.76 -9.82 20.52 8.48 -10.92 21.08 coo 42.85 14.77 24.15 41.85 15.11 26.02 13.48 -2.38 17.76 11.93 -1.34 18.68 2ag0_c11 source 2ag0 BENZALDEHYDE LYASE : 3 hits 2ag0_c11 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 78 ASP~? 6.31 CL CL A 305 231 ASP A 48 ASP.? -15.94 CL CL A 307s 294 ASP A 88 ASP^? 16.22 CL CL A 305 coo 27.89 102.52 14.98 29.35 101.92 13.57 25.71 9.07 -1.28 24.93 9.58 0.62 coo 14.74 93.05 -1.00 14.30 94.22 0.73 26.96 2.23 21.50 26.58 3.74 22.88 coo 33.16 106.80 7.72 33.34 104.87 6.92 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 88 ASP^? 16.22 CL CL A 305 231 ASP A 47 ASP.? 12.21 O1 PEG B 312 294 ASP A 78 ASP~? 6.31 CL CL A 305 coo 27.89 102.52 14.98 29.35 101.92 13.57 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 14.74 93.05 -1.00 14.30 94.22 0.73 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 33.16 106.80 7.72 33.34 104.87 6.92 25.71 9.07 -1.28 24.93 9.58 0.62 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 88 ASP^? 16.22 CL CL A 305 231 ASP A 48 ASP.? -15.94 CL CL A 307s 294 ASP A 78 ASP~? 6.31 CL CL A 305 coo 27.89 102.52 14.98 29.35 101.92 13.57 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 14.74 93.05 -1.00 14.30 94.22 0.73 26.96 2.23 21.50 26.58 3.74 22.88 coo 33.16 106.80 7.72 33.34 104.87 6.92 25.71 9.07 -1.28 24.93 9.58 0.62 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP A 88 ASP^? 16.22 CL CL A 305 231 ASP B 48 ASP.? 14.63 ZN ZN A 303 294 ASP A 78 ASP~? 6.31 CL CL A 305 coo 27.89 102.52 14.98 29.35 101.92 13.57 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 14.74 93.05 -1.00 14.30 94.22 0.73 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 33.16 106.80 7.72 33.34 104.87 6.92 25.71 9.07 -1.28 24.93 9.58 0.62 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP B 88 ASP^? 4.66 O4 PEG B 312 231 ASP A 78 ASP~? 6.31 CL CL A 305 294 ASP B 9 ASP^? 7.08 CL CL B 310 coo 27.89 102.52 14.98 29.35 101.92 13.57 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 14.74 93.05 -1.00 14.30 94.22 0.73 25.71 9.07 -1.28 24.93 9.58 0.62 coo 33.16 106.80 7.72 33.34 104.87 6.92 20.52 -16.92 -1.41 18.60 -16.56 -0.65 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 5 hits 2amg_c06 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG B 21 ARG~? 10.16 CL CL B 310 A 161 ASP B 9 ASP^? 7.08 CL CL B 310 A 174 TYR B 86 TYR^? 6.73 CL CL B 310 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 19.96 -17.22 4.85 17.58 -15.73 4.95 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG B 21 ARG~? 10.16 CL CL B 310 B 161 ASP B 9 ASP^? 7.08 CL CL B 310 B 174 TYR B 86 TYR^? 6.73 CL CL B 310 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo -14.86 10.19 8.14 -14.82 12.31 8.42 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo -21.46 12.70 8.53 -19.04 12.30 7.24 19.96 -17.22 4.85 17.58 -15.73 4.95 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG B 21 ARG~? 10.16 CL CL B 310 C 161 ASP B 9 ASP^? 7.08 CL CL B 310 C 174 TYR B 86 TYR^? 6.73 CL CL B 310 coo 2.84 19.43 40.34 1.59 20.35 37.65 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo -0.62 11.10 28.05 -0.65 13.15 27.46 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 5.94 13.28 27.17 3.53 13.05 28.58 19.96 -17.22 4.85 17.58 -15.73 4.95 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG B 21 ARG~? 10.16 CL CL B 310 D 161 ASP B 9 ASP^? 7.08 CL CL B 310 D 174 TYR B 86 TYR^? 6.73 CL CL B 310 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 19.96 -17.22 4.85 17.58 -15.73 4.95 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c11 naa= 3 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 1 3 # 1 A 182 LYS A 72 LYS~? 17.83 ZN ZN A 303 A 184 LYS A 92 LYS^? 11.11 CL CL B 310 A 345 ASP A 88 ASP^? 16.22 CL CL A 305 coo 5.98 42.76 7.73 10.19 38.62 9.02 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 2.77 37.17 4.99 6.33 34.76 8.06 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 0.07 40.30 18.65 -0.21 42.34 18.18 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 2 3 # 2 A 182 LYS A 92 LYS^? 11.11 CL CL B 310 A 184 LYS A 72 LYS~? 17.83 ZN ZN A 303 A 345 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 5.98 42.76 7.73 10.19 38.62 9.02 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 2.77 37.17 4.99 6.33 34.76 8.06 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 0.07 40.30 18.65 -0.21 42.34 18.18 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 3 3 # 3 A 182 LYS B 72 LYS~? -3.48 O1 PEG B 312s A 184 LYS B 92 LYS^? 11.01 CL CL A 307 A 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 5.98 42.76 7.73 10.19 38.62 9.02 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 2.77 37.17 4.99 6.33 34.76 8.06 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 0.07 40.30 18.65 -0.21 42.34 18.18 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 4 3 # 4 A 182 LYS B 92 LYS^? 11.01 CL CL A 307 A 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s A 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 5.98 42.76 7.73 10.19 38.62 9.02 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 2.77 37.17 4.99 6.33 34.76 8.06 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 0.07 40.30 18.65 -0.21 42.34 18.18 27.27 -14.86 3.96 28.42 -13.55 5.17 2dw7_c32 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c32 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 92 LYS^? 11.11 CL CL B 310 B 184 LYS A 72 LYS~? 17.83 ZN ZN A 303 B 345 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 38.76 2.27 4.00 34.00 5.99 4.37 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 40.63 7.13 9.06 35.85 7.36 8.95 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS B 92 LYS^? 11.01 CL CL A 307 B 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s B 345 ASP A 48 ASP.? -15.94 CL CL A 307s coo 38.76 2.27 4.00 34.00 5.99 4.37 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 40.63 7.13 9.06 35.85 7.36 8.95 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 26.96 2.23 21.50 26.58 3.74 22.88 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS A 72 LYS~? 17.83 ZN ZN A 303 C 184 LYS A 92 LYS^? 11.11 CL CL B 310 C 345 ASP A 88 ASP^? 16.22 CL CL A 305 coo -5.66 12.40 71.13 -2.66 9.98 66.50 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 0.95 12.72 73.51 1.58 12.72 68.31 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo -4.59 24.28 66.67 -6.26 24.34 67.99 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 2 3 # 2 C 182 LYS A 92 LYS^? 11.11 CL CL B 310 C 184 LYS A 72 LYS~? 17.83 ZN ZN A 303 C 345 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo -5.66 12.40 71.13 -2.66 9.98 66.50 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 0.95 12.72 73.51 1.58 12.72 68.31 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo -4.59 24.28 66.67 -6.26 24.34 67.99 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 3 3 # 3 C 182 LYS B 72 LYS~? -3.48 O1 PEG B 312s C 184 LYS B 92 LYS^? 11.01 CL CL A 307 C 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo -5.66 12.40 71.13 -2.66 9.98 66.50 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 0.95 12.72 73.51 1.58 12.72 68.31 25.00 -4.81 12.30 28.64 -2.55 7.65 coo -4.59 24.28 66.67 -6.26 24.34 67.99 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 4 3 # 4 C 182 LYS B 92 LYS^? 11.01 CL CL A 307 C 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s C 345 ASP A 48 ASP.? -15.94 CL CL A 307s coo -5.66 12.40 71.13 -2.66 9.98 66.50 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 0.95 12.72 73.51 1.58 12.72 68.31 23.06 -12.55 15.81 27.03 -9.57 14.36 coo -4.59 24.28 66.67 -6.26 24.34 67.99 26.96 2.23 21.50 26.58 3.74 22.88 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 5 3 # 5 C 182 LYS B 92 LYS^? 11.01 CL CL A 307 C 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s C 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo -5.66 12.40 71.13 -2.66 9.98 66.50 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 0.95 12.72 73.51 1.58 12.72 68.31 23.06 -12.55 15.81 27.03 -9.57 14.36 coo -4.59 24.28 66.67 -6.26 24.34 67.99 27.27 -14.86 3.96 28.42 -13.55 5.17 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 1 3 # 1 D 182 LYS A 72 LYS~? 17.83 ZN ZN A 303 D 184 LYS A 92 LYS^? 11.11 CL CL B 310 D 345 ASP A 88 ASP^? 16.22 CL CL A 305 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 2 3 # 2 D 182 LYS A 92 LYS^? 11.11 CL CL B 310 D 184 LYS A 72 LYS~? 17.83 ZN ZN A 303 D 345 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 3 3 # 3 D 182 LYS B 72 LYS~? -3.48 O1 PEG B 312s D 184 LYS B 92 LYS^? 11.01 CL CL A 307 D 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 4 3 # 4 D 182 LYS B 92 LYS^? 11.01 CL CL A 307 D 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s D 345 ASP A 48 ASP.? -15.94 CL CL A 307s coo 29.31 -12.29 40.88 26.50 -8.82 44.94 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 26.96 2.23 21.50 26.58 3.74 22.88 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 5 3 # 5 D 182 LYS B 92 LYS^? 11.01 CL CL A 307 D 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s D 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 27.27 -14.86 3.96 28.42 -13.55 5.17 2dw7_c35 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c35 naa= 3 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 1 3 # 1 E 182 LYS A 72 LYS~? 17.83 ZN ZN A 303 E 184 LYS A 92 LYS^? 11.11 CL CL B 310 E 345 ASP A 88 ASP^? 16.22 CL CL A 305 coo -21.16 62.58 121.86 -16.35 60.33 119.23 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo -23.22 55.98 120.74 -18.11 55.31 120.43 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo -17.15 59.71 133.33 -17.96 61.54 134.01 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 2 3 # 2 E 182 LYS A 92 LYS^? 11.11 CL CL B 310 E 184 LYS A 72 LYS~? 17.83 ZN ZN A 303 E 345 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo -21.16 62.58 121.86 -16.35 60.33 119.23 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo -23.22 55.98 120.74 -18.11 55.31 120.43 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo -17.15 59.71 133.33 -17.96 61.54 134.01 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 3 3 # 3 E 182 LYS B 72 LYS~? -3.48 O1 PEG B 312s E 184 LYS B 92 LYS^? 11.01 CL CL A 307 E 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo -21.16 62.58 121.86 -16.35 60.33 119.23 23.06 -12.55 15.81 27.03 -9.57 14.36 coo -23.22 55.98 120.74 -18.11 55.31 120.43 25.00 -4.81 12.30 28.64 -2.55 7.65 coo -17.15 59.71 133.33 -17.96 61.54 134.01 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 4 3 # 4 E 182 LYS B 92 LYS^? 11.01 CL CL A 307 E 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s E 345 ASP A 48 ASP.? -15.94 CL CL A 307s coo -21.16 62.58 121.86 -16.35 60.33 119.23 25.00 -4.81 12.30 28.64 -2.55 7.65 coo -23.22 55.98 120.74 -18.11 55.31 120.43 23.06 -12.55 15.81 27.03 -9.57 14.36 coo -17.15 59.71 133.33 -17.96 61.54 134.01 26.96 2.23 21.50 26.58 3.74 22.88 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 5 3 # 5 E 182 LYS B 92 LYS^? 11.01 CL CL A 307 E 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s E 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo -21.16 62.58 121.86 -16.35 60.33 119.23 25.00 -4.81 12.30 28.64 -2.55 7.65 coo -23.22 55.98 120.74 -18.11 55.31 120.43 23.06 -12.55 15.81 27.03 -9.57 14.36 coo -17.15 59.71 133.33 -17.96 61.54 134.01 27.27 -14.86 3.96 28.42 -13.55 5.17 2dw7_c36 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c36 naa= 3 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 1 3 # 1 F 182 LYS A 72 LYS~? 17.83 ZN ZN A 303 F 184 LYS A 92 LYS^? 11.11 CL CL B 310 F 345 ASP A 88 ASP^? 16.22 CL CL A 305 coo 10.64 34.02 91.30 6.30 35.60 95.11 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 13.75 39.76 94.12 11.42 37.23 97.89 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 16.35 26.90 99.56 16.81 25.90 97.75 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 2 3 # 2 F 182 LYS B 72 LYS~? -3.48 O1 PEG B 312s F 184 LYS B 92 LYS^? 11.01 CL CL A 307 F 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 10.64 34.02 91.30 6.30 35.60 95.11 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 13.75 39.76 94.12 11.42 37.23 97.89 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 16.35 26.90 99.56 16.81 25.90 97.75 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 3 3 # 3 F 182 LYS B 92 LYS^? 11.01 CL CL A 307 F 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s F 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 10.64 34.02 91.30 6.30 35.60 95.11 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 13.75 39.76 94.12 11.42 37.23 97.89 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 16.35 26.90 99.56 16.81 25.90 97.75 27.27 -14.86 3.96 28.42 -13.55 5.17 2dw7_c37 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c37 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS A 72 LYS~? 17.83 ZN ZN A 303 G 184 LYS A 92 LYS^? 11.11 CL CL B 310 G 345 ASP A 88 ASP^? 16.22 CL CL A 305 coo 39.68 42.04 76.11 43.42 46.43 74.96 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 36.69 47.69 78.93 39.38 50.40 75.35 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 33.43 44.37 65.47 33.10 42.30 65.37 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 2 3 # 2 G 182 LYS B 72 LYS~? -3.48 O1 PEG B 312s G 184 LYS B 92 LYS^? 11.01 CL CL A 307 G 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 39.68 42.04 76.11 43.42 46.43 74.96 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 36.69 47.69 78.93 39.38 50.40 75.35 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 33.43 44.37 65.47 33.10 42.30 65.37 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 3 3 # 3 G 182 LYS B 92 LYS^? 11.01 CL CL A 307 G 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s G 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 39.68 42.04 76.11 43.42 46.43 74.96 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 36.69 47.69 78.93 39.38 50.40 75.35 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 33.43 44.37 65.47 33.10 42.30 65.37 27.27 -14.86 3.96 28.42 -13.55 5.17 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 1 3 # 1 H 182 LYS A 72 LYS~? 17.83 ZN ZN A 303 H 184 LYS A 92 LYS^? 11.11 CL CL B 310 H 345 ASP A 88 ASP^? 16.22 CL CL A 305 coo 71.58 83.18 80.51 66.88 79.77 79.84 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 73.65 78.64 75.66 68.14 79.07 75.04 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 67.43 90.73 71.39 68.27 92.30 72.52 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 2 3 # 2 H 182 LYS A 92 LYS^? 11.11 CL CL B 310 H 184 LYS A 72 LYS~? 17.83 ZN ZN A 303 H 345 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 71.58 83.18 80.51 66.88 79.77 79.84 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 73.65 78.64 75.66 68.14 79.07 75.04 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 67.43 90.73 71.39 68.27 92.30 72.52 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 3 3 # 3 H 182 LYS B 72 LYS~? -3.48 O1 PEG B 312s H 184 LYS B 92 LYS^? 11.01 CL CL A 307 H 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 71.58 83.18 80.51 66.88 79.77 79.84 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 73.65 78.64 75.66 68.14 79.07 75.04 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 67.43 90.73 71.39 68.27 92.30 72.52 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 4 3 # 4 H 182 LYS B 92 LYS^? 11.01 CL CL A 307 H 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s H 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 71.58 83.18 80.51 66.88 79.77 79.84 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 73.65 78.64 75.66 68.14 79.07 75.04 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 67.43 90.73 71.39 68.27 92.30 72.52 27.27 -14.86 3.96 28.42 -13.55 5.17 2dw7_c39 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c39 naa= 3 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 1 3 # 1 I 182 LYS A 72 LYS~? 17.83 ZN ZN A 303 I 184 LYS A 92 LYS^? 11.11 CL CL B 310 I 345 ASP A 88 ASP^? 16.22 CL CL A 305 coo 60.20 96.92 42.53 57.60 93.13 38.67 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 54.31 95.46 46.01 55.34 91.59 42.65 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 66.35 87.81 48.53 68.10 89.01 48.77 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 2 3 # 2 I 182 LYS A 92 LYS^? 11.11 CL CL B 310 I 184 LYS A 72 LYS~? 17.83 ZN ZN A 303 I 345 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 60.20 96.92 42.53 57.60 93.13 38.67 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 54.31 95.46 46.01 55.34 91.59 42.65 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 66.35 87.81 48.53 68.10 89.01 48.77 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 3 3 # 3 I 182 LYS B 72 LYS~? -3.48 O1 PEG B 312s I 184 LYS B 92 LYS^? 11.01 CL CL A 307 I 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 60.20 96.92 42.53 57.60 93.13 38.67 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 54.31 95.46 46.01 55.34 91.59 42.65 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 66.35 87.81 48.53 68.10 89.01 48.77 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 4 3 # 4 I 182 LYS B 92 LYS^? 11.01 CL CL A 307 I 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s I 345 ASP A 48 ASP.? -15.94 CL CL A 307s coo 60.20 96.92 42.53 57.60 93.13 38.67 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 54.31 95.46 46.01 55.34 91.59 42.65 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 66.35 87.81 48.53 68.10 89.01 48.77 26.96 2.23 21.50 26.58 3.74 22.88 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 5 3 # 5 I 182 LYS B 92 LYS^? 11.01 CL CL A 307 I 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s I 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 60.20 96.92 42.53 57.60 93.13 38.67 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 54.31 95.46 46.01 55.34 91.59 42.65 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 66.35 87.81 48.53 68.10 89.01 48.77 27.27 -14.86 3.96 28.42 -13.55 5.17 2dw7_c40 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c40 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 72 LYS~? 17.83 ZN ZN A 303 J 184 LYS A 92 LYS^? 11.11 CL CL B 310 J 345 ASP A 88 ASP^? 16.22 CL CL A 305 coo 25.22 70.55 14.03 27.64 73.07 18.65 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 31.73 69.87 11.50 32.73 70.19 16.40 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 25.87 58.42 18.79 23.95 58.54 17.90 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS A 92 LYS^? 11.11 CL CL B 310 J 184 LYS A 72 LYS~? 17.83 ZN ZN A 303 J 345 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 25.22 70.55 14.03 27.64 73.07 18.65 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 31.73 69.87 11.50 32.73 70.19 16.40 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 25.87 58.42 18.79 23.95 58.54 17.90 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 3 3 # 3 J 182 LYS B 72 LYS~? -3.48 O1 PEG B 312s J 184 LYS B 92 LYS^? 11.01 CL CL A 307 J 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 25.22 70.55 14.03 27.64 73.07 18.65 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 31.73 69.87 11.50 32.73 70.19 16.40 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 25.87 58.42 18.79 23.95 58.54 17.90 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 4 3 # 4 J 182 LYS B 92 LYS^? 11.01 CL CL A 307 J 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s J 345 ASP A 48 ASP.? -15.94 CL CL A 307s coo 25.22 70.55 14.03 27.64 73.07 18.65 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 31.73 69.87 11.50 32.73 70.19 16.40 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 25.87 58.42 18.79 23.95 58.54 17.90 26.96 2.23 21.50 26.58 3.74 22.88 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS A 72 LYS~? 17.83 ZN ZN A 303 K 184 LYS A 92 LYS^? 11.11 CL CL B 310 K 345 ASP A 88 ASP^? 16.22 CL CL A 305 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 2 3 # 2 K 182 LYS A 92 LYS^? 11.11 CL CL B 310 K 184 LYS A 72 LYS~? 17.83 ZN ZN A 303 K 345 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 3 3 # 3 K 182 LYS B 72 LYS~? -3.48 O1 PEG B 312s K 184 LYS B 92 LYS^? 11.01 CL CL A 307 K 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 4 3 # 4 K 182 LYS B 92 LYS^? 11.01 CL CL A 307 K 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s K 345 ASP A 48 ASP.? -15.94 CL CL A 307s coo 51.91 50.98 -7.18 47.83 49.38 -11.15 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 26.96 2.23 21.50 26.58 3.74 22.88 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 5 3 # 5 K 182 LYS B 92 LYS^? 11.01 CL CL A 307 K 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s K 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 27.27 -14.86 3.96 28.42 -13.55 5.17 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 92 LYS^? 11.11 CL CL B 310 L 184 LYS A 72 LYS~? 17.83 ZN ZN A 303 L 345 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS B 92 LYS^? 11.01 CL CL A 307 L 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s L 345 ASP A 48 ASP.? -15.94 CL CL A 307s coo 20.72 21.86 -37.85 25.46 24.17 -34.95 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 26.96 2.23 21.50 26.58 3.74 22.88 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 92 LYS^? 11.11 CL CL B 310 M 184 LYS A 72 LYS~? 17.83 ZN ZN A 303 M 345 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 10.78 -8.54 -11.40 8.75 -9.01 -11.79 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 1 3 # 1 N 182 LYS A 72 LYS~? 17.83 ZN ZN A 303 N 184 LYS A 92 LYS^? 11.11 CL CL B 310 N 345 ASP A 88 ASP^? 16.22 CL CL A 305 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 2 3 # 2 N 182 LYS A 92 LYS^? 11.11 CL CL B 310 N 184 LYS A 72 LYS~? 17.83 ZN ZN A 303 N 345 ASP A 88 ASP^? 16.22 CL CL A 305 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 3 3 # 3 N 182 LYS B 72 LYS~? -3.48 O1 PEG B 312s N 184 LYS B 92 LYS^? 11.01 CL CL A 307 N 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 4 3 # 4 N 182 LYS B 92 LYS^? 11.01 CL CL A 307 N 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s N 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 27.27 -14.86 3.96 28.42 -13.55 5.17 2dw7_c45 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c45 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS A 72 LYS~? 17.83 ZN ZN A 303 O 184 LYS A 92 LYS^? 11.11 CL CL B 310 O 345 ASP A 88 ASP^? 16.22 CL CL A 305 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 31.95 -0.90 -1.70 33.94 -1.29 -2.43 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 2 3 # 2 O 182 LYS A 92 LYS^? 11.11 CL CL B 310 O 184 LYS A 72 LYS~? 17.83 ZN ZN A 303 O 345 ASP B 48 ASP.? 14.63 ZN ZN A 303 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 10.78 -8.54 -11.40 8.75 -9.01 -11.79 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 3 3 # 3 O 182 LYS B 72 LYS~? -3.48 O1 PEG B 312s O 184 LYS B 92 LYS^? 11.01 CL CL A 307 O 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 27.27 -14.86 3.96 28.42 -13.55 5.17 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 4 3 # 4 O 182 LYS B 92 LYS^? 11.01 CL CL A 307 O 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s O 345 ASP A 48 ASP.? -15.94 CL CL A 307s coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 26.96 2.23 21.50 26.58 3.74 22.88 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 5 3 # 5 O 182 LYS B 92 LYS^? 11.01 CL CL A 307 O 184 LYS B 72 LYS~? -3.48 O1 PEG B 312s O 345 ASP B 88 ASP^? 4.66 O4 PEG B 312 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 25.00 -4.81 12.30 28.64 -2.55 7.65 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 23.06 -12.55 15.81 27.03 -9.57 14.36 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 27.27 -14.86 3.96 28.42 -13.55 5.17 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c46 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 86 TYR^? 7.10 CL CL A 305 A 245 ASP A 88 ASP^? 16.22 CL CL A 305 A 273 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 29.34 5.60 1.24 26.89 6.10 2.52 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR B 80 TYR~? 5.35 CL CL B 310 A 245 ASP B 9 ASP^? 7.08 CL CL B 310 A 273 LYS A 95 LYS.? 9.36 CL CL B 309 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR B 86 TYR^? 6.73 CL CL B 310 A 245 ASP B 88 ASP^? 4.66 O4 PEG B 312 A 273 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 9.74 16.83 -36.21 11.10 17.13 -33.77 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 27.27 -14.86 3.96 28.42 -13.55 5.17 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 23.06 -12.55 15.81 27.03 -9.57 14.36 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 3 hits 2gsa_c02 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 102 ASP A 78 ASP~? 6.31 CL CL A 305 A 193 GLY A 41 GLY^? 3.79 CL CL A 306 coo 14.96 29.22 19.55 15.62 29.93 17.67 24.25 11.32 4.20 23.54 9.34 4.43 coo 19.64 30.69 22.61 18.18 29.94 21.25 25.71 9.07 -1.28 24.93 9.58 0.62 coo 14.54 28.99 9.76 15.06 29.59 10.02 20.71 5.55 9.04 20.91 4.99 8.47 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 102 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 193 GLY B 41 GLY^? -3.88 CL CL B 309s coo 14.96 29.22 19.55 15.62 29.93 17.67 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 19.64 30.69 22.61 18.18 29.94 21.25 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 14.54 28.99 9.76 15.06 29.59 10.02 11.75 -9.68 2.90 12.54 -9.55 3.14 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 2 hits 2lpr_c02 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 6 PHE^? 10.79 CL CL A 305 A 263 ASP A 88 ASP^? 16.22 CL CL A 305 A 292 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 51.51 50.32 16.39 52.13 49.68 13.75 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 54.43 44.82 23.74 55.21 45.06 21.80 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 63.95 45.30 16.71 59.11 49.15 16.05 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 56 PHE^? 7.07 CL CL A 307 A 263 ASP A 48 ASP.? -15.94 CL CL A 307s A 292 LYS B 96 LYS.? 11.54 CL CL A 306 coo 51.51 50.32 16.39 52.13 49.68 13.75 28.85 5.55 12.29 27.69 7.22 14.19 coo 54.43 44.82 23.74 55.21 45.06 21.80 26.96 2.23 21.50 26.58 3.74 22.88 coo 63.95 45.30 16.71 59.11 49.15 16.05 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE A 65 PHE.? 9.58 C2 CAC A 313 A 263 ASP B 47 ASP.? 11.08 ZN ZN A 303 A 292 LYS A 95 LYS.? 9.36 CL CL B 309 coo 51.51 50.32 16.39 52.13 49.68 13.75 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 54.43 44.82 23.74 55.21 45.06 21.80 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 63.95 45.30 16.71 59.11 49.15 16.05 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE B 6 PHE^? 11.00 CL CL B 308 A 263 ASP B 88 ASP^? 4.66 O4 PEG B 312 A 292 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 51.51 50.32 16.39 52.13 49.68 13.75 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 54.43 44.82 23.74 55.21 45.06 21.80 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 63.95 45.30 16.71 59.11 49.15 16.05 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE B 65 PHE.? 11.19 C1 PEG B 312 A 263 ASP A 47 ASP.? 12.21 O1 PEG B 312 A 292 LYS B 95 LYS.? 9.10 CL CL A 306 coo 51.51 50.32 16.39 52.13 49.68 13.75 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 54.43 44.82 23.74 55.21 45.06 21.80 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 63.95 45.30 16.71 59.11 49.15 16.05 20.80 3.86 14.18 20.78 8.31 16.72 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 5 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 6 PHE^? 10.79 CL CL A 305 B 263 ASP A 88 ASP^? 16.22 CL CL A 305 B 292 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 49.99 26.05 6.28 51.46 26.87 8.49 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 60.53 31.67 0.97 57.79 27.51 3.63 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 56 PHE^? 7.07 CL CL A 307 B 263 ASP A 48 ASP.? -15.94 CL CL A 307s B 292 LYS B 96 LYS.? 11.54 CL CL A 306 coo 49.99 26.05 6.28 51.46 26.87 8.49 28.85 5.55 12.29 27.69 7.22 14.19 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 26.96 2.23 21.50 26.58 3.74 22.88 coo 60.53 31.67 0.97 57.79 27.51 3.63 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE A 65 PHE.? 9.58 C2 CAC A 313 B 263 ASP B 47 ASP.? 11.08 ZN ZN A 303 B 292 LYS A 95 LYS.? 9.36 CL CL B 309 coo 49.99 26.05 6.28 51.46 26.87 8.49 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 60.53 31.67 0.97 57.79 27.51 3.63 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE B 6 PHE^? 11.00 CL CL B 308 B 263 ASP B 88 ASP^? 4.66 O4 PEG B 312 B 292 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 49.99 26.05 6.28 51.46 26.87 8.49 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 60.53 31.67 0.97 57.79 27.51 3.63 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE B 56 PHE^? 6.57 CL CL B 310 B 263 ASP B 48 ASP.? 14.63 ZN ZN A 303 B 292 LYS A 96 LYS.? 5.78 O2 CAC A 313 coo 49.99 26.05 6.28 51.46 26.87 8.49 14.31 -14.42 -3.67 11.53 -14.35 -4.06 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 60.53 31.67 0.97 57.79 27.51 3.63 8.76 -5.89 1.16 6.19 -2.58 4.65 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 177 PHE B 65 PHE.? 11.19 C1 PEG B 312 B 263 ASP A 47 ASP.? 12.21 O1 PEG B 312 B 292 LYS B 95 LYS.? 9.10 CL CL A 306 coo 49.99 26.05 6.28 51.46 26.87 8.49 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 60.53 31.67 0.97 57.79 27.51 3.63 20.80 3.86 14.18 20.78 8.31 16.72 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 6 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 6 PHE^? 10.79 CL CL A 305 C 263 ASP A 88 ASP^? 16.22 CL CL A 305 C 292 LYS A 72 LYS~? 17.83 ZN ZN A 303 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 24.33 -3.38 3.44 25.04 -4.58 5.85 coo 19.84 12.02 9.33 18.68 11.23 7.75 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo 12.82 3.49 4.98 17.80 5.59 1.90 22.18 2.53 -8.14 23.09 -3.13 -10.80 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 56 PHE^? 7.07 CL CL A 307 C 263 ASP A 48 ASP.? -15.94 CL CL A 307s C 292 LYS B 96 LYS.? 11.54 CL CL A 306 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 28.85 5.55 12.29 27.69 7.22 14.19 coo 19.84 12.02 9.33 18.68 11.23 7.75 26.96 2.23 21.50 26.58 3.74 22.88 coo 12.82 3.49 4.98 17.80 5.59 1.90 17.33 4.64 12.77 13.37 4.64 15.16 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE A 65 PHE.? 9.58 C2 CAC A 313 C 263 ASP B 47 ASP.? 11.08 ZN ZN A 303 C 292 LYS A 95 LYS.? 9.36 CL CL B 309 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 15.37 4.31 -5.77 16.86 5.34 -3.63 coo 19.84 12.02 9.33 18.68 11.23 7.75 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 12.82 3.49 4.98 17.80 5.59 1.90 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE B 6 PHE^? 11.00 CL CL B 308 C 263 ASP B 9 ASP^? 7.08 CL CL B 310 C 292 LYS A 95 LYS.? 9.36 CL CL B 309 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 19.84 12.02 9.33 18.68 11.23 7.75 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo 12.82 3.49 4.98 17.80 5.59 1.90 10.49 -7.40 -1.88 7.13 -10.96 -4.27 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE B 6 PHE^? 11.00 CL CL B 308 C 263 ASP B 88 ASP^? 4.66 O4 PEG B 312 C 292 LYS B 72 LYS~? -3.48 O1 PEG B 312s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 22.82 -7.57 3.65 22.94 -7.04 0.92 coo 19.84 12.02 9.33 18.68 11.23 7.75 27.27 -14.86 3.96 28.42 -13.55 5.17 coo 12.82 3.49 4.98 17.80 5.59 1.90 23.06 -12.55 15.81 27.03 -9.57 14.36 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE B 65 PHE.? 11.19 C1 PEG B 312 C 263 ASP A 47 ASP.? 12.21 O1 PEG B 312 C 292 LYS B 95 LYS.? 9.10 CL CL A 306 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 17.22 -8.48 17.88 16.17 -9.84 15.69 coo 19.84 12.02 9.33 18.68 11.23 7.75 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 12.82 3.49 4.98 17.80 5.59 1.90 20.80 3.86 14.18 20.78 8.31 16.72 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 6 hits 2oat_c05 naa= 3 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 178 TRP A 74 TRP~? 8.77 CL CL A 305 A 263 ASP A 73 ASP~? 14.36 ZN ZN A 303 A 292 LYS A 92 LYS^? 11.11 CL CL B 310 coo 48.96 45.07 19.49 48.62 41.39 18.16 18.76 9.45 -4.73 19.86 8.05 -1.25 coo 54.43 44.82 23.74 55.21 45.06 21.80 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 63.95 45.30 16.71 59.11 49.15 16.05 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 178 TRP B 74 TRP~? 9.22 CL CL B 308 A 263 ASP B 73 ASP~? 8.36 C1 PEG B 312 A 292 LYS B 92 LYS^? 11.01 CL CL A 307 coo 48.96 45.07 19.49 48.62 41.39 18.16 14.76 -14.11 16.53 14.47 -13.16 12.72 coo 54.43 44.82 23.74 55.21 45.06 21.80 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 63.95 45.30 16.71 59.11 49.15 16.05 25.00 -4.81 12.30 28.64 -2.55 7.65 2oat_c06 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c06 naa= 3 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 178 TRP A 74 TRP~? 8.77 CL CL A 305 B 263 ASP A 73 ASP~? 14.36 ZN ZN A 303 B 292 LYS A 92 LYS^? 11.11 CL CL B 310 coo 45.83 31.15 4.65 45.88 34.74 6.24 18.76 9.45 -4.73 19.86 8.05 -1.25 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 60.53 31.67 0.97 57.79 27.51 3.63 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 178 TRP B 74 TRP~? 9.22 CL CL B 308 B 263 ASP B 73 ASP~? 8.36 C1 PEG B 312 B 292 LYS B 92 LYS^? 11.01 CL CL A 307 coo 45.83 31.15 4.65 45.88 34.74 6.24 14.76 -14.11 16.53 14.47 -13.16 12.72 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 60.53 31.67 0.97 57.79 27.51 3.63 25.00 -4.81 12.30 28.64 -2.55 7.65 2oat_c07 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c07 naa= 3 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 178 TRP A 74 TRP~? 8.77 CL CL A 305 C 263 ASP A 73 ASP~? 14.36 ZN ZN A 303 C 292 LYS A 92 LYS^? 11.11 CL CL B 310 coo 20.52 16.65 4.15 17.32 18.91 4.39 18.76 9.45 -4.73 19.86 8.05 -1.25 coo 19.84 12.02 9.33 18.68 11.23 7.75 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 12.82 3.49 4.98 17.80 5.59 1.90 19.55 -4.78 -4.39 22.13 -9.97 -1.89 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 178 TRP B 74 TRP~? 9.22 CL CL B 308 C 263 ASP B 73 ASP~? 8.36 C1 PEG B 312 C 292 LYS B 92 LYS^? 11.01 CL CL A 307 coo 20.52 16.65 4.15 17.32 18.91 4.39 14.76 -14.11 16.53 14.47 -13.16 12.72 coo 19.84 12.02 9.33 18.68 11.23 7.75 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 12.82 3.49 4.98 17.80 5.59 1.90 25.00 -4.81 12.30 28.64 -2.55 7.65 2oat_c08 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c08 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 88 ASP^? 16.22 CL CL A 305 166 GLY A 41 GLY^? 3.79 CL CL A 306 169 GLU A 49 GLU.? 12.26 CL CL A 306 coo 8.28 6.87 1.62 10.08 5.77 1.34 31.95 -0.90 -1.70 33.94 -1.29 -2.43 coo -8.58 13.22 3.21 -8.90 13.15 4.05 20.71 5.55 9.04 20.91 4.99 8.47 coo -16.67 7.89 2.78 -17.65 6.56 1.49 21.20 3.66 19.03 19.27 4.46 18.88 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP B 73 ASP~? 8.36 C1 PEG B 312 166 GLY B 84 GLY.? 11.09 O4 PEG B 312 169 GLU B 15 GLU~? 13.88 CL CL B 310 coo 8.28 6.87 1.62 10.08 5.77 1.34 21.44 -15.50 19.28 23.24 -15.58 20.39 coo -8.58 13.22 3.21 -8.90 13.15 4.05 20.99 -24.23 3.61 20.27 -23.84 3.57 coo -16.67 7.89 2.78 -17.65 6.56 1.49 15.04 -27.14 -3.41 16.60 -25.82 -3.70 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP B 88 ASP^? 4.66 O4 PEG B 312 166 GLY B 41 GLY^? -3.88 CL CL B 309s 169 GLU B 49 GLU.? 12.07 C2 CAC A 313 coo 8.28 6.87 1.62 10.08 5.77 1.34 27.27 -14.86 3.96 28.42 -13.55 5.17 coo -8.58 13.22 3.21 -8.90 13.15 4.05 11.75 -9.68 2.90 12.54 -9.55 3.14 coo -16.67 7.89 2.78 -17.65 6.56 1.49 7.03 -7.10 -6.90 6.04 -5.38 -6.16 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 3 hits 2tdt_c00 naa= 3 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 86 TYR^? 7.10 CL CL A 305 A 172 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 174 TYR A 80 TYR~? 5.67 CL CL A 307 coo 26.78 20.44 0.03 28.51 18.26 0.09 29.34 5.60 1.24 26.89 6.10 2.52 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 24.25 11.32 4.20 23.54 9.34 4.43 coo 24.73 15.69 1.93 26.72 14.32 3.31 28.47 9.96 3.42 27.66 10.97 5.91 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR B 86 TYR^? 6.73 CL CL B 310 A 172 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 174 TYR B 80 TYR~? 5.35 CL CL B 310 coo 26.78 20.44 0.03 28.51 18.26 0.09 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 24.73 15.69 1.93 26.72 14.32 3.31 15.15 -19.22 4.72 12.71 -19.06 3.39 2tmd_c02 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 2 hits 2tmd_c02 naa= 3 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 86 TYR^? 7.10 CL CL A 305 B 172 HIS A 24 HIS~? 3.26 ZN ZN A 301s B 174 TYR A 80 TYR~? 5.67 CL CL A 307 coo 44.86 1.98 33.27 42.75 1.12 31.67 29.34 5.60 1.24 26.89 6.10 2.52 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 24.25 11.32 4.20 23.54 9.34 4.43 coo 45.95 0.11 28.25 43.87 0.82 26.55 28.47 9.96 3.42 27.66 10.97 5.91 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR B 86 TYR^? 6.73 CL CL B 310 B 172 HIS B 24 HIS~? 3.28 ZN ZN B 302s B 174 TYR B 80 TYR~? 5.35 CL CL B 310 coo 44.86 1.98 33.27 42.75 1.12 31.67 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 45.95 0.11 28.25 43.87 0.82 26.55 15.15 -19.22 4.72 12.71 -19.06 3.39 2tmd_c03 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 2 hits 2tmd_c03 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR B 80 TYR~? 5.35 CL CL B 310 A 214 ASP B 9 ASP^? 7.08 CL CL B 310 A 256 LYS A 92 LYS^? 11.11 CL CL B 310 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 15.15 -19.22 4.72 12.71 -19.06 3.39 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 19.55 -4.78 -4.39 22.13 -9.97 -1.89 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 1 hits 2tpl_c04 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 17 ARG~? -3.60 CL CL A 307s A 130 SER A 52 SER~? 16.21 CL CL A 307 A 159 LYS A 16 LYS~? 15.92 CL CL A 307 coo 18.35 45.84 20.99 16.20 47.83 21.89 29.80 8.18 9.40 27.73 6.82 7.62 coo 15.14 43.67 10.77 15.61 44.43 13.04 31.84 7.85 19.89 31.12 7.70 22.23 coo 11.57 48.49 22.18 13.51 49.99 17.21 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG B 17 ARG~? -3.61 CL CL B 310s A 130 SER B 52 SER~? -15.43 CL CL B 310s A 159 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 18.35 45.84 20.99 16.20 47.83 21.89 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo 15.14 43.67 10.77 15.61 44.43 13.04 9.78 -16.42 -10.12 8.17 -17.33 -11.63 coo 11.57 48.49 22.18 13.51 49.99 17.21 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 A 59 ARG B 21 ARG~? 10.16 CL CL B 310 A 130 SER B 52 SER~? -15.43 CL CL B 310s A 159 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 18.35 45.84 20.99 16.20 47.83 21.89 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo 15.14 43.67 10.77 15.61 44.43 13.04 9.78 -16.42 -10.12 8.17 -17.33 -11.63 coo 11.57 48.49 22.18 13.51 49.99 17.21 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 A 59 ARG B 21 ARG~? 10.16 CL CL B 310 A 130 SER B 59 SER^? 3.99 CL CL B 308s A 159 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 18.35 45.84 20.99 16.20 47.83 21.89 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo 15.14 43.67 10.77 15.61 44.43 13.04 17.09 -11.30 2.44 17.22 -12.60 4.35 coo 11.57 48.49 22.18 13.51 49.99 17.21 14.27 -25.10 0.23 14.58 -27.01 3.12 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 4 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 17 ARG~? -3.60 CL CL A 307s B 130 SER A 52 SER~? 16.21 CL CL A 307 B 159 LYS A 16 LYS~? 15.92 CL CL A 307 coo 58.72 31.58 20.45 60.80 29.39 20.94 29.80 8.18 9.40 27.73 6.82 7.62 coo 61.66 35.17 10.39 61.29 34.14 12.56 31.84 7.85 19.89 31.12 7.70 22.23 coo 65.38 28.77 21.17 63.49 28.03 16.12 34.52 13.28 7.19 39.00 11.44 3.22 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG B 17 ARG~? -3.61 CL CL B 310s B 130 SER B 52 SER~? -15.43 CL CL B 310s B 159 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 58.72 31.58 20.45 60.80 29.39 20.94 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo 61.66 35.17 10.39 61.29 34.14 12.56 9.78 -16.42 -10.12 8.17 -17.33 -11.63 coo 65.38 28.77 21.17 63.49 28.03 16.12 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 B 59 ARG B 21 ARG~? 10.16 CL CL B 310 B 130 SER B 52 SER~? -15.43 CL CL B 310s B 159 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 58.72 31.58 20.45 60.80 29.39 20.94 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo 61.66 35.17 10.39 61.29 34.14 12.56 9.78 -16.42 -10.12 8.17 -17.33 -11.63 coo 65.38 28.77 21.17 63.49 28.03 16.12 14.27 -25.10 0.23 14.58 -27.01 3.12 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 B 59 ARG B 21 ARG~? 10.16 CL CL B 310 B 130 SER B 59 SER^? 3.99 CL CL B 308s B 159 LYS B 16 LYS~? 9.68 ZN ZN B 304 coo 58.72 31.58 20.45 60.80 29.39 20.94 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo 61.66 35.17 10.39 61.29 34.14 12.56 17.09 -11.30 2.44 17.22 -12.60 4.35 coo 65.38 28.77 21.17 63.49 28.03 16.12 14.27 -25.10 0.23 14.58 -27.01 3.12 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 4 hits 2tps_c01 naa= 3 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 1 3 # 1 18 ARG A 27 ARG~? 9.04 CL CL A 305 195 HIS A 24 HIS~? 3.26 ZN ZN A 301s 199 ASP A 78 ASP~? 6.31 CL CL A 305 coo 21.96 2.03 15.24 19.33 1.86 13.55 21.75 13.08 -2.42 22.26 10.12 -3.14 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 24.25 11.32 4.20 23.54 9.34 4.43 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 25.71 9.07 -1.28 24.93 9.58 0.62 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 2 3 # 2 18 ARG B 27 ARG~? 9.37 CL CL B 308 195 HIS B 24 HIS~? 3.28 ZN ZN B 302s 199 ASP B 78 ASP~? 6.36 ZN ZN B 302 coo 21.96 2.03 15.24 19.33 1.86 13.55 12.55 -18.09 13.90 15.25 -16.65 13.55 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 16.87 -17.86 9.95 15.14 -17.20 8.90 3cla_c00 source 3cla TYPE III CHLORAMPHENICOL ACETYLTRANSFERASE ( C: 2 hits 3cla_c00 naa= 3 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 A 158 ASP A 78 ASP~? 6.31 CL CL A 305 A 161 ARG A 27 ARG~? 9.04 CL CL A 305 A 186 HIS A 24 HIS~? 3.26 ZN ZN A 301s coo 18.62 26.83 58.17 18.48 28.64 57.08 25.71 9.07 -1.28 24.93 9.58 0.62 coo 23.76 27.69 57.88 24.05 29.81 55.69 21.75 13.08 -2.42 22.26 10.12 -3.14 coo 16.67 31.22 54.64 18.74 31.15 54.14 24.25 11.32 4.20 23.54 9.34 4.43 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 A 158 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 161 ARG B 27 ARG~? 9.37 CL CL B 308 A 186 HIS B 24 HIS~? 3.28 ZN ZN B 302s coo 18.62 26.83 58.17 18.48 28.64 57.08 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 23.76 27.69 57.88 24.05 29.81 55.69 12.55 -18.09 13.90 15.25 -16.65 13.55 coo 16.67 31.22 54.64 18.74 31.15 54.14 11.77 -17.25 6.59 12.69 -15.38 6.18 4mdh_c02 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 2 hits 4mdh_c02 naa= 3 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 B 158 ASP B 78 ASP~? 6.36 ZN ZN B 302 B 161 ARG B 27 ARG~? 9.37 CL CL B 308 B 186 HIS B 24 HIS~? 3.28 ZN ZN B 302s coo 44.53 16.44 28.54 44.89 18.45 28.77 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 39.64 19.27 28.15 40.19 21.74 29.94 12.55 -18.09 13.90 15.25 -16.65 13.55 coo 48.32 20.00 31.44 46.45 20.91 31.50 11.77 -17.25 6.59 12.69 -15.38 6.18 4mdh_c03 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 1 hits 4mdh_c03 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 17 ARG~? -3.60 CL CL A 307s 127 ARG A 21 ARG~? 8.34 C22 1PE A 311s 270 GLU A 15 GLU~? 17.38 CL CL A 307 coo -1.14 25.72 1.64 0.76 28.10 1.50 29.80 8.18 9.40 27.73 6.82 7.62 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 25.14 13.51 10.69 25.11 15.00 13.42 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 36.85 15.40 11.10 38.87 16.11 11.22 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG A 17 ARG~? -3.60 CL CL A 307s 127 ARG A 21 ARG~? 8.34 C22 1PE A 311s 270 GLU A 49 GLU.? 12.26 CL CL A 306 coo -1.14 25.72 1.64 0.76 28.10 1.50 29.80 8.18 9.40 27.73 6.82 7.62 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 25.14 13.51 10.69 25.11 15.00 13.42 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 21.20 3.66 19.03 19.27 4.46 18.88 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG A 21 ARG~? 8.34 C22 1PE A 311s 127 ARG A 17 ARG~? -3.60 CL CL A 307s 270 GLU A 49 GLU.? 12.26 CL CL A 306 coo -1.14 25.72 1.64 0.76 28.10 1.50 25.14 13.51 10.69 25.11 15.00 13.42 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 29.80 8.18 9.40 27.73 6.82 7.62 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 21.20 3.66 19.03 19.27 4.46 18.88 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 3 hits 5cpa_c01 naa= 3 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 1 3 # 1 A 81 ASP A 9 ASP^? 7.20 CL CL A 307 A 99 GLY A 58 GLY^? 7.04 CL CL A 307 A 125 ASN A 43 ASN^? 7.86 CL CL A 307 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 32.44 3.50 6.30 30.77 4.75 6.60 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 28.51 2.01 6.75 28.22 2.24 7.53 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 25.90 0.17 10.25 24.19 -0.21 9.00 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 2 3 # 2 A 81 ASP B 9 ASP^? 7.08 CL CL B 310 A 99 GLY B 58 GLY^? 7.10 CL CL B 310 A 125 ASN B 43 ASN^? 8.09 CL CL B 308 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 20.52 -16.92 -1.41 18.60 -16.56 -0.65 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 19.36 -13.08 -0.04 18.65 -12.88 -0.47 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 17.50 -9.23 -1.99 17.56 -8.09 -0.19 1hkd_p00 source 1hkd PEA LECTIN ALPHA CHAIN : 2 hits 1hkd_p00 naa= 3 ULMN 3 1k12_p00 LECTIN user 1 3 # 1 A 52 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 79 ARG A 17 ARG~? -3.60 CL CL A 307s A 86 ARG A 21 ARG~? 8.34 C22 1PE A 311s coo -5.53 26.98 5.69 -5.98 25.70 4.09 24.25 11.32 4.20 23.54 9.34 4.43 coo -12.15 26.35 6.05 -10.94 27.19 3.35 29.80 8.18 9.40 27.73 6.82 7.62 coo -9.59 20.48 4.28 -9.21 22.28 1.82 25.14 13.51 10.69 25.11 15.00 13.42 ULMN 3 1k12_p00 LECTIN user 2 3 # 2 A 52 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 79 ARG A 21 ARG~? 8.34 C22 1PE A 311s A 86 ARG A 17 ARG~? -3.60 CL CL A 307s coo -5.53 26.98 5.69 -5.98 25.70 4.09 24.25 11.32 4.20 23.54 9.34 4.43 coo -12.15 26.35 6.05 -10.94 27.19 3.35 25.14 13.51 10.69 25.11 15.00 13.42 coo -9.59 20.48 4.28 -9.21 22.28 1.82 29.80 8.18 9.40 27.73 6.82 7.62 ULMN 3 1k12_p00 LECTIN user 3 3 # 3 A 52 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 79 ARG B 17 ARG~? -3.61 CL CL B 310s A 86 ARG B 21 ARG~? 10.16 CL CL B 310 coo -5.53 26.98 5.69 -5.98 25.70 4.09 11.77 -17.25 6.59 12.69 -15.38 6.18 coo -12.15 26.35 6.05 -10.94 27.19 3.35 14.51 -18.33 -1.30 15.06 -15.90 0.47 coo -9.59 20.48 4.28 -9.21 22.28 1.82 7.31 -19.18 1.19 5.97 -20.30 -1.38 ULMN 3 1k12_p00 LECTIN user 4 3 # 4 A 52 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 79 ARG B 21 ARG~? 10.16 CL CL B 310 A 86 ARG B 17 ARG~? -3.61 CL CL B 310s coo -5.53 26.98 5.69 -5.98 25.70 4.09 11.77 -17.25 6.59 12.69 -15.38 6.18 coo -12.15 26.35 6.05 -10.94 27.19 3.35 7.31 -19.18 1.19 5.97 -20.30 -1.38 coo -9.59 20.48 4.28 -9.21 22.28 1.82 14.51 -18.33 -1.30 15.06 -15.90 0.47 1k12_p00 source 1k12 LECTIN : 4 hits 1k12_p00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 12 ASN.? 17.53 CL CL A 307 coo 5.80 63.03 55.85 5.52 65.03 56.45 40.38 5.75 9.96 41.03 3.99 10.95 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 35 ASN.? -3.83 C1 CAC A 313s coo 5.80 63.03 55.85 5.52 65.03 56.45 5.46 9.42 0.51 4.48 8.02 1.68 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 43 ASN^? 7.86 CL CL A 307 coo 5.80 63.03 55.85 5.52 65.03 56.45 25.90 0.17 10.25 24.19 -0.21 9.00 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 50 ASN.? 13.13 CL CL A 307 coo 5.80 63.03 55.85 5.52 65.03 56.45 26.00 7.74 20.99 24.12 8.66 20.66 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 67 ASN~? 8.15 ZN ZN A 303 coo 5.80 63.03 55.85 5.52 65.03 56.45 14.02 0.88 -12.67 14.89 2.62 -13.50 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN B 12 ASN.? 16.85 CL CL B 310 coo 5.80 63.03 55.85 5.52 65.03 56.45 20.42 -23.48 -7.49 21.29 -22.60 -9.16 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN B 35 ASN.? 17.32 O2 CAC A 313 coo 5.80 63.03 55.85 5.52 65.03 56.45 5.40 -3.36 18.41 3.28 -3.68 18.28 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 43 ASN^? 8.09 CL CL B 308 coo 5.80 63.03 55.85 5.52 65.03 56.45 17.50 -9.23 -1.99 17.56 -8.09 -0.19 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN B 50 ASN.? 13.34 CL CL B 309 coo 5.80 63.03 55.85 5.52 65.03 56.45 6.69 -11.33 -9.11 5.16 -10.77 -7.82 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN B 67 ASN~? 12.71 C1 PEG B 312 coo 5.80 63.03 55.85 5.52 65.03 56.45 22.54 -6.70 23.21 22.14 -8.65 23.93 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 10 hits 1kbk_p00 naa= 1 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR A 3 TYR^? 10.95 ZN ZN A 303 A 112 PHE A 94 PHE^? 7.85 CL CL B 308 A 140 ASN B 43 ASN^? 8.09 CL CL B 308 coo -6.29 44.15 17.65 -9.00 44.92 17.68 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo -7.38 52.77 16.75 -5.54 52.71 18.82 13.53 -4.89 0.44 12.53 -5.50 2.96 coo -4.46 50.64 12.29 -5.69 49.89 13.85 17.50 -9.23 -1.99 17.56 -8.09 -0.19 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 2 3 # 2 A 56 TYR B 3 TYR^? 11.16 C1 PEG B 312 A 112 PHE B 94 PHE^? 7.88 CL CL A 305 A 140 ASN A 43 ASN^? 7.86 CL CL A 307 coo -6.29 44.15 17.65 -9.00 44.92 17.68 20.49 -5.14 16.12 21.33 -4.29 18.62 coo -7.38 52.77 16.75 -5.54 52.71 18.82 19.59 0.56 11.28 18.19 2.21 9.54 coo -4.46 50.64 12.29 -5.69 49.89 13.85 25.90 0.17 10.25 24.19 -0.21 9.00 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 2 hits 1o8s_p00 naa= 3 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 17 ARG~? -3.60 CL CL A 307s A 188 TYR A 86 TYR^? 7.10 CL CL A 305 A 190 SER A 59 SER^? 3.89 CL CL A 305s coo 37.69 7.64 13.51 38.82 8.84 16.11 29.80 8.18 9.40 27.73 6.82 7.62 coo 47.14 12.10 13.73 48.75 12.33 16.01 29.34 5.60 1.24 26.89 6.10 2.52 coo 43.77 6.93 15.46 45.49 7.21 17.11 24.86 2.91 6.28 24.83 4.11 4.27 2p3i_p00 source 2p3i VP4 : 1 hits 2p3i_p00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 2 TYR^? -4.58 O2 CAC A 313s I 306 VAL A 4 VAL^? 10.73 CL CL A 305 I 308 VAL A 61 VAL^? -4.65 CL CL A 305s coo 26.18 35.24 6.87 24.33 35.18 8.97 10.20 -0.74 -0.90 7.99 0.53 0.19 coo 23.55 29.53 9.81 23.15 27.39 10.24 18.14 -1.81 -0.18 18.31 -3.48 1.32 coo 16.43 30.18 9.35 15.05 30.67 11.01 18.76 2.71 3.31 18.98 4.59 2.19 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 2 TYR^? -4.58 O2 CAC A 313s I 306 VAL A 4 VAL^? 10.73 CL CL A 305 I 308 VAL A 91 VAL^? 12.24 CL CL A 305 coo 26.18 35.24 6.87 24.33 35.18 8.97 10.20 -0.74 -0.90 7.99 0.53 0.19 coo 23.55 29.53 9.81 23.15 27.39 10.24 18.14 -1.81 -0.18 18.31 -3.48 1.32 coo 16.43 30.18 9.35 15.05 30.67 11.01 22.22 -2.10 -4.10 21.90 -0.15 -5.01 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 3 TYR^? 10.95 ZN ZN A 303 I 306 VAL A 4 VAL^? 10.73 CL CL A 305 I 308 VAL A 61 VAL^? -4.65 CL CL A 305s coo 26.18 35.24 6.87 24.33 35.18 8.97 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 23.55 29.53 9.81 23.15 27.39 10.24 18.14 -1.81 -0.18 18.31 -3.48 1.32 coo 16.43 30.18 9.35 15.05 30.67 11.01 18.76 2.71 3.31 18.98 4.59 2.19 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 3 TYR^? 10.95 ZN ZN A 303 I 306 VAL A 91 VAL^? 12.24 CL CL A 305 I 308 VAL A 89 VAL^? 10.66 CL CL A 305 coo 26.18 35.24 6.87 24.33 35.18 8.97 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 23.55 29.53 9.81 23.15 27.39 10.24 22.22 -2.10 -4.10 21.90 -0.15 -5.01 coo 16.43 30.18 9.35 15.05 30.67 11.01 27.72 0.28 -2.00 26.27 1.63 -2.91 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 86 TYR^? 7.10 CL CL A 305 I 306 VAL A 85 VAL.? 9.29 CL CL A 307 I 308 VAL A 20 VAL~? 10.30 CL CL A 307 coo 26.18 35.24 6.87 24.33 35.18 8.97 29.34 5.60 1.24 26.89 6.10 2.52 coo 23.55 29.53 9.81 23.15 27.39 10.24 33.38 8.09 3.34 32.11 9.08 4.82 coo 16.43 30.18 9.35 15.05 30.67 11.01 29.36 15.83 5.12 30.39 15.03 3.31 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR A 86 TYR^? 7.10 CL CL A 305 I 306 VAL A 89 VAL^? 10.66 CL CL A 305 I 308 VAL A 91 VAL^? 12.24 CL CL A 305 coo 26.18 35.24 6.87 24.33 35.18 8.97 29.34 5.60 1.24 26.89 6.10 2.52 coo 23.55 29.53 9.81 23.15 27.39 10.24 27.72 0.28 -2.00 26.27 1.63 -2.91 coo 16.43 30.18 9.35 15.05 30.67 11.01 22.22 -2.10 -4.10 21.90 -0.15 -5.01 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR B 2 TYR^? 13.50 CL CL A 306 I 306 VAL B 4 VAL^? 10.97 CL CL B 308 I 308 VAL B 61 VAL^? -4.80 CL CL B 308s coo 26.18 35.24 6.87 24.33 35.18 8.97 15.58 -0.36 14.99 13.00 0.51 15.42 coo 23.55 29.53 9.81 23.15 27.39 10.24 20.06 -4.95 10.22 20.56 -3.53 8.54 coo 16.43 30.18 9.35 15.05 30.67 11.01 15.52 -7.71 7.99 14.85 -9.45 9.15 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR B 2 TYR^? 13.50 CL CL A 306 I 306 VAL B 4 VAL^? 10.97 CL CL B 308 I 308 VAL B 91 VAL^? 5.09 C1 PEG B 312 coo 26.18 35.24 6.87 24.33 35.18 8.97 15.58 -0.36 14.99 13.00 0.51 15.42 coo 23.55 29.53 9.81 23.15 27.39 10.24 20.06 -4.95 10.22 20.56 -3.53 8.54 coo 16.43 30.18 9.35 15.05 30.67 11.01 24.34 -8.45 11.38 23.20 -9.72 12.73 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR B 3 TYR^? 11.16 C1 PEG B 312 I 306 VAL B 4 VAL^? 10.97 CL CL B 308 I 308 VAL B 61 VAL^? -4.80 CL CL B 308s coo 26.18 35.24 6.87 24.33 35.18 8.97 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 23.55 29.53 9.81 23.15 27.39 10.24 20.06 -4.95 10.22 20.56 -3.53 8.54 coo 16.43 30.18 9.35 15.05 30.67 11.01 15.52 -7.71 7.99 14.85 -9.45 9.15 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR B 3 TYR^? 11.16 C1 PEG B 312 I 306 VAL B 91 VAL^? 5.09 C1 PEG B 312 I 308 VAL B 89 VAL^? -4.10 O4 PEG B 312s coo 26.18 35.24 6.87 24.33 35.18 8.97 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 23.55 29.53 9.81 23.15 27.39 10.24 24.34 -8.45 11.38 23.20 -9.72 12.73 coo 16.43 30.18 9.35 15.05 30.67 11.01 24.54 -13.45 7.26 22.66 -14.19 8.04 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR B 80 TYR~? 5.35 CL CL B 310 I 306 VAL B 81 VAL~? 7.29 C4 PEG B 312 I 308 VAL B 89 VAL^? -4.10 O4 PEG B 312s coo 26.18 35.24 6.87 24.33 35.18 8.97 15.15 -19.22 4.72 12.71 -19.06 3.39 coo 23.55 29.53 9.81 23.15 27.39 10.24 20.16 -21.07 7.89 21.41 -20.00 9.30 coo 16.43 30.18 9.35 15.05 30.67 11.01 24.54 -13.45 7.26 22.66 -14.19 8.04 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR B 86 TYR^? 6.73 CL CL B 310 I 306 VAL B 89 VAL^? -4.10 O4 PEG B 312s I 308 VAL B 91 VAL^? 5.09 C1 PEG B 312 coo 26.18 35.24 6.87 24.33 35.18 8.97 19.96 -17.22 4.85 17.58 -15.73 4.95 coo 23.55 29.53 9.81 23.15 27.39 10.24 24.54 -13.45 7.26 22.66 -14.19 8.04 coo 16.43 30.18 9.35 15.05 30.67 11.01 24.34 -8.45 11.38 23.20 -9.72 12.73 1cqt_d00 source 1cqt GENE REGULATION/DNA : 12 hits 1cqt_d00 naa= 3 ULMN 4 1dsz_d00 TRANSCRIPTION/DNA user 1 4 # 1 A1153 GLU A 15 GLU~? 17.38 CL CL A 307 A1156 LYS A 16 LYS~? 15.92 CL CL A 307 A1160 ARG A 17 ARG~? -3.60 CL CL A 307s A1161 ARG A 21 ARG~? 8.34 C22 1PE A 311s coo 24.91 6.66 1.99 23.65 5.59 0.65 36.85 15.40 11.10 38.87 16.11 11.22 coo 18.15 8.28 2.24 21.63 3.94 -0.54 34.52 13.28 7.19 39.00 11.44 3.22 coo 15.01 1.75 1.61 16.32 0.90 4.30 29.80 8.18 9.40 27.73 6.82 7.62 coo 14.98 2.34 8.97 17.45 4.34 8.92 25.14 13.51 10.69 25.11 15.00 13.42 1dsz_d00 source 1dsz TRANSCRIPTION/DNA : 1 hits 1dsz_d00 naa= 4 ULMN 4 1hbx_d00 GENE REGULATION user 1 4 # 1 D 140 THR A 13 THR~? 12.05 CL CL A 307 D 143 ARG A 21 ARG~? 8.34 C22 1PE A 311s D 158 TYR B 3 TYR^? 11.16 C1 PEG B 312 D 163 LYS B 95 LYS.? 9.10 CL CL A 306 coo 59.11 133.43 75.29 57.02 133.64 74.76 36.58 8.43 8.32 36.19 7.36 6.46 coo 52.93 123.10 78.03 50.59 121.17 78.38 25.14 13.51 10.69 25.11 15.00 13.42 coo 39.29 134.52 82.26 37.39 135.28 80.34 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 42.67 127.66 76.73 46.82 129.80 74.10 20.80 3.86 14.18 20.78 8.31 16.72 1hbx_d00 source 1hbx GENE REGULATION : 1 hits 1hbx_d00 naa= 4 ULMN 4 1kb6_d00 TRANSCRIPTION/DNA user 1 4 # 1 B 242 GLU A 15 GLU~? 17.38 CL CL A 307 B 245 LYS A 16 LYS~? 15.92 CL CL A 307 B 249 ARG A 17 ARG~? -3.60 CL CL A 307s B 250 ARG A 21 ARG~? 8.34 C22 1PE A 311s coo -0.89 32.39 60.42 -0.92 32.12 58.30 36.85 15.40 11.10 38.87 16.11 11.22 coo -4.54 26.92 60.10 0.40 29.01 56.76 34.52 13.28 7.19 39.00 11.44 3.22 coo 0.78 21.41 59.82 1.77 24.31 59.87 29.80 8.18 9.40 27.73 6.82 7.62 coo 0.56 22.39 66.71 0.61 25.40 66.07 25.14 13.51 10.69 25.11 15.00 13.42 1kb6_d00 source 1kb6 TRANSCRIPTION/DNA : 1 hits 1kb6_d00 naa= 4 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 59 SER^? 3.89 CL CL A 305s B 37 ASN A 43 ASN^? 7.86 CL CL A 307 B 45 THR B 39 THR^? 8.33 O2 CAC A 313 coo -19.49 41.97 71.08 -17.37 40.80 71.17 24.86 2.91 6.28 24.83 4.11 4.27 coo -23.05 39.62 69.74 -22.86 39.59 67.61 25.90 0.17 10.25 24.19 -0.21 9.00 coo -30.87 34.84 80.57 -28.94 34.51 81.49 10.69 -4.51 7.70 11.48 -3.65 5.83 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER B 59 SER^? 3.99 CL CL B 308s B 37 ASN B 43 ASN^? 8.09 CL CL B 308 B 45 THR A 39 THR^? 8.50 CL CL A 305 coo -19.49 41.97 71.08 -17.37 40.80 71.17 17.09 -11.30 2.44 17.22 -12.60 4.35 coo -23.05 39.62 69.74 -22.86 39.59 67.61 17.50 -9.23 -1.99 17.56 -8.09 -0.19 coo -30.87 34.84 80.57 -28.94 34.51 81.49 14.21 3.91 6.70 14.94 2.35 8.05 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 2 hits 2z3x_d00 naa= 3 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 G 386 ARG A 17 ARG~? -3.60 CL CL A 307s G 387 HIS A 24 HIS~? 3.26 ZN ZN A 301s G 390 SER A 59 SER^? 3.89 CL CL A 305s coo 93.17 52.97 31.81 95.66 54.71 32.14 29.80 8.18 9.40 27.73 6.82 7.62 coo 95.60 53.07 40.31 97.10 52.52 41.67 24.25 11.32 4.20 23.54 9.34 4.43 coo 93.25 46.91 38.79 94.12 47.43 36.62 24.86 2.91 6.28 24.83 4.11 4.27 3qrf_d00 source 3qrf DNA BINDING PROTEIN/DNA : 1 hits 3qrf_d00 naa= 3 ULMN 3 3uby_d00 HYDROLASE/DNA user 1 3 # 1 A 162 TYR A 3 TYR^? 10.95 ZN ZN A 303 A 164 MET A 1 MET?? 10.74 ZN ZN A 303 A 165 TYR A 2 TYR^? -4.58 O2 CAC A 313s coo 9.07 -0.64 37.53 6.51 -1.49 38.21 15.55 -0.59 -5.31 14.15 -1.10 -7.68 coo 15.31 0.97 33.48 17.04 -1.81 36.11 9.56 -1.16 -5.94 10.14 -4.22 -7.96 coo 12.73 -3.12 32.95 14.22 -4.94 34.46 10.20 -0.74 -0.90 7.99 0.53 0.19 ULMN 3 3uby_d00 HYDROLASE/DNA user 2 3 # 2 A 162 TYR B 3 TYR^? 11.16 C1 PEG B 312 A 164 MET B 1 MET?? 13.93 CL CL A 307 A 165 TYR B 2 TYR^? 13.50 CL CL A 306 coo 9.07 -0.64 37.53 6.51 -1.49 38.21 20.49 -5.14 16.12 21.33 -4.29 18.62 coo 15.31 0.97 33.48 17.04 -1.81 36.11 18.09 -0.75 19.45 22.36 -0.37 18.91 coo 12.73 -3.12 32.95 14.22 -4.94 34.46 15.58 -0.36 14.99 13.00 0.51 15.42 3uby_d00 source 3uby HYDROLASE/DNA : 2 hits 3uby_d00 naa= 3 ULMN 3 4hp3_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 C 61 LYS A 72 LYS~? 17.83 ZN ZN A 303 C 90 HIS A 0 HIS.? -3.23 ZN ZN A 303s C 91 GLN A 64 GLN^? -3.49 C2 CAC A 313s coo -19.62 -7.95 11.61 -14.74 -11.23 10.80 22.18 2.53 -8.14 23.09 -3.13 -10.80 coo -14.60 -21.92 8.98 -13.75 -22.48 7.16 7.36 3.84 -7.81 6.63 5.12 -9.32 coo -19.27 -22.51 13.20 -20.06 -20.67 12.43 9.17 2.67 -2.61 7.16 3.33 -2.48 ULMN 3 4hp3_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 C 61 LYS A 92 LYS^? 11.11 CL CL B 310 C 90 HIS A 0 HIS.? -3.23 ZN ZN A 303s C 91 GLN A 64 GLN^? -3.49 C2 CAC A 313s coo -19.62 -7.95 11.61 -14.74 -11.23 10.80 19.55 -4.78 -4.39 22.13 -9.97 -1.89 coo -14.60 -21.92 8.98 -13.75 -22.48 7.16 7.36 3.84 -7.81 6.63 5.12 -9.32 coo -19.27 -22.51 13.20 -20.06 -20.67 12.43 9.17 2.67 -2.61 7.16 3.33 -2.48 ULMN 3 4hp3_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 C 61 LYS B 29 LYS~? 10.16 CL CL B 309 C 90 HIS B 0 HIS.? -19.60 C1 PEG B 312s C 91 GLN B 64 GLN^? 16.90 CL CL B 308 coo -19.62 -7.95 11.61 -14.74 -11.23 10.80 5.16 -12.71 12.47 1.26 -15.97 8.59 coo -14.60 -21.92 8.98 -13.75 -22.48 7.16 14.07 -2.85 23.00 13.20 -3.63 24.76 coo -19.27 -22.51 13.20 -20.06 -20.67 12.43 13.48 -2.38 17.76 11.93 -1.34 18.68 ULMN 3 4hp3_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 C 61 LYS B 72 LYS~? -3.48 O1 PEG B 312s C 90 HIS B 0 HIS.? -19.60 C1 PEG B 312s C 91 GLN B 64 GLN^? 16.90 CL CL B 308 coo -19.62 -7.95 11.61 -14.74 -11.23 10.80 23.06 -12.55 15.81 27.03 -9.57 14.36 coo -14.60 -21.92 8.98 -13.75 -22.48 7.16 14.07 -2.85 23.00 13.20 -3.63 24.76 coo -19.27 -22.51 13.20 -20.06 -20.67 12.43 13.48 -2.38 17.76 11.93 -1.34 18.68 ULMN 3 4hp3_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 C 61 LYS B 92 LYS^? 11.01 CL CL A 307 C 90 HIS B 0 HIS.? -19.60 C1 PEG B 312s C 91 GLN B 64 GLN^? 16.90 CL CL B 308 coo -19.62 -7.95 11.61 -14.74 -11.23 10.80 25.00 -4.81 12.30 28.64 -2.55 7.65 coo -14.60 -21.92 8.98 -13.75 -22.48 7.16 14.07 -2.85 23.00 13.20 -3.63 24.76 coo -19.27 -22.51 13.20 -20.06 -20.67 12.43 13.48 -2.38 17.76 11.93 -1.34 18.68 4hp3_d00 source 4hp3 DNA BINDING PROTEIN/DNA : 5 hits 4hp3_d00 naa= 3 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS A 0 HIS.? -3.23 ZN ZN A 303s A 208 ASP A 73 ASP~? 14.36 ZN ZN A 303 A 296 SER B 59 SER^? 3.99 CL CL B 308s coo 12.72 17.48 24.71 12.80 19.37 23.81 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 18.47 29.19 29.68 19.30 29.17 27.75 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 6.89 17.22 46.63 5.08 16.21 47.91 17.09 -11.30 2.44 17.22 -12.60 4.35 ULMN 3 2odj_o00 PORIN D user 2 3 # 2 A 156 HIS A 0 HIS.? -3.23 ZN ZN A 303s A 208 ASP B 47 ASP.? 11.08 ZN ZN A 303 A 296 SER A 59 SER^? 3.89 CL CL A 305s coo 12.72 17.48 24.71 12.80 19.37 23.81 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 18.47 29.19 29.68 19.30 29.17 27.75 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo 6.89 17.22 46.63 5.08 16.21 47.91 24.86 2.91 6.28 24.83 4.11 4.27 ULMN 3 2odj_o00 PORIN D user 3 3 # 3 A 156 HIS A 0 HIS.? -3.23 ZN ZN A 303s A 208 ASP B 48 ASP.? 14.63 ZN ZN A 303 A 296 SER A 59 SER^? 3.89 CL CL A 305s coo 12.72 17.48 24.71 12.80 19.37 23.81 7.36 3.84 -7.81 6.63 5.12 -9.32 coo 18.47 29.19 29.68 19.30 29.17 27.75 10.78 -8.54 -11.40 8.75 -9.01 -11.79 coo 6.89 17.22 46.63 5.08 16.21 47.91 24.86 2.91 6.28 24.83 4.11 4.27 ULMN 3 2odj_o00 PORIN D user 4 3 # 4 A 156 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 208 ASP A 73 ASP~? 14.36 ZN ZN A 303 A 296 SER B 59 SER^? 3.99 CL CL B 308s coo 12.72 17.48 24.71 12.80 19.37 23.81 24.25 11.32 4.20 23.54 9.34 4.43 coo 18.47 29.19 29.68 19.30 29.17 27.75 21.65 6.61 -10.76 21.87 5.79 -12.65 coo 6.89 17.22 46.63 5.08 16.21 47.91 17.09 -11.30 2.44 17.22 -12.60 4.35 ULMN 3 2odj_o00 PORIN D user 5 3 # 5 A 156 HIS B 0 HIS.? -19.60 C1 PEG B 312s A 208 ASP A 47 ASP.? 12.21 O1 PEG B 312 A 296 SER B 59 SER^? 3.99 CL CL B 308s coo 12.72 17.48 24.71 12.80 19.37 23.81 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 18.47 29.19 29.68 19.30 29.17 27.75 26.48 -3.27 20.58 24.45 -3.78 20.72 coo 6.89 17.22 46.63 5.08 16.21 47.91 17.09 -11.30 2.44 17.22 -12.60 4.35 ULMN 3 2odj_o00 PORIN D user 6 3 # 6 A 156 HIS B 0 HIS.? -19.60 C1 PEG B 312s A 208 ASP A 48 ASP.? -15.94 CL CL A 307s A 296 SER B 59 SER^? 3.99 CL CL B 308s coo 12.72 17.48 24.71 12.80 19.37 23.81 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 18.47 29.19 29.68 19.30 29.17 27.75 26.96 2.23 21.50 26.58 3.74 22.88 coo 6.89 17.22 46.63 5.08 16.21 47.91 17.09 -11.30 2.44 17.22 -12.60 4.35 ULMN 3 2odj_o00 PORIN D user 7 3 # 7 A 156 HIS B 0 HIS.? -19.60 C1 PEG B 312s A 208 ASP B 73 ASP~? 8.36 C1 PEG B 312 A 296 SER A 52 SER~? 16.21 CL CL A 307 coo 12.72 17.48 24.71 12.80 19.37 23.81 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 18.47 29.19 29.68 19.30 29.17 27.75 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 6.89 17.22 46.63 5.08 16.21 47.91 31.84 7.85 19.89 31.12 7.70 22.23 ULMN 3 2odj_o00 PORIN D user 8 3 # 8 A 156 HIS B 0 HIS.? -19.60 C1 PEG B 312s A 208 ASP B 73 ASP~? 8.36 C1 PEG B 312 A 296 SER A 59 SER^? 3.89 CL CL A 305s coo 12.72 17.48 24.71 12.80 19.37 23.81 14.07 -2.85 23.00 13.20 -3.63 24.76 coo 18.47 29.19 29.68 19.30 29.17 27.75 21.44 -15.50 19.28 23.24 -15.58 20.39 coo 6.89 17.22 46.63 5.08 16.21 47.91 24.86 2.91 6.28 24.83 4.11 4.27 2odj_o00 source 2ODJ PORIN D : 8 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS A 0 HIS.? -3.23 ZN ZN A 303s B 208 ASP B 47 ASP.? 11.08 ZN ZN A 303 B 296 SER A 59 SER^? 3.89 CL CL A 305s coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 7.36 3.84 -7.81 6.63 5.12 -9.32 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 15.08 -4.94 -11.66 14.38 -3.13 -10.90 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 24.86 2.91 6.28 24.83 4.11 4.27 ULMN 3 2odj_o01 PORIN D user 2 3 # 2 B 156 HIS A 24 HIS~? 3.26 ZN ZN A 301s B 208 ASP A 73 ASP~? 14.36 ZN ZN A 303 B 296 SER B 59 SER^? 3.99 CL CL B 308s coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 24.25 11.32 4.20 23.54 9.34 4.43 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 21.65 6.61 -10.76 21.87 5.79 -12.65 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 17.09 -11.30 2.44 17.22 -12.60 4.35 ULMN 3 2odj_o01 PORIN D user 3 3 # 3 B 156 HIS B 0 HIS.? -19.60 C1 PEG B 312s B 208 ASP A 47 ASP.? 12.21 O1 PEG B 312 B 296 SER B 59 SER^? 3.99 CL CL B 308s coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 14.07 -2.85 23.00 13.20 -3.63 24.76 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 26.48 -3.27 20.58 24.45 -3.78 20.72 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 17.09 -11.30 2.44 17.22 -12.60 4.35 2odj_o01 source 2ODJ PORIN D : 3 hits 2odj_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER B 59 SER^? 3.99 CL CL B 308s A 166 PHE A 6 PHE^? 10.79 CL CL A 305 A 182 PHE B 94 PHE^? 7.88 CL CL A 305 coo -46.28 37.24 81.97 -44.96 39.32 82.40 17.09 -11.30 2.44 17.22 -12.60 4.35 coo -36.62 39.62 84.60 -38.76 41.24 85.25 24.33 -3.38 3.44 25.04 -4.58 5.85 coo -36.55 45.66 79.22 -38.34 43.94 80.53 19.59 0.56 11.28 18.19 2.21 9.54 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 1 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER B 59 SER^? 3.99 CL CL B 308s B 166 PHE A 6 PHE^? 10.79 CL CL A 305 B 182 PHE B 94 PHE^? 7.88 CL CL A 305 coo -19.94 46.29 97.83 -22.38 46.56 97.60 17.09 -11.30 2.44 17.22 -12.60 4.35 coo -29.59 43.40 95.66 -28.22 45.54 94.50 24.33 -3.38 3.44 25.04 -4.58 5.85 coo -32.72 50.15 98.46 -30.32 48.85 97.77 19.59 0.56 11.28 18.19 2.21 9.54 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 1 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER B 59 SER^? 3.99 CL CL B 308s C 166 PHE A 6 PHE^? 10.79 CL CL A 305 C 182 PHE B 94 PHE^? 7.88 CL CL A 305 coo -2.19 64.27 51.12 -3.34 62.10 50.60 17.09 -11.30 2.44 17.22 -12.60 4.35 coo -11.14 61.91 46.89 -9.88 60.30 48.76 24.33 -3.38 3.44 25.04 -4.58 5.85 coo -7.71 55.92 42.70 -7.18 57.60 44.85 19.59 0.56 11.28 18.19 2.21 9.54 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 1 hits 2r11_o02 naa= 3 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 78 ASP~? 6.31 CL CL A 305 A 86 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 250 ALA A 26 ALA~? 3.84 OH4 1PE A 311 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 25.71 9.07 -1.28 24.93 9.58 0.62 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 24.25 11.32 4.20 23.54 9.34 4.43 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 19.35 16.64 2.62 20.12 17.75 1.91 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 78 ASP~? 6.31 CL CL A 305 A 86 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 250 ALA A 40 ALA^? 3.90 CL CL A 305 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 25.71 9.07 -1.28 24.93 9.58 0.62 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 24.25 11.32 4.20 23.54 9.34 4.43 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 17.79 5.14 6.68 17.95 6.32 5.72 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 86 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 250 ALA B 26 ALA~? 10.59 CL CL B 309 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 6.34 -17.54 11.68 6.25 -18.99 12.16 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 3 hits 2wwt_o00 naa= 3 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 B 49 ASP A 78 ASP~? 6.31 CL CL A 305 B 86 HIS A 24 HIS~? 3.26 ZN ZN A 301s B 250 ALA A 26 ALA~? 3.84 OH4 1PE A 311 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 25.71 9.07 -1.28 24.93 9.58 0.62 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 24.25 11.32 4.20 23.54 9.34 4.43 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 19.35 16.64 2.62 20.12 17.75 1.91 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 B 49 ASP A 78 ASP~? 6.31 CL CL A 305 B 86 HIS A 24 HIS~? 3.26 ZN ZN A 301s B 250 ALA A 40 ALA^? 3.90 CL CL A 305 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 25.71 9.07 -1.28 24.93 9.58 0.62 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 24.25 11.32 4.20 23.54 9.34 4.43 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 17.79 5.14 6.68 17.95 6.32 5.72 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 B 49 ASP B 78 ASP~? 6.36 ZN ZN B 302 B 86 HIS B 24 HIS~? 3.28 ZN ZN B 302s B 250 ALA B 26 ALA~? 10.59 CL CL B 309 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 16.87 -17.86 9.95 15.14 -17.20 8.90 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 11.77 -17.25 6.59 12.69 -15.38 6.18 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 6.34 -17.54 11.68 6.25 -18.99 12.16 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 B 49 ASP B 78 ASP~? 6.36 ZN ZN B 302 B 86 HIS B 24 HIS~? 3.28 ZN ZN B 302s B 250 ALA B 40 ALA^? 3.96 CL CL B 308 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 16.87 -17.86 9.95 15.14 -17.20 8.90 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 11.77 -17.25 6.59 12.69 -15.38 6.18 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 11.68 -7.85 6.20 11.37 -9.01 7.19 2wwt_o01 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 4 hits 2wwt_o01 naa= 3 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 C 49 ASP A 78 ASP~? 6.31 CL CL A 305 C 86 HIS A 24 HIS~? 3.26 ZN ZN A 301s C 250 ALA A 26 ALA~? 3.84 OH4 1PE A 311 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 25.71 9.07 -1.28 24.93 9.58 0.62 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 24.25 11.32 4.20 23.54 9.34 4.43 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 19.35 16.64 2.62 20.12 17.75 1.91 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 C 49 ASP A 78 ASP~? 6.31 CL CL A 305 C 86 HIS A 24 HIS~? 3.26 ZN ZN A 301s C 250 ALA A 40 ALA^? 3.90 CL CL A 305 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 25.71 9.07 -1.28 24.93 9.58 0.62 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 24.25 11.32 4.20 23.54 9.34 4.43 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 17.79 5.14 6.68 17.95 6.32 5.72 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 C 49 ASP B 78 ASP~? 6.36 ZN ZN B 302 C 86 HIS B 24 HIS~? 3.28 ZN ZN B 302s C 250 ALA B 26 ALA~? 10.59 CL CL B 309 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 6.34 -17.54 11.68 6.25 -18.99 12.16 2wwt_o02 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 3 hits 2wwt_o02 naa= 3 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 D 49 ASP A 78 ASP~? 6.31 CL CL A 305 D 86 HIS A 24 HIS~? 3.26 ZN ZN A 301s D 250 ALA A 26 ALA~? 3.84 OH4 1PE A 311 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 25.71 9.07 -1.28 24.93 9.58 0.62 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 24.25 11.32 4.20 23.54 9.34 4.43 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 19.35 16.64 2.62 20.12 17.75 1.91 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 D 49 ASP A 78 ASP~? 6.31 CL CL A 305 D 86 HIS A 24 HIS~? 3.26 ZN ZN A 301s D 250 ALA A 40 ALA^? 3.90 CL CL A 305 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 25.71 9.07 -1.28 24.93 9.58 0.62 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 24.25 11.32 4.20 23.54 9.34 4.43 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 17.79 5.14 6.68 17.95 6.32 5.72 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 D 49 ASP B 78 ASP~? 6.36 ZN ZN B 302 D 86 HIS B 24 HIS~? 3.28 ZN ZN B 302s D 250 ALA B 26 ALA~? 10.59 CL CL B 309 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 6.34 -17.54 11.68 6.25 -18.99 12.16 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 D 49 ASP B 78 ASP~? 6.36 ZN ZN B 302 D 86 HIS B 24 HIS~? 3.28 ZN ZN B 302s D 250 ALA B 40 ALA^? 3.96 CL CL B 308 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 16.87 -17.86 9.95 15.14 -17.20 8.90 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 11.77 -17.25 6.59 12.69 -15.38 6.18 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 11.68 -7.85 6.20 11.37 -9.01 7.19 2wwt_o03 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 4 hits 2wwt_o03 naa= 3 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 E 49 ASP A 78 ASP~? 6.31 CL CL A 305 E 86 HIS A 24 HIS~? 3.26 ZN ZN A 301s E 250 ALA A 26 ALA~? 3.84 OH4 1PE A 311 coo -36.18 24.97 18.78 -36.93 26.11 17.11 25.71 9.07 -1.28 24.93 9.58 0.62 coo -36.85 29.32 15.06 -38.90 29.14 15.48 24.25 11.32 4.20 23.54 9.34 4.43 coo -44.49 29.68 13.98 -43.47 28.67 13.52 19.35 16.64 2.62 20.12 17.75 1.91 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 E 49 ASP A 78 ASP~? 6.31 CL CL A 305 E 86 HIS A 24 HIS~? 3.26 ZN ZN A 301s E 250 ALA A 40 ALA^? 3.90 CL CL A 305 coo -36.18 24.97 18.78 -36.93 26.11 17.11 25.71 9.07 -1.28 24.93 9.58 0.62 coo -36.85 29.32 15.06 -38.90 29.14 15.48 24.25 11.32 4.20 23.54 9.34 4.43 coo -44.49 29.68 13.98 -43.47 28.67 13.52 17.79 5.14 6.68 17.95 6.32 5.72 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 E 49 ASP B 78 ASP~? 6.36 ZN ZN B 302 E 86 HIS B 24 HIS~? 3.28 ZN ZN B 302s E 250 ALA B 26 ALA~? 10.59 CL CL B 309 coo -36.18 24.97 18.78 -36.93 26.11 17.11 16.87 -17.86 9.95 15.14 -17.20 8.90 coo -36.85 29.32 15.06 -38.90 29.14 15.48 11.77 -17.25 6.59 12.69 -15.38 6.18 coo -44.49 29.68 13.98 -43.47 28.67 13.52 6.34 -17.54 11.68 6.25 -18.99 12.16 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 E 49 ASP B 78 ASP~? 6.36 ZN ZN B 302 E 86 HIS B 24 HIS~? 3.28 ZN ZN B 302s E 250 ALA B 40 ALA^? 3.96 CL CL B 308 coo -36.18 24.97 18.78 -36.93 26.11 17.11 16.87 -17.86 9.95 15.14 -17.20 8.90 coo -36.85 29.32 15.06 -38.90 29.14 15.48 11.77 -17.25 6.59 12.69 -15.38 6.18 coo -44.49 29.68 13.98 -43.47 28.67 13.52 11.68 -7.85 6.20 11.37 -9.01 7.19 2wwt_o04 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 4 hits 2wwt_o04 naa= 3 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 F 49 ASP A 78 ASP~? 6.31 CL CL A 305 F 86 HIS A 24 HIS~? 3.26 ZN ZN A 301s F 250 ALA A 26 ALA~? 3.84 OH4 1PE A 311 coo -82.12 8.55 35.60 -81.93 9.84 37.19 25.71 9.07 -1.28 24.93 9.58 0.62 coo -84.21 11.81 39.90 -82.43 12.70 39.26 24.25 11.32 4.20 23.54 9.34 4.43 coo -78.49 17.13 41.31 -79.25 15.85 41.61 19.35 16.64 2.62 20.12 17.75 1.91 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 F 49 ASP A 78 ASP~? 6.31 CL CL A 305 F 86 HIS A 24 HIS~? 3.26 ZN ZN A 301s F 250 ALA A 40 ALA^? 3.90 CL CL A 305 coo -82.12 8.55 35.60 -81.93 9.84 37.19 25.71 9.07 -1.28 24.93 9.58 0.62 coo -84.21 11.81 39.90 -82.43 12.70 39.26 24.25 11.32 4.20 23.54 9.34 4.43 coo -78.49 17.13 41.31 -79.25 15.85 41.61 17.79 5.14 6.68 17.95 6.32 5.72 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 F 49 ASP B 78 ASP~? 6.36 ZN ZN B 302 F 86 HIS B 24 HIS~? 3.28 ZN ZN B 302s F 250 ALA B 26 ALA~? 10.59 CL CL B 309 coo -82.12 8.55 35.60 -81.93 9.84 37.19 16.87 -17.86 9.95 15.14 -17.20 8.90 coo -84.21 11.81 39.90 -82.43 12.70 39.26 11.77 -17.25 6.59 12.69 -15.38 6.18 coo -78.49 17.13 41.31 -79.25 15.85 41.61 6.34 -17.54 11.68 6.25 -18.99 12.16 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 F 49 ASP B 78 ASP~? 6.36 ZN ZN B 302 F 86 HIS B 24 HIS~? 3.28 ZN ZN B 302s F 250 ALA B 40 ALA^? 3.96 CL CL B 308 coo -82.12 8.55 35.60 -81.93 9.84 37.19 16.87 -17.86 9.95 15.14 -17.20 8.90 coo -84.21 11.81 39.90 -82.43 12.70 39.26 11.77 -17.25 6.59 12.69 -15.38 6.18 coo -78.49 17.13 41.31 -79.25 15.85 41.61 11.68 -7.85 6.20 11.37 -9.01 7.19 2wwt_o05 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 4 hits 2wwt_o05 naa= 3 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 1 3 # 1 A 220 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 250 ASP A 78 ASP~? 6.31 CL CL A 305 A 328 SER A 59 SER^? 3.89 CL CL A 305s coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 24.25 11.32 4.20 23.54 9.34 4.43 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 25.71 9.07 -1.28 24.93 9.58 0.62 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 24.86 2.91 6.28 24.83 4.11 4.27 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 2 3 # 2 A 220 HIS B 24 HIS~? 3.28 ZN ZN B 302s A 250 ASP B 78 ASP~? 6.36 ZN ZN B 302 A 328 SER B 59 SER^? 3.99 CL CL B 308s coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 11.77 -17.25 6.59 12.69 -15.38 6.18 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 16.87 -17.86 9.95 15.14 -17.20 8.90 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 17.09 -11.30 2.44 17.22 -12.60 4.35 3nwu_o00 source 3NWU SERINE PROTEASE HTRA1 : 2 hits 3nwu_o00 naa= 3 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 1 3 # 1 B 220 HIS A 24 HIS~? 3.26 ZN ZN A 301s B 250 ASP A 78 ASP~? 6.31 CL CL A 305 B 328 SER A 59 SER^? 3.89 CL CL A 305s coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 24.25 11.32 4.20 23.54 9.34 4.43 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 25.71 9.07 -1.28 24.93 9.58 0.62 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 24.86 2.91 6.28 24.83 4.11 4.27 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 2 3 # 2 B 220 HIS B 24 HIS~? 3.28 ZN ZN B 302s B 250 ASP B 78 ASP~? 6.36 ZN ZN B 302 B 328 SER B 59 SER^? 3.99 CL CL B 308s coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 11.77 -17.25 6.59 12.69 -15.38 6.18 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 16.87 -17.86 9.95 15.14 -17.20 8.90 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 17.09 -11.30 2.44 17.22 -12.60 4.35 3nwu_o01 source 3NWU SERINE PROTEASE HTRA1 : 2 hits 3nwu_o01 naa= 3 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 1 3 # 1 C 220 HIS A 24 HIS~? 3.26 ZN ZN A 301s C 250 ASP A 78 ASP~? 6.31 CL CL A 305 C 328 SER A 59 SER^? 3.89 CL CL A 305s coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 24.25 11.32 4.20 23.54 9.34 4.43 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 25.71 9.07 -1.28 24.93 9.58 0.62 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 24.86 2.91 6.28 24.83 4.11 4.27 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 2 3 # 2 C 220 HIS B 24 HIS~? 3.28 ZN ZN B 302s C 250 ASP B 78 ASP~? 6.36 ZN ZN B 302 C 328 SER B 59 SER^? 3.99 CL CL B 308s coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 11.77 -17.25 6.59 12.69 -15.38 6.18 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 16.87 -17.86 9.95 15.14 -17.20 8.90 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 17.09 -11.30 2.44 17.22 -12.60 4.35 3nwu_o02 source 3NWU SERINE PROTEASE HTRA1 : 2 hits 3nwu_o02 naa= 3 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 A 98 SER A 59 SER^? 3.89 CL CL A 305s A 123 HIS A 24 HIS~? 3.26 ZN ZN A 301s A 172 ASP A 78 ASP~? 6.31 CL CL A 305 coo 45.74 29.80 42.79 47.58 31.06 41.64 24.86 2.91 6.28 24.83 4.11 4.27 coo 44.17 25.61 37.60 45.21 25.56 35.81 24.25 11.32 4.20 23.54 9.34 4.43 coo 39.85 24.35 34.94 41.12 25.58 33.83 25.71 9.07 -1.28 24.93 9.58 0.62 3qwd_o00 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o00 naa= 3 ULMN 3 3qwd_o01 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 B 98 SER A 59 SER^? 3.89 CL CL A 305s B 123 HIS A 24 HIS~? 3.26 ZN ZN A 301s B 172 ASP A 78 ASP~? 6.31 CL CL A 305 coo 71.87 39.14 40.71 71.75 41.26 39.36 24.86 2.91 6.28 24.83 4.11 4.27 coo 73.25 34.64 35.72 73.65 35.23 33.78 24.25 11.32 4.20 23.54 9.34 4.43 coo 70.98 30.38 33.77 70.74 32.03 32.50 25.71 9.07 -1.28 24.93 9.58 0.62 3qwd_o01 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o01 naa= 3 ULMN 3 3qwd_o02 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 C 98 SER A 59 SER^? 3.89 CL CL A 305s C 123 HIS A 24 HIS~? 3.26 ZN ZN A 301s C 172 ASP A 78 ASP~? 6.31 CL CL A 305 coo 80.36 64.80 34.44 78.44 65.95 33.29 24.86 2.91 6.28 24.83 4.11 4.27 coo 83.70 62.42 29.01 83.15 62.88 27.08 24.25 11.32 4.20 23.54 9.34 4.43 coo 85.17 57.73 27.21 83.46 58.45 26.25 25.71 9.07 -1.28 24.93 9.58 0.62 3qwd_o02 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o02 naa= 3 ULMN 3 3qwd_o03 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 D 98 SER A 59 SER^? 3.89 CL CL A 305s D 123 HIS A 24 HIS~? 3.26 ZN ZN A 301s D 172 ASP A 78 ASP~? 6.31 CL CL A 305 coo 65.12 87.33 28.49 62.90 86.32 27.74 24.86 2.91 6.28 24.83 4.11 4.27 coo 67.96 87.91 22.28 66.90 87.63 20.52 24.25 11.32 4.20 23.54 9.34 4.43 coo 72.12 85.84 19.92 70.35 84.94 19.30 25.71 9.07 -1.28 24.93 9.58 0.62 3qwd_o03 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o03 naa= 3 ULMN 3 3qwd_o04 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 E 98 SER A 59 SER^? 3.89 CL CL A 305s E 123 HIS A 24 HIS~? 3.26 ZN ZN A 301s E 172 ASP A 78 ASP~? 6.31 CL CL A 305 coo 37.23 89.57 27.33 36.32 87.23 27.07 24.86 2.91 6.28 24.83 4.11 4.27 coo 37.64 91.40 20.82 36.88 90.22 19.31 24.25 11.32 4.20 23.54 9.34 4.43 coo 41.40 92.80 17.47 40.89 90.79 17.30 25.71 9.07 -1.28 24.93 9.58 0.62 3qwd_o04 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o04 naa= 3 ULMN 3 3qwd_o05 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 F 98 SER A 59 SER^? 3.89 CL CL A 305s F 123 HIS A 24 HIS~? 3.26 ZN ZN A 301s F 172 ASP A 78 ASP~? 6.31 CL CL A 305 coo 17.74 70.20 32.16 18.92 67.99 31.89 24.86 2.91 6.28 24.83 4.11 4.27 coo 15.23 70.97 25.89 15.37 69.49 24.46 24.25 11.32 4.20 23.54 9.34 4.43 coo 15.81 74.47 22.06 16.86 72.70 21.69 25.71 9.07 -1.28 24.93 9.58 0.62 3qwd_o05 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o05 naa= 3 ULMN 3 3qwd_o06 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 G 98 SER A 59 SER^? 3.89 CL CL A 305s G 123 HIS A 24 HIS~? 3.26 ZN ZN A 301s G 172 ASP A 78 ASP~? 6.31 CL CL A 305 coo 21.77 43.27 39.21 24.15 42.72 38.52 24.86 2.91 6.28 24.83 4.11 4.27 coo 18.42 41.13 33.64 19.33 40.10 32.10 24.25 11.32 4.20 23.54 9.34 4.43 coo 15.38 43.36 30.02 17.34 43.09 29.34 25.71 9.07 -1.28 24.93 9.58 0.62 3qwd_o06 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o06 naa= 3 ULMN 3 3qwd_o07 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 H 98 SER A 59 SER^? 3.89 CL CL A 305s H 123 HIS A 24 HIS~? 3.26 ZN ZN A 301s H 172 ASP A 78 ASP~? 6.31 CL CL A 305 coo 156.20 56.60 78.78 153.83 56.16 78.10 24.86 2.91 6.28 24.83 4.11 4.27 coo 159.24 56.62 72.66 158.17 56.50 70.89 24.25 11.32 4.20 23.54 9.34 4.43 coo 162.98 53.88 70.28 161.08 53.28 69.65 25.71 9.07 -1.28 24.93 9.58 0.62 3qwd_o07 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o07 naa= 3 ULMN 3 3qwd_o08 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 I 98 SER A 59 SER^? 3.89 CL CL A 305s I 123 HIS A 24 HIS~? 3.26 ZN ZN A 301s I 172 ASP A 78 ASP~? 6.31 CL CL A 305 coo 129.29 63.53 77.27 127.98 61.40 77.00 24.86 2.91 6.28 24.83 4.11 4.27 coo 129.99 65.24 70.73 129.03 64.19 69.22 24.25 11.32 4.20 23.54 9.34 4.43 coo 133.90 66.07 67.39 133.05 64.19 67.15 25.71 9.07 -1.28 24.93 9.58 0.62 3qwd_o08 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o08 naa= 3 ULMN 3 3qwd_o09 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 J 98 SER A 59 SER^? 3.89 CL CL A 305s J 123 HIS A 24 HIS~? 3.26 ZN ZN A 301s J 172 ASP A 78 ASP~? 6.31 CL CL A 305 coo 106.76 47.89 81.70 107.53 45.50 81.44 24.86 2.91 6.28 24.83 4.11 4.27 coo 104.68 49.18 75.33 104.59 47.70 73.89 24.25 11.32 4.20 23.54 9.34 4.43 coo 105.94 52.49 71.50 106.71 50.57 71.17 25.71 9.07 -1.28 24.93 9.58 0.62 3qwd_o09 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o09 naa= 3 ULMN 3 3qwd_o10 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 K 98 SER A 59 SER^? 3.89 CL CL A 305s K 123 HIS A 24 HIS~? 3.26 ZN ZN A 301s K 172 ASP A 78 ASP~? 6.31 CL CL A 305 coo 105.44 20.79 88.82 107.67 19.79 88.18 24.86 2.91 6.28 24.83 4.11 4.27 coo 101.74 19.42 83.14 102.50 18.27 81.61 24.25 11.32 4.20 23.54 9.34 4.43 coo 99.17 22.17 79.49 101.04 21.51 78.80 25.71 9.07 -1.28 24.93 9.58 0.62 3qwd_o10 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o10 naa= 3 ULMN 3 3qwd_o11 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 L 98 SER A 59 SER^? 3.89 CL CL A 305s L 123 HIS A 24 HIS~? 3.26 ZN ZN A 301s L 172 ASP A 78 ASP~? 6.31 CL CL A 305 coo 126.72 3.21 92.89 128.70 4.33 91.79 24.86 2.91 6.28 24.83 4.11 4.27 coo 124.38 -0.64 87.74 125.44 -0.88 85.98 24.25 11.32 4.20 23.54 9.34 4.43 coo 120.03 -1.09 84.87 121.54 -0.11 83.83 25.71 9.07 -1.28 24.93 9.58 0.62 3qwd_o11 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o11 naa= 3 ULMN 3 3qwd_o12 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 M 98 SER A 59 SER^? 3.89 CL CL A 305s M 123 HIS A 24 HIS~? 3.26 ZN ZN A 301s M 172 ASP A 78 ASP~? 6.31 CL CL A 305 coo 154.12 8.07 91.14 154.40 10.16 89.78 24.86 2.91 6.28 24.83 4.11 4.27 coo 154.65 3.37 86.18 155.13 3.88 84.24 24.25 11.32 4.20 23.54 9.34 4.43 coo 151.68 -0.46 84.21 151.70 1.23 82.98 25.71 9.07 -1.28 24.93 9.58 0.62 3qwd_o12 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o12 naa= 3 ULMN 3 3qwd_o13 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 N 98 SER A 59 SER^? 3.89 CL CL A 305s N 123 HIS A 24 HIS~? 3.26 ZN ZN A 301s N 172 ASP A 78 ASP~? 6.31 CL CL A 305 coo 167.14 31.88 84.83 165.46 33.38 83.69 24.86 2.91 6.28 24.83 4.11 4.27 coo 170.00 29.01 79.37 169.53 29.60 77.44 24.25 11.32 4.20 23.54 9.34 4.43 coo 170.55 24.16 77.55 169.03 25.18 76.56 25.71 9.07 -1.28 24.93 9.58 0.62 3qwd_o13 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o13 naa= 3